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Abstract 
 Connexin 26 (Cx26) and Cx30 are the two predominant gap junction 
constituents expressed in the mammalian cochlea. Mutations in either gene cause 
hereditary deafness, indicating an essential role for connexins in auditory function. Gap 
junctions consisting of Cx26 and Cx30 have been implicated in several cochlear 
processes; however, the precise functions and life-cycle of connexins in the cochlea are 
poorly defined. Three aspects of inner ear connexin biology were investigated. 
Most connexins traffic to the plasma membrane (PM) via the conventional 
secretory pathway. Conflicting data exists for Cx26 trafficking, whereas that of Cx30 
had not been previously studied. Trafficking of Cx26 and Cx30 were investigated using 
stably-transfected HeLa cell lines. Treatment with brefeldin-A (a Golgi-disrupting drug) 
did not prevent targeting of Cx30 to the PM, whereas Cx26 was strongly inhibited. 
These data suggest that Cx30 may traffic to the PM via a Golgi-independent pathway, 
which is in contrast to a Golgi-dependent pathway for Cx26. 
 Gap junctional intercellular communication (GJIC) pathways are hypothesised 
to support K
+
 recycling in the cochlea. This study investigated the development of GJIC 
in the lateral wall (LW) of live rat cochlear slices. Cx26 and Cx30 immunofluorescence 
revealed a progressive increase of gap junction expression from postnatal day 0 (P0) to 
P7-P8. Dye-coupling was compartmentalised between P2-P5, but was extensive by P7. 
These data suggest that GJIC matures several days in advance of hearing onset and 
provides anatomical evidence of a putative K
+
-recycling pathway. 
Finally, Cx30
–/–
 mice are deaf and fail to develop an endocochlear potential 
(EP). This study investigated the expression of proteins involved in EP generation and 
found that the potassium channel Kir4.1 was noticeably reduced in the stria vascularis 
(SV) of Cx30
–/–
 mice. In contrast to a separate study, the SV endothelial barrier was 
intact. In addition, anatomical analysis was consistent with loss of Cx30 retarding 
maturation of SV.  
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1 INTRODUCTION 
As many as 3 in 1000 children are born deaf or develop profound hearing loss by 
the age of five years (reviewed by Morton and Nance, 2006) and at least 50-60% of 
these cases are genetically inherited, making hearing impairment the most common 
inherited sensory disorder (Marazita et al., 1993). Around 70% of cases are non-
syndromic (where deafness is the only phenotype) and approximately half of these are 
attributed to recessive mutations in genes that encode “connexin” proteins that form 
“gap junctions” (Denoyelle et al., 1999). In addition, several dominantly inherited 
mutations in human connexin genes cause hearing loss that are also associated with 
other syndromes, such as skin disease (reviewed by Scott and Kelsell, 2011). Despite 
the high frequency of deafness, our understanding of the role of these proteins in the 
normal physiology of the inner ear remains to be clarified. This thesis investigates some 
of the properties and functions of connexins in the mammalian inner ear and discusses 
their potential role in hearing and deafness. This chapter broadly introduces the field of 
gap junctions and gives a general description of what gap junctions are and how they 
are formed. In addition, the general structure and function of the mammalian hearing 
system is introduced as well as the gap junction networks within the inner ear.  
 
1.1 Gap Junctions 
The evolution of multicellular organisms from primitive single-cell structures 
required the development of intercellular communication. Without such development, 
cells would act independently rather than in a cooperative syncytium where it “becomes 
possible to exploit resources that no single cell could utilize so well” (Alberts et al., 
1994). The development of cell-cell communication allows multicellular structures to 
coordinate responses to external stimuli and determine the differentiation and function 
of individual cells as well as more complex tissues and organs in the animal kingdom. 
As well as extracellular signalling, direct intercellular communication is paramount for 
regulating the internal environment of a multicellular organism. This direct 
communication is mediated by gap junctions.     
Gap junctions are clusters of pore-forming transmembrane channels that connect 
the cytoplasm of adjacent cells, providing pathways for the transfer of ions, metabolites 
    19 
and second messengers up to ~1 kDa in molecular mass (reviewed in Bruzzone et al., 
1996; Laird, 2006). Thus, gap junctions permit nutrient transfer between cells, 
metabolic coupling and buffering of ions. Gap junctions have also been implicated in 
the propagation of second messengers such as cAMP, growth regulation, differentiation 
and development in all vertebrate multicellular systems (Goodenough et al., 1996; 
Alexander and Goldberg, 2003; Bruzzone and Dermietzel, 2006).  
1.1.1 Identification of intercellular communication and gap junctions 
The first description of intercellular communication was suggested by Engelmann 
in 1877, who predicted that cardiac cells were in direct contact when alive, but became 
independent as they die – a process termed ‘healing-over’ (as mentioned in Weidmann, 
1952; De Mello, 1983). Evidence of direct intercellular communication was not 
described until the 1950s through electrophysiological studies of Purkinje fibres of the 
mammalian heart (Weidmann, 1952) and motor synapses of the giant crayfish 
(Furshpan and Potter, 1959). Loewenstein (1966) then demonstrated ionic coupling 
between epithelial cells and showed gap junction sensitivity to changes in Ca
2+
 
concentration for the first time. 
Gap junction structures were first identified in thin-section electron micrographs 
(EM) of goldfish Mauthner cell synapses, where they were recognised as closely-
packed, honeycomb-like hexagonal arrays (Robertson, 1963). These structures 
also found in negatively stained plasma membranes from rat liver fractions 
and Emmelot, 1965) (Image deleted due to copyright 
 
 
Figure 1-1A). A subsequent study of mouse heart and liver tissue pre-treated with 
a membrane-impermeable, colloidal form of lanthanum showed electron dense 
material between two closely opposed plasma membranes (Revel and Karnovsky, 
1967). These junctional structures resulted in a very narrow “gap” of ~20 Å (~2 
nm) between membranes (Image deleted due to copyright 
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Figure 1-1B) and led to the eventual term “gap junction”. Confirmation that these 
junctions were composed of hexagonal gap junction units, rather than tight junctions 
was verified using the freeze-fracture technique (Chalcroft and Bullivant, 1970; 
Goodenough and Revel, 1970). In addition to the techniques described, X-ray 
diffraction analysis revealed that the extracellular “gap” between the membranes was 
bridged by two hexameric hemichannels (otherwise known as connexons) that dock 
together to form a complete intercellular channel or gap junction (Makowski et al., 
1977).  
In vertebrates, each hemichannel is composed of six connexin subunits (see below 
for detailed gap junction structure). The discovery that invertebrates also express gap 
junction proteins suggests that the ability for cells to communicate via gap junctions and 
hemichannels is evolutionarily conserved. Invertebrate gap junctions are composed of 
subunits called innexins, which share similar topography, but not sequence homology, 
to connexins (reviewed by Phelan, 2005). In addition, studies in the last decade have 
also identified a separate family of vertebrate proteins that share homology to 
invertebrate innexins, but not connexins. These proteins, called pannexins, are classed 
within the gap junction family of proteins due to their homology to innexins and similar 
topography to innexins and connexins. However, recent data has suggested that 
pannexins function mostly as membrane channels, termed pannexons, rather than 
functional intercellular channels (reviewed by Scemes, 2011; Sosinsky et al., 2011). 
Pannexon channels are suggested to participate in purinergic signalling and calcium-
wave propagation by releasing ATP into the extracellular space. Thus, pannexins may 
be important for migratory patterns, regenerative signals, cell proliferation and 
development  (reviewed by Barbe et al., 2006). 
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Image deleted due to copyright 
 
 
Figure 1-1. Early electron micrographs of gap junction channels. 
(A) Negatively stained rat liver plasma membrane revealing the hexagonal 
configuration of gap junction channels (adapted from Benedetti and Emmelot, 1965). 
(B) A high magnification image of a mouse cardiac gap junction. The intercellular 
space (ics) is reduced to a gap about 20 Å (~2 nm) wide (g) in the junctional area 
(adapted from Revel and Karnovsky, 1967). 
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1.1.2 Connexin nomenclature 
A variety of biochemical techniques developed in the 1970s led to the isolation 
and identification of gap junction constituents (Goodenough and Stoeckenius, 1972; 
Goodenough, 1974), and it was Goodenough (1974) who first proposed the term 
“connexin” as an amalgamation of the words ‘connection’ and ‘nexus’. At the 
molecular level, connexins were first cloned in 1986 (Paul, 1986; Kumar and Gilula, 
1986) and since then, a total of 21 connexin-coding genes have been identified in 
humans and 20 in mice (Willecke et al., 2002) (see Table 1-1). Historically, connexin 
genes were classified according to their phylogenetic homology, which took into 
account genetic structure, sequence homology and matching of specific genetic motifs 
(Kumar and Gilula, 1992). 
 Connexin genes are named with a prefix of Gj (‘Gap Junction’) followed by a 
Greek letter which represents the classification group (α, β, γ, δ, and ε). In addition, a 
number corresponding to the order of identification is also added. For example, 
connexin 43 (Cx43) has the gene name Gja1, indicating that it belongs to the α group of 
connexins and was the first α-connexin gene to be identified. The connexin protein 
name is based on the predicted molecular mass (in kDa) of the connexin (e.g. Cx43 has 
a molecular mass of 43 kDa). To distinguish human connexins from other species, 
connexin genes and proteins are written in upper-case letters, such as CX43 or GJA1, 
compared to Cx43 or Gja1 for other species, including mouse. 
 Nineteen connexins can be grouped as sequence-orthologous pairs between 
humans and mice, however there are connexin genes that occur only in the mouse 
(Cx33) or in the human genome (Cx25 and Cx59). Further complexity in connexin 
nomenclature arises from orthologous connexins that have differing molecular masses. 
For example, Cx57 is the mouse orthologue of human Cx62. In addition, Cx23 is not 
expressed in primates due to a premature stop mutation in the GJE1 gene, yet it is 
highly conserved across other species, including mice. This has led to the presumption 
that the primate GJE1 gene is a non-functional pseudogene (Sonntag et al., 2009). These 
complexities mean that connexin nomenclature has been a matter of debate for some 
time (Sohl and Willecke, 2003; Kidder, 2009). The current classification of all known 
mammalian connexins is summarised in Table 1-1. 
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Table 1-1. Nomenclature of mouse and human connexins.  
Information is organised so that corresponding orthologues are aligned in the same row. 
There are five main connexin families: alpha (Gja), beta (Gjb), gamma (Gjc), delta 
(Gjd) and epsilon (Gje). Genes in brackets indicate previously assigned gene names. 
Missing gene numbers have been assigned to other species that do not have orthologues 
in the mouse or human genomes. For example Gja2 codes for Cx38 in Xenopus laevis. 
Data adapted from Beyer and Berthoud (2009) and from the HUGO Gene Nomenclature 
Committee website (http://www.genenames.org/genefamilies/GJ, accessed August 
2011). 
Mouse Connexins Human Connexins 
Protein Gene Protein Gene 
Cx43 
Cx46 
Cx37 
Cx40 
Cx33 
Cx50 
- 
Cx57 
 
Cx32 
Cx26 
Cx31 
Cx30.3 
Cx31.1 
Cx30 
- 
 
Cx45 
Cx47 
Cx29 
 
Cx36 
Cx30.2 
Cx39 
 
Cx23 
Gja1 
Gja3 
Gja4 
Gja5 
Gja6 
Gja8 
- 
Gja10 
 
Gjb1 
Gjb2 
Gjb3 
Gjb4 
Gjb5 
Gjb6 
- 
 
Gjc1 
Gjc2 
Gjc3 
 
Gjd2 
Gjd3 
Gjd4 
 
Gje1 
CX43 
CX46 
CX37 
CX40 
- 
CX50 
CX59 
CX62 
 
CX32 
CX26 
CX31 
CX30.3 
CX31.1 
CX30 
CX25 
 
CX45 
CX47 
CX30.2/CX31.3 
 
CX36 
CX31.9 
CX40.1 
 
CX23 
GJA1 
GJA3 
GJA4 
GJA5 
- 
GJA8 
GJA9 (GJA10) 
GJA10 
 
GJB1 
GJB2 
GJB3 
GJB4 
GJB5 
GJB6 
GJB7 
 
GJC1 (GJA7) 
GJC2 (GJC12) 
GJC3 (GJE1) 
 
GJD2 (GJA9) 
GJD3 (GJC1) 
GJD4 
 
GJE1 
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1.1.3 Structure of gap junctions 
A model of the topological structure of the liver connexin (later identified as 
Cx32) was first demonstrated by Zimmer et al. (1987) using a combination of 
proteolytic digestion and site-directed antibodies. This model is thought to be consistent 
across all members of the connexin family. Each connexin spans the membrane four 
times forming four transmembrane domains (M1-M4), which are connected by two 
extracellular loops (E1, E2). On the cytoplasmic side of the membrane, one cytoplasmic 
loop (CL), an amino-terminus (NT) and a carboxyl-terminus (CT) complete the 
connexin structure (Figure 1-2). 
 
 
 
 
 
 
 
 
The four transmembrane domains, the two extracellular loops and the amino-
terminus are the most conserved regions between connexins, as determined by sequence 
analysis. In particular, E1 and E2 are amongst the most conserved regions, with each 
loop containing three cysteine residues (see Figure 1-2) separated by a set number of 
amino acids. E1 contains C-X6-C-X3-C and E2 contains C-X4-C-X5-C sequence motifs. 
The only exceptions to these rules are for Cx31, which contains a C-X5-C-X5-C motif in 
E2, and Cx23, which has only two cysteines in E1 and E2. The CL and CT domains 
have highly divergent amino acid (aa) sequences, with the CT having the greatest 
variability between connexins. Changes in the length of the CT are responsible for most 
differences in molecular mass and can vary drastically from 10 to 12 aa in Cx26, 
Cx30.3 and Cx31.1 to more than 310 aa in CX59 and CX62 (reviewed in Beyer and 
Berthoud, 2009). 
Figure 1-2. Connexin membrane topology. 
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Each connexin oligomerises with five other connexins to form a hexameric 
connexon (hemichannel). Adjacent cells each provide one hemichannel that dock 
together at closely associated apposing cell membranes to form an intercellular channel 
or gap junction (Image (C) deleted due to copyright 
 
Figure 1-3A). Docking of opposing connexons is determined by the extracellular 
loops, with E2 influencing whether two connexons are compatible (White et al., 
1995). The highly conserved cysteine residues form disulphide bonds between the 
extracellular loops (John and Revel, 1991) and are essential for the functioning of 
channel (Dahl et al., 1992). Connexons can be homomeric, consisting of only one 
connexin subtype; or heteromeric, consisting of more than one connexin type 
(Image (C) deleted due to copyright 
 
Figure 1-3B). Likewise, gap junctions can be homotypic, with each connexon 
containing six identical connexins; or heterotypic, containing different connexons with 
varying composition and/or stoichiometry. The compatibility of different homomeric 
connexons to form heterotypic channels likely depends on specific motifs in the 
extracellular loops (reviewed by Koval, 2006). 
The initial higher-order structure of gap junctions was first revealed by analysis of 
2D crystals at 19Å resolution (Unwin and Ennis, 1984). Since then, advances in 
techniques used to detect high-resolution structures, such as atomic force 
and electron crystallography, have led to a great increase in knowledge of how 
hemichannels dock together and how the spatial resolution of single amino acids 
regulate gap junction permeability. Both techniques have revealed that the 
loops of a connexon form six alternating ‘peaks and valleys’ (Image (C) deleted 
due to copyright 
 
Figure 1-3C) (Perkins et al., 1998). After a 30
o
 rotation, the peaks of one connexon 
fit into the valleys of the apposed connexon by a predicted “lock and key” 
mechanism, thus forming a tightly sealed channel (Image (C) deleted due to 
copyright 
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Figure 1-3D) (Hoh et al., 1993; Perkins et al., 1998). Further analysis has revealed 
a 3-dimensional model of a C-terminally truncated Cx43 channel at 7.5Å using cryo-
electron-microscopy (Unger et al., 1999). More recently, the crystal structure of a Cx26 
gap junction at 3.5Å resolution has been reported (Maeda et al., 2009). The authors 
propose that Cx26 gap junctions have a narrow funnel leading from the cytoplasmic 
entrance to the transmembrane pore. The funnel is regulated by conformational changes 
in the N-terminal regions of connexin subunits, and thus determines the molecular size 
restriction at the channel entrance. The conformational changes in the Cx26 N-termini 
are predicted to play a role in the gating of the channel by transjunctional voltage. 
 
 
 
  
Image (C) deleted due to copyright 
 
Figure 1-3. Structure of gap junction channels.  
(A) A single connexin binds to five other connexins to form a hexameric connexon or 
hemichannel. Two connexons dock together to form an intercellular channel. (B) 
Intercellular channels bridge the 2 nm gap of extracellular space (ES) between two 
opposing plasma membranes (PM1, PM2). Thus, the intercellular channels are referred 
to as gap junctions (GJ), which can contain more than one connexin and a range of 
different hemichannel and gap junction configurations. (C) Computer reconstruction of 
a connexon, revealing the peaks and valleys on the extracellular surface. (D) A gap 
junction model of two docked connexons showing a tight seal between the peaks and 
valleys after a 30
o
 rotation. Images (C) and (D) were adapted from Perkins et al., 1998. 
A 
B 
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1.1.4 Gap junction expression and disease 
Connexin expression and gap junctional intercellular communication (GJIC) 
exists in almost all mammalian cell types (reviewed by Saez et al., 2003; Laird, 2006). 
Cx43 has been detected in at least 35 distinct tissues and cells types, making it the most 
prevalent connexin subtype expressed in mammals (reviewed by Laird, 2006). In 
addition, many cells and/or tissues express more than one connexin, for example 
keratinocyte populations can express up to 10 different connexin isoforms (Di et al., 
2001). These expression patterns allow for inter-mixing of connexins within family 
subgroups, and therefore, can lead to a large number of different gap junction 
configurations. This property allows gap junctions with different configurations to 
regulate certain properties, such as permeability, and confer sensitivities to changes in 
cellular cues, such as pH, voltage-gating and Ca
2+
 signalling (reviewed by Harris, 
2001). In addition, over-lapping connexin expression could represent an evolutionary 
compensatory mechanism for the loss or mutation of a particular connexin, although 
this is not always the case, since some mutations can exert dominant-negative effects or 
develop a pathological gain-of-function (reviewed by Laird, 2006). 
Mutations in connexin genes account for many inherited diseases, ranging from 
deafness to neuropathies, skin disease, cataracts and oculodentodigital dysplasia, the 
inheritance of which can be autosomal dominant, autosomal recessive or X-linked 
(reviewed by White and Paul, 1999; Beyer and Berthoud, 2009). Connexin mutants can 
confer disease through a variety of defects, including faulty protein folding and 
oligomerisation, trafficking defects, ER-associated cell death, aberrant hemichannel 
activity and non-functional channels. The first condition connected to a mutation in a 
connexin gene was that of the X-linked form of Charcot-Marie-Tooth disease (CMTX). 
The mutation was mapped to the X-chromosome region where the CX32 gene, GJB1, 
resides and was subsequently confirmed by direct sequencing (Bergoffen et al., 1993). 
More than 200 mutations associated with CMTX have since been identified in the GJB1 
gene, which cause a progressive neuropathy resulting in the degeneration of peripheral 
nerves.  
More than 20 dominant mutations in the GJA1 gene (codes for CX43) are 
associated with oculodentodigital dysplasia. This disease causes craniofacial 
abnormalities and malformations of fingers and teeth, as well as cardiac abnormalities 
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(reviewed by Paznekas et al., 2009). Other diseases linked to connexin mutations 
include cataracts, which are formed by precipitation of crystallins within the lens fibre 
cells. Cx46 and Cx50 are essential for lens homeostasis and mouse models with gene 
deletions form cataracts (reviewed by Mathias et al., 2010). 
Connexin diseases can also be caused by more than one connexin isoform and can 
affect more than one system. For example, mutations in GJB2 (Cx26), GJB3 (Cx31), 
GJB4 (Cx30.3) and GJB6 (Cx30) can cause hearing loss (non-syndromic), skin disease, 
or hearing loss with skin disease (syndromic). Some of these mutations are described in 
further detail in chapter 5, and reviewed by Scott and Kelsell (2011). 
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1.2 The Mammalian Inner Ear 
1.2.1 General structure of the inner ear 
The ear is comprised of three compartments, namely the outer, middle and inner 
ear. The outer ear, including the pinna and the external auditory canal, is 
focusing acoustic energy towards the tympanic membrane (ear drum). Vibrations 
tympanic membrane are relayed to the connecting malleus, incus, and stapes, 
together form the middle ear ossicular chain. These bones, the smallest bones in 
body, amplify and transmit sound energy from the air-filled outer/middle ear to 
fluid-filled inner ear via the oval window (Images deleted due to copyright 
 
 
 
 
 
Figure 1-4A).   
 The inner ear is a complex structure and consists of two sensory systems: the 
cochlea for hearing and the vestibular system for balance. In humans and higher 
primates, the structure is encased within the petrous portion of the temporal bone, the 
hardest bone in the body, and consists of a series of interconnected bony labyrinthine 
channels. In other mammals, the inner ear is contained within an easily-accessible 
auditory bulla (Forge and Wright, 2002). The bony labyrinth is filled with a fluid called 
perilymph, the composition of which is similar to other extracellular fluids (low in K
+
 
ions, high in Na
+
 ions). Within the bony channels, and enclosed in perilymph, is a 
membranous, epithelial labyrinth. These epithelial tubes are filled with a fluid called 
endolymph, whose unusual composition more closely resembles that of intracellular 
fluid (high in K
+
 ions, low in Na
+
 ions). A more detailed description of these fluids can 
be found in chapter 4. 
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Images deleted due to copyright 
 
 
 
 
 
Figure 1-4. Structure of the human ear. 
(A) Anatomical diagram indicating the location and components of the outer (green), 
middle (blue/red) and inner (purple/yellow) ears in humans. Image adapted from 
Chittka and Brockmann, 2005. (B) A diagram of a cross-section through the human 
inner ear. The white spaces of the bony labyrinth are filled with perilymphatic fluid, 
whereas the grey-shaded membranous labyrinths are filled with endolymphatic fluid. 
The six sensory epithelia are shaded in black. (C) Cross-section of a slice through the 
cochlear duct (red box). The sensory epithelia (organ of Corti), ion transporting 
epithelia (stria vascularis) and less specialised epithelia (Reissner’s membrane) lining 
the endolymphatic duct (scala media) are labelled. Images (B) and (C) adapted from 
Forge and Wright, 2002. 
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Three types of epithelium line the endolymphatic compartment: sensory epithelia, 
ion-transporting epithelia and relatively non-specialised epithelia. The mammalian 
ear uses six sensory epithelia to detect sound and head motion (Images deleted due 
to copyright 
 
 
 
 
 
Figure 1-4B, C). The organ of Corti in the cochlear duct detects sound, cristae of 
the three semi-circular canals detect angular acceleration, and maculae of saccule and 
utricle detect linear acceleration and head tilt. Each sensory epithelium contains a highly 
ordered array of polarised mechanosensory hair cells. Each hair cell is surrounded and 
isolated from other hair cells by non-sensory supporting cells. This organisation requires 
exquisite developmental precision, described as “one of the most remarkable displays of 
precision micro-engineering in the vertebrate body” (Swanson et al., 1990). The apical 
surfaces between these cells are joined by tight junctions to form the reticular lamina, 
which acts as a diffusion barrier to prevent mixing of endolymphatic and perilymphatic 
fluids (reviewed by Raphael and Altschuler, 2003). 
1.2.2 Sensory epithelium and mechanoelectrical transduction 
Hair cells are the mechanosensory transducers of the inner ear, of which there are 
four types: inner hair cells (IHCs) and outer hair cells (OHCs) in the cochlear 
Corti, and type I and type II hair cells in the vestibular sensory epithelia. This 
will focus primarily on the cochlear sensory epithelium (organ of Corti), which 
of one row of IHCs and three rows of OHCs (see Image deleted due to copyright. 
 
 
 
Figure 1-5).  
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Hair cells are named as such due to the actin-rich stereocilial bundles located at 
their apical surface. The individual cilia are arranged in rows of graded heights, 
resembling a staircase pattern (Lin et al., 2005). Between each row of stereocilia are a 
number of fibrillar extracellular cross-links. Numerous lateral and ankle links join the 
shafts of adjacent stereocilia, whereas a single filament, termed the tip link, stretches 
from the tip of the shorter stereocilium to the lateral membrane of the neighbouring, 
taller stereocilium (reviewed by Gillespie et al., 2005). First identified by Pickles in 
1984, tip links are thought to interact with and directly open the mechanoelectrical 
transduction (MET) channel on the shorter stereocilia, when stretched (Pickles et al., 
1984; Beurg et al., 2009). This mechanism is aided by an acellular matrix that sits atop 
the stereocilia of hair cells (except IHCs). This structure is known as the tectorial 
membrane in the organ of Corti; the otoconial membrane in the maculae; and the cupula 
in the cristae. The matrix provides a stable structure, which, upon sound stimulation or 
head movement, accentuates the displacement of the hair bundles towards the taller 
stereocilia.  
The organ of Corti lies upon a resonant structure called the basilar membrane 
(BM). This structure is important for spatially dispersing sound waves to separate 
frequencies along the length of the cochlea. The mass and stiffness properties of the BM 
vary along a base-to-apex gradient: the BM is stiff and low in mass at the basal end of 
the cochlear coil and is therefore sensitive to high resonant frequencies, whereas at the 
apical end of the coil the BM is less stiff and high in mass, allowing for low frequency 
sensitivity. According to the place theory, sound-induced deflections of the basilar 
membrane cause vibrations of hair cells at particular tonotopic regions. This causes hair 
bundle deflection towards the taller sterocilia and forces the tip links to stretch and the 
cation-selective MET channels to open. The open state causes an influx of K
+
 ions from 
endolymph into hair cells. This process is driven primarily by a high potential, the 
endocochlear potential (EP), in the scala media, which is +80 to +100 mV more positive 
in respect to perilymph (von Békésy, 1952). This unusually high potential is generated 
and maintained by the ion-transporting epithelium, the stria vascularis (see next 
section), and depends on tight junctions that electrically isolate endolymph from 
perilymph (reviewed in Hibino et al., 2010). The potential difference of ~140 mV 
between endolymph and the resting potential of a cochlear hair cell (~-60 mV) accounts 
for the driving force of K
+
 entry, irrespective of the K
+
 concentration. Therefore, the EP 
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is essential for hearing. A more detailed description of the EP is described in results 
chapter 4. It is of note to point out that the EP driving force for K
+
 entry into hair cells 
only occurs in the organ of Corti, since an equivalent high potential is not present in the 
vestibular organ. 
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Image deleted due to copyright. 
 
 
 
Figure 1-5. Illustration of the sensory epithelium of the mammalian inner ear. 
The schematic shows the inner (IHC) and outer hair cells (OHCs) of the organ of Corti, 
surrounded by various supporting cells, including Deiters’, Hensen’s and Claudius cells. 
The tips of OHCs are usually embedded in the tectorial membrane. The apical surfaces 
of hair cells and supporting cells are bathed in endolymph that fills the scala media. 
Image modified from Raphael and Altschuler, 2003  (originally derived from Retzius, 
1884). 
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Within the organ of Corti, IHCs receive ~95% of the afferent neurons (Spoendlin, 
1972) and so are classed as the true sensory receptors of the cochlea. During sound 
stimulation, influx of K
+
 ions through the MET channel causes IHC depolarisation and 
the opening of voltage-sensitive Ca
2+
 channels. The increase in intracellular Ca
2+
 then 
triggers the release of the neurotransmitter glutamate at the basal end of the IHC. 
Afferent auditory neurons, which surround the basal pole of hair cells, are then activated 
and relay action potentials to the auditory cortex. Conversely, the MET channels close 
when the stereocilia are angled in the opposite direction (towards the smallest 
stereocilia), which allows the cells to hyperpolarise and thus suppresses 
neurotransmitter release. IHCs are therefore described as mechanoelectrical transducers, 
converting mechanical sound stimuli into electrical nerve impulses. The transduction 
process in hair cells has been reviewed in detail by Fettiplace and Ricci, 2006.  
In contrast, OHCs are innervated mostly by efferent neurons that do not convey 
electrical signals to the brain. Rather than transmitting acoustic information, OHCs have 
been implicated in the amplification of sound through the contraction and relaxation of 
their lateral membranes in response to K
+
-induced voltage changes. This phenomenon 
occurs via the motor protein prestin, and is assumed to play a primary role in the 
“cochlear amplifier” effect (Ashmore, 1987; Liberman et al., 2002). These electromotile 
responses are thought to provide an active feedback to the basilar membrane, thus 
enhancing the sensitivity of IHCs at specific frequencies. The activity of prestin in 
OHCs has been shown to amplify sound by as much as 40-65 dB (Liberman et al., 
2002). Thus, OHC amplification establishes the high frequency tuning and 
discrimination of the cochlea (Geleoc and Holt, 2003). The energy for the cochlear 
amplifier is provided by the EP, and therefore, loss of EP results in reduced 
functionality of OHCs and hearing impairment (Ruggero and Rich, 1991). 
1.2.3 Ion transporting epithelium 
The stria vascularis (SV) of the cochlea and the dark cell regions of the vestibular 
vestibular system constitute the ion transporting epithelia of the inner ear. The SV 
the upper boundary between the spiral ligament and scala media (Images deleted 
due to copyright 
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Figure 1-4) and functions mainly to generate and maintain the high 
endolymphatic K
+
 concentration and EP (as reviewed by Hibino and Kurachi, 2006; 
Zdebik et al., 2009). Therefore, the SV unit can be described as a remote power source 
supplying the energy required for the mammalian cochlear amplifier (Zdebik et al., 
2009). To perform this task, a rich blood supply is required, and is achieved by 
encompassing a network of thin capillaries between two epithelial sheets, hence the 
term “stria vascularis”. The SV is composed of three cell layers: marginal cells which 
face the endolymphatic compartment, basal cells which face the spiral ligament, and 
intermediate cells, which are connected to basal cells and protrude through the 
intrastrial space (Image deleted due to copyright. 
 
 
 
 
 
Figure 1-6). Tight junctions between marginal cells, between basal cells and 
between endothelial cells enclose the intrastrial space and electrically isolate the SV 
compartment from endolymph, perilymph and the lumen of blood capillaries (Souter 
and Forge, 1998). This feature is essential for generating and maintaining the EP.  
The vestibular dark cells form a single layer on top of pigmented cells at the base 
of each crista and around the utricular macula. There is no dark cell region in the 
saccule (Forge and Wright, 2002). Dark cells function in an almost identical way to 
marginal cells in that both cell types are primarily involved in K
+
 secretion into 
endolymph. However, in contrast to the cochlea, the ion-transporting epithelia of the 
vestibular system consist only of a single layer of dark cells. The specialised cells, 
namely basal and intermediate cells important for generating the EP in the cochlea, are 
absent in the vestibular epithelia. As a result, the potential of the vestibular endolymph 
    37 
is on the order of only a few millivolts, yet the K
+
 concentration remains around 150 
mM.  
The development of SV and generation of EP is described in more detail in 
chapter 4, but is introduced briefly here. In rodents such as mice and rats, the 
endolymphatic K
+
 concentration (~150 mM) is established 6-7 days after birth (DAB). 
Concomitantly, the onset of EP occurs from 7-8 DAB, which continues to rise until 
maturation (+80 to +90 mV) around 16 DAB (Bosher and Warren, 1971). Marginal 
cells express ion transporters from birth (i.e. before the EP is detected) suggesting that 
these cells are primarily concerned with active K
+
 transport rather than EP generation 
(Image deleted due to copyright. 
 
 
 
 
 
Figure 1-6). The latter is attributed to maturation of intermediate cells and 
formation of tight junctions between basal cells (Souter and Forge, 1998). Intermediate 
cells are melanocytes (contain melanin pigment) that are derived from the neural crest 
and are entirely enclosed within the SV compartment. They are connected to basal cells 
through gap junctions and have extensive cellular processes that wrap around capillaries 
and inter-twine with those of marginal cell infoldings. Due to the expression of melanin 
and an inwardly-rectifying K
+
 channel called Kir4.1 (KCNJ10), intermediate cells are 
proposed to have two roles in the SV. Firstly, the presence of melanin and enzymes 
involved in detoxifying oxidative waste suggest that intermediate cells are important for 
protecting the SV under conditions of stress (Spector and Carr, 1979). Secondly, the 
expression of Kir4.1 is essential for K
+
 diffusion into the intrastrial space and for the 
generation of the EP (Ando and Takeuchi, 1999). The loss of intermediate cells and/or 
Kir4.1 channels causes deafness and highlights the essential role of these cells in 
cochlear physiology (Steel and Barkway, 1989; Marcus et al., 2002).  
Basal cells are flat and elongated and constitute the basal layer of the SV. During 
development, basal cells are derived from mesenchymal cells that also form the spiral 
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ligament. Formation of a tight junction barrier between basal cells isolates the intrastrial 
space from perilymph of the spiral ligament. This process coincides with and is essential 
for the onset and rise of EP (Souter and Forge, 1998). Transgenic mice with a knock-out 
of the basal cell tight junction protein, claudin-11, do not develop a tight junction 
barrier, nor do they generate an EP (Gow et al., 2004; Kitajiri et al., 2004), suggesting 
that basal cells, as well as intermediate cells, are vital for SV function. Gap junctions are 
found in large numbers between adjacent basal cells, basal and intermediate cells and 
basal cells and fibrocytes in the spiral ligament (Forge, 1984). Gap junctions allow 
transcellular transport into the SV, whereas tight junctions prevent paracellular flow of 
perilymph into the SV. Thus, basal cells form a cell-permeable partition between 
intermediate cells and fibrocytes. This is proposed to allow cycling of K
+
 ions from the 
spiral ligament to marginal cells, whilst also electrically isolating the compartment from 
perilymph (Kikuchi et al., 2000). 
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Image deleted due to copyright. 
 
 
 
 
 
Figure 1-6. Schematic diagram of the ion transporting epithelium  
Inset, a transverse section through the cochlear duct. Blood vessels are represented in 
red. The stria is a highly vascularised tissue composed of numerous branched 
capillaries. Large diagram, the stria vascularis is a stratified epithelium consisting of 
three layers: marginal cells (M), intermediate cells (I) and basal cells (B). The apical 
surfaces of marginal cells face scala media and pump K
+
 into endolymph via 
KCNQ1/E1 channels. Their basolateral membranes in contrast siphon K
+
 from the 
intracellular space via Na
+
,K
+
-ATPase and Na
+
,K
+
,2Cl
-
 transporters. Intermediate cells 
express the inwardly-rectifying K
+
 channel Kir4.1 (KCNJ10) and provide the K
+
 for 
marginal cells. Basal cells line the spiral ligament and are connected to fibrocytes (F) 
and intermediate cells via gap junctions (double bars). The intrastrial space is filled with 
capillaries and processes emanating from marginal and intermediate cells. Tight 
junctions (black boxes) seal the SV compartment from endolymph and perilymph at the 
marginal and basal cell layers. K
+
 concentration and electric potential are indicated for 
perilymph (taken as reference), intrastrial space and endolymph. The EP is generated 
across the basal and intermediate cell layers. Ion transporters are indicated by arrows. 
Image adapted from Cohen-Salmon et al., 2007. 
    40 
1.3 Gap junctions in the mammalian inner ear 
The majority of cells within the auditory and vestibular organs of vertebrates are 
extensively coupled by numerous and often large (more than 100,000 channels per 
plaque) gap junctions (Forge et al., 2003a). Evidence of these gap junctions first arose 
in the 1970s using the freeze-fracture technique. Supporting cells of the organ of Corti 
(Jahnke, 1975; Gulley and Reese, 1976; Iurato et al., 1976; Tachibana and Morioka, 
1976), supporting cells of the maculae (Jahnke, 1975; Laciano et al., 1977), and cells of 
the spiral ligament and SV (Jahnke, 1975; Reale et al., 1975) were all discovered to 
contain gap junction plaques.  
1.3.1 Gap junction networks  
Based on immunohistochemical and ultrastructural analysis, two gap junction 
networks – the epithelial gap junction network and the connective tissue gap junction 
network – have been described within the mammalian cochlear duct (Kikuchi et al., 
1995) and vestibular system (Kikuchi et al., 1994). The cochlear epithelial gap junction 
network consists of gap junctions between non-sensory epithelial cells, including 
interdental cells, inner sulcus cells, organ of Corti supporting cells, outer sulcus cells 
and root cells projecting into the spiral ligament (Kikuchi et al., 1995; Forge et al., 
2003a) (Figure 1-7). In recent dye-transfer studies, it has been proposed that the mature 
epithelial gap junction network segregates into two directional pathways, separated by 
inner and outer pillar cells (Jagger and Forge, 2006). The lateral pathway connects outer 
pillar cells and OHC supporting cells with the outer sulcus. Whereas the medial 
pathway connects inner pillar cells, IHC supporting cells, and cells of the inner sulcus. 
No gap junctions have been identified between hair cells and supporting cells, as 
confirmed by electron microscopy, electrophysiology and dye transfer studies (Gulley 
and Reese, 1976; Santos-Sacchi and Dallos, 1983; Jagger and Forge, 2006). The 
connective tissue gap junction network consists of fibrocytes within the spiral ligament 
and spiral limbus, basal cells and intermediate cells of the SV and mesenchymal cells 
that line the scala vestibuli. No gap junctions have been identified between marginal 
cells or between marginal cells and intermediate cells, suggesting that, like hair cells, 
marginal cells are isolated from the gap junction syncytium (Kikuchi et al., 1995).  
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1.3.2 Connexin expression 
In the mammalian inner ear, a variety of connexin subtypes have been detected 
by RT-PCR, cDNA macroarray and immunohistochemistry. In one study, the RNA 
transcription levels of 16 different connexin isoforms was quantified from mouse 
cochleae (Ahmad et al., 2003). Only Cx26, Cx29, Cx30 and Cx43 were consistently 
detected, and Cx31 occasionally detected in cochlear tissue, as also confirmed (except 
for Cx29) by Forge et al. (2003a). A recent study has reported the expression of Cx30.3 
in the rat cochlea (Wang et al., 2010). However, Cx30.3 mRNA has not been detected in 
other studies (Forge et al., 2003a) and Cx30.3-null mice do not suffer any degree of 
hearing loss (Zheng-Fischhofer et al., 2007), suggesting that this connexin may not be 
essential for cochlear function. Cx31 has been detected in fibrocytes of the spiral 
ligament and spiral limbus, the expression of which increases with age, but decreases 
from base to apex (Xia et al., 2000; Forge et al., 2003a). Like Cx30.3-null mice, those 
with a deletion of the Cx31 gene, Gjb3, do not exhibit any degree of hearing loss (Plum 
et al., 2001). This suggests that other connexins in the cochlea can compensate for the 
loss of Cx30.3 and Cx31. However, human mutations of both Cx30.3 (Lopez-Bigas et 
al., 2002) and Cx31 (Xia et al., 1998; Kelsell et al., 2000) have been shown to cause 
hearing loss and/or skin disease, suggesting a dominant-negative or gain-of-function 
effect. In the mouse cochlea, Cx29 expression has been confirmed in myelinating 
cochlear Schwann cells and is important for the survival of spiral ganglion neurons 
(Tang et al., 2006; Eiberger et al., 2006). Weak Cx43 expression has been detected in 
the non-sensory epithelia, fibrocytes and stria vascularis with variable results 
(Lautermann et al., 1998; Liu et al., 2001; Suzuki et al., 2003). In contrast, Cx43 has not 
been detected in the organ of Corti of mice and is instead confined to the cells lining the 
inside of the bony wall (most likely type III fibrocytes) and the bone of the otic capsule 
(Forge et al., 2003a; Cohen-Salmon et al., 2004). A reporter gene approach has also 
identified Cx45 expression in the vasculature of the murine cochlea (Cohen-Salmon et 
al., 2004). 
The two predominant connexin isoforms expressed in the cochlea and the 
vestibular system are Cx26 and Cx30, which are found in almost all cells comprising 
the epithelial and connective tissue gap junction systems (Kikuchi et al., 1994; Kikuchi 
et al., 1995; Lautermann et al., 1998; Ahmad et al., 2003; Forge et al., 2003a; Sun et al., 
2005). In addition, many of the gap junction plaques reveal co-localisation patterns for 
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Cx26 and Cx30 (see Figure 1-8), suggesting that gap junctions might form 
heteromeric/heterotypic configurations (Lautermann et al., 1998; Forge et al., 2003a). 
This has since been confirmed by co-immunoprecipitation (Ahmad et al., 2003; Forge et 
al., 2003b; Yum et al., 2007) and electrophysiology (Zhao and Santos-Sacchi, 2000). 
Despite these findings, there is strong evidence to suggest that not all gap junctions are 
homogenous in the cochlea. For example, in the mature cochlea, Cx30 expression 
appears upregulated in Deiters’ cells compared with Cx26 expression (Sun et al., 2005, 
Figure 1-8). In addition, electrophysiological and dye-transfer studies have led to the 
prediction that Cx26 and Cx30 are differentially distributed between supporting cells, 
which may lead to asymmetric coupling and formation of separate communication 
compartments (Zhao and Santos-Sacchi, 2000; Jagger and Forge, 2006). 
1.3.3 Function of inner ear gap junctions 
The arrangement of gap junctions into the epithelial and connective tissue gap 
junction networks has prompted the idea that gap junctions provide a route for K
+
 
recirculation from the hair cell vicinity to endolymph. This mechanism is described 
briefly, but has been reviewed extensively elsewhere (Kikuchi et al., 2000; 
Wangemann, 2002; Wangemann, 2006; Hibino and Kurachi, 2006; Zhao et al., 2006). 
The model suggests that K
+
 ions released from hair cells during the mechanosensory 
transduction process are immediately siphoned by surrounding supporting cells to 
prevent continuous hair cell depolarisation. From here the ions are transported through 
the epithelial gap junction network to the outer sulcus. Potassium channels in the root 
processes are then predicted to secrete K
+
 into the extracellular space of the lateral wall 
(Jagger et al., 2010). From here, K
+
 ions enter the connective tissue gap junction 
network and diffuse through the syncytium where they are released by intermediate 
cells into the intrastrial space. The extracellular K
+
 ions are siphoned by marginal cells 
and then secreted back into endolymph, thus completing the K
+
 recycling pathway. The 
process of K
+
 ion movement through the connective tissue gap junction network to 
intermediate cells is hypothesised to be crucial for the generation and maintenance of 
EP. This model is based primarily on indirect evidence from protein expression data and 
requires technological advances to conclusively prove a role for connexins in K
+
 
recycling. 
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Images deleted due to copyright.  
Figure 1-7. Schematic diagram of the two gap junction networks within the 
mammalian cochlea. 
The epithelial gap junction network (grey shaded cells) and the connective tissue gap 
junction network (black cells) are indicated. The connective tissue gap junction network 
can be sub-divided into lateral and medial regions, connected by mesenchymal cells 
lining the scala vestibuli. Image adapted from Kikuchi et al., 1995. 
 Figure 1-8. Co-expression study of Cx26 and Cx30 in the mammalian cochlea. 
An illustration annotated with confocal images from various cochlear regions showing 
Cx26 (red) and Cx30 (green) immunolabelling. Numbers give the percentage of gap 
junction plaques that have Cx26 and Cx30 co-localisation. Note the lack of co-
localisation (5%) and predominant expression of Cx30 in the Deiters’ cell region. Image 
adapted from Sun et al., 2005. 
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In addition to the recirculation pathway, the gap junction networks create a 
substantial intracellular volume for a role in buffering K
+
 ions away from the vicinity of 
hair cells (Nickel et al., 2009). This theory has been questioned since the loss of one 
connexin (either Cx26 or Cx30) cannot compensate for the loss of the other (Cohen-
Salmon et al., 2002; Teubner et al., 2003b), even though both homotypic gap junctions 
have been shown to transfer K
+
. However, the inability of one connexin to compensate 
for the other could be explained by asymmetric coupling. Electrophysiological studies 
have shown that asymmetrical voltage gating between coupled supporting cells induces 
a directional transjunctional current, which would facilitate funnelling of ions, such as 
K
+
, away from sensory cells (Zhao and Santos-Sacchi, 2000; Zhao, 2000; Sun et al., 
2005). This suggests an essential role for specific heterotypic/heteromeric gap junction 
configurations within the supporting cell network. 
 In addition to roles in K
+
 diffusion, there is increasing evidence that cochlear 
gap junctions are important for biochemical coupling. Intercellular transfer of the Ca
2+
-
mobilising second messenger inositol 1,4,5-triphosphate (IP3) is considered to be 
essential for calcium wave propagation in the immature organ of Corti, and deafness-
causing Cx26 and Cx30 mutations lead to disrupted IP3 transfer (Beltramello et al., 
2005; Zhang et al., 2005; Anselmi et al., 2008). In addition, heteromeric Cx26/Cx30 gap 
junctions have been shown to permit faster intercellular Ca
2+
 signalling than Cx26 or 
Cx30 homotypic channels (Sun et al., 2005). As well as biochemical coupling, a recent 
report has suggested that cochlear gap junctions are also important for metabolite 
transfer. The intercellular transfer of a fluorescent glucose analogue (2-NBDG) between 
cochlear supporting cells was severely reduced in Cx30-null mice (Chang et al., 2008). 
An emerging idea for inner ear connexins is a role in adenosine-5’-triphosphate 
(ATP) release through unpaired hemichannels (Gale et al., 2004; Zhao et al., 2005; 
Anselmi et al., 2008; Majumder et al., 2010). This purinergic signalling mechanism is 
proposed to occur in unison with second messenger transfer through gap junctions to 
sustain long-range intercellular Ca
2+
 signal propagation. ATP release through 
hemichannels is also suggested to have a role in reducing OHC electromotility, and thus 
hearing sensitivity, via P2 receptor activation (Zhao et al., 2005).  
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1.4 Scope of the thesis 
Cx26 and Cx30 are the two predominant connexins expressed in the cochlea and 
are critically important for functional hearing and cochlear physiology. However, our 
understanding of how these proteins function in the inner ear is still lacking. Several 
reports have indicated cochlear gap junctions in asymmetric coupling, K
+
 buffering and 
recycling, cochlear development and biochemical coupling. Although the bigger picture 
is now emerging for these connexins, certain aspects of their life-cycle and role in 
cochlear physiology remain unsolved. In the cochlea, it still remains to be seen why 
Cx26 or Cx30 cannot compensate for the loss of the other, and why certain mutations 
lead to hearing loss only, whereas others lead to syndromic hearing loss. Cx26 and 
Cx30 transgenic mouse models are deaf from birth (discussed in chapter 5), suggesting 
a role for these connexins in cochlear development and maturation. However, these 
roles have not been fully elucidated. For any possible therapeutic techniques in the 
future, it is essential we understand the exact role and properties of these connexins in 
cochlear development and physiology. 
In light if these issues, this thesis investigates the properties and functions of inner 
ear connexins in three parallel studies, with each study utilising a different experimental 
system: 
1) In vitro heterologous expression studies to investigate the trafficking pathways 
of Cx26 and Cx30. 
2) In situ studies to investigate the development of gap junctional intercellular 
communication in the cochlear lateral wall.  
3) In vivo studies to investigate the mechanism leading to hearing impairment and 
cochlear pathology in Cx30-knockout mice.  
Since these three topics are somewhat dissimilar, each results chapter includes its own 
introduction, which describes the reasons for the investigation, and discussion sections. 
The last chapter is a short general discussion, in which the three parallel studies are 
discussed in relation to cochlear physiology and development.  
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2 MATERIALS AND METHODS 
2.1 Materials 
All materials and reagents were purchased from Sigma-Aldrich (UK) unless stated. 
2.2 Cell Culture 
2.2.1 HeLa cell culture 
Human HeLa cervical carcinoma cells (OHIO, ECACC) were used for connexin 
expression studies. These cells are gap junction deficient making them ideal mammalian 
hosts for studying specific connexin properties. Cells were grown in tissue culture flasks 
(75 cm
2) under sterile conditions in Dulbecco’s Modified Eagle medium (DMEM), 
supplemented with 10% foetal bovine serum (FBS), 1% penicillin/streptomycin, 0.5% 
Amphotericin B (FungizoneTM) and 2 mM glutamine, at 37
o
C in a humidified 5% CO2 
incubator. To split the cells they were first rinsed with Hank’s Balanced Salt Solution 
(HBSS) followed by a brief rinse with 1X trypsin/ethylenediaminetetraacetic acid 
(EDTA) solution and then incubated with 1 ml trypsin/EDTA for 3-5 mins at 37
o
C to 
detach the cells. Trypsin activity was quenched by adding 8 mls of DMEM containing 
FBS. Cells were split into 1:10 dilutions and passaged every 4-7 days, changing the 
medium when required. 
2.2.2 Connexin expression constructs 
Wild-type (wt) rat Cx26 cDNA cloned into pCR3 (Invitrogen) was a gift from 
Prof. H. Evans and Dr. P. Martin Martin et al., 1999. Wt mouse Cx30 cDNA cloned into 
pCR3 was generated previously by Dr. N. Marziano (Marziano et al., 2003). These 
constructs were used for stable HeLa cell transfection (see below). The stably 
transfected mouse Cx43-HeLa cell line (cDNA inserted into pIREShyg, Clontech) was a 
gift from Prof. N. Severs (Imperial College, London). Mutant Cx26 constructs, D66H 
and G59A fused to an enhanced green fluorescent protein tag (eGFP), were created by 
Dr. N. Marziano (Marziano et al., 2003) and used for transient transfections.  
2.2.3 Transient expression of connexin constructs 
HeLa cells were grown on heat sterilised 13 mm glass coverslips in 24-well 
culture plates until 80-90% confluency. Cells were transfected with 0.8-1 µg of 
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connexin plasmids and 2 µl Lipofectamine
TM
 2000 (Invitrogen) according to 
manufacturer’s guidelines and incubated for 24-48 hours. Cells were fixed in 4% 
paraformaldehyde for 20-30 minutes at room temperature, washed in PBS and prepared 
for immunofluorescence labelling as described below. 
2.2.4 Stable expression of connexin constructs 
Stably transfected Cx26-HeLa were produced previously by Dr. R. Nickel in our 
lab. To obtain a stably transfected Cx30 cell-line, HeLa cells were plated in 35 mm petri 
dishes and transfected as described above, but with DNA scaled up to 3 µg per well. 
After 24-48 hours, cells were harvested with 500 µl trypsin/EDTA solution and split 1:5 
to several culture dishes (10 cm in diameter, Nunc) containing 10 ml DMEM and 500 
µg/ml of the selection antibiotic Geneticin (G418). After seven days, by which time 
non-transfected and transiently transfected cells are thought to be dead, the 
concentration of G418 was reduced to 250 µg/ml to prevent cytotoxic effects. The 
selection medium was changed every 4 days for 2-3 weeks. Once cell clones reached a 
diameter of 2-3 mm, they were harvested using trypsin-soaked sterile cloning discs (3 
mm) and transferred to a 24-well plate. Cells were grown to confluency in the presence 
of G418, harvested and transferred to increased sized culture vessels up to 75 cm
2
 
flasks. Cell samples were plated onto coverslips between harvesting, fixed and checked 
for connexin expression using immunocytochemistry. Both the Cx26 and Cx30 stably 
transfected cell lines were maintained in G418-containing medium. The Cx43-HeLa cell 
line was maintained in medium containing hygromycin (250-500 µg/ml).  
2.2.5 Cryopreservation of cell lines 
For freezing, cells were grown to near-confluency in a 75 cm
2
 flask with fresh 
medium changed 24 hours prior to cryopreservation. Cells were harvested as above, 
resuspended in 10 ml medium and centrifuged at 1000 rpm for 5 minutes. The cell pellet 
was resuspended in a 5 ml solution of 50% FBS and 50% dimethyl sulphoxide 
(DMSO). Aliquots (1 ml) were placed into cryovials and frozen at -80
o
C for 24 hours 
before being transferred to liquid nitrogen for long-term storage. To re-activate cell 
lines, vials were defrosted in a 37
o
C waterbath, diluted in 5 ml medium and grown to 
confluency in 25 cm
2
 flasks. 
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2.2.6 Drug treatment 
Brefeldin-A (BFA), a Golgi-disrupting drug, was reconstituted in 100% ethanol 
to a stock concentration of 5 mg/ml and stored at -20
o
C until required. Stably-
transfected HeLa cells were grown to 60-70% confluency on 13 mm glass coverslips in 
6 mm culture dishes. Medium was replaced with fresh DMEM containing 5 µg/ml BFA 
(or 0.01% (v/v) ethanol for control purposes) and incubated for 5-7 hours at 37
o
C. Cells 
were then washed briefly in HBSS and then fixed in 4% PFA for 20-30 minutes at room 
temperature. 
2.2.7 Temperature manipulation 
Stably transfected HeLa cells were grown to 70-80% confluency on 13 mm glass 
coverslips in 6 mm culture dishes and then incubated in a CO2 atmosphere at 19-20
o
C 
for the hours indicated in the figure. The temperature was checked regularly and never 
reached higher than 20.3
o
C or lower than 19.4
o
C. Cells were rinsed briefly in HBSS and 
then fixed in 4% PFA for 20-30 minutes at room temperature. 
2.3 Animals 
Adult (P21+) tri-colour guinea pigs were used for cochlear fibrocyte cultures 
and Sprague-Dawley rats for live cochlear slicing. Animals were killed by cervical 
dislocation or by CO2 inhalation followed by cervical dislocation in accordance with 
Schedule 1 of the United Kingdom Animals (Scientific Procedures) Act of 1986.  
2.4 Primary Culture of Cochlear Fibrocytes 
Fibrocyte cell culture was essentially carried out as described by Gratton et al. 
(1996), but with modifications. Decapitated heads were skinned, disinfected briefly in 
70% ethanol and transferred to sterile ice cold HBSS supplemented with HEPES. All 
dissections from this point were performed under sterile conditions in a laminar flow 
hood with heat sterilized instruments. The heads were sagitally cut in half, lower jaws 
removed and brain and temporal bones removed. The bullae were excised and the outer 
bony casing trimmed away with forceps (rat) or bone nibblers (guinea pig). The 
cochlear bone was first scored with a No. 11 scalpel blade and then removed in small 
pieces from apex-to-base to reveal the intact spiral ligament. The cochlea was removed 
from the connecting vestibular system with the scalpel and spiral ligament peeled away 
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from the organ of Corti using a needle and fine forceps. The spiral ligament was cut into 
3-6 segments and gently placed onto rat tail collagen type-I coated petri dishes. A 
minimal amount of fibrocyte culture media (MEM-α, supplemented with 10% fetal 
bovine serum (FBS), 1% insulin-transferrin-selenium (ITS) 1% penicillin/streptomycin 
and 0.5% Amphotericin B (FungizoneTM)) was dropped onto the tissue segments. To 
facilitate attachment the dishes were incubated at 37
o
C for ~10 minutes until the culture 
medium had reduced in volume and the tissue had attached. In some instances a 
sterilized glass coverslip was placed over the tissue fragments to aid adhesion and cell 
growth. Further media was added to each well and incubated at 37
o
C in a 5% CO2, 95% 
air atmosphere, with fresh media changed every 3 days. After ~4 days in culture 
fibrocyte migration from tissue explants was visible. Full confluency was reached after 
2-3 weeks at which point the cells were sub-cultured into 25 cm
2
 flasks and allowed to 
grow to near confluency before being split 1:1 into a larger 75 cm
2
 flask. Fresh media 
was changed every 3 days and cells split 1:10 once a week or when fully confluent. Cell 
stocks were prepared as described above (2.2.5). 
2.5 Immunofluorescence labelling and confocal microscopy 
Processing for immunofluorescence labelling was carried out in humidified 
chambers at room temperature on an orbital shaker, unless stated otherwise. Cell 
monolayers were fixed with 4% PFA for 20-30 minutes. Whole cochleae were fixed by 
making a small hole in apical region of the otic capsule and gently perfusing PFA 
through the round window. Fixation was continued on a rotator for 1 hour and cochleae 
processed for cryosectioning or slicing (see section 2.9 below). Live cochlear slices 
were fixed with 4% PFA for 30-45 minutes. Tissue sections/slices and cell monolayers 
were incubated for 1 hour in PBS containing 10% goat serum (or 10% horse serum for 
KCNQ1), 0.1% (monolayers) or 0.2% (tissue) Triton X-100 (TX-100) to block non-
specific sites and permeabilise the cells. Specimens were incubated with various 
combinations of monoclonal and polyclonal primary antibodies (see Table 2-1) in PBS 
containing 0.1 M L-Lysine and 0.1%/0.2% TX-100 overnight at 4
o
C. Primary 
antibodies were omitted for negative controls. Following three 10 minute washes with 
PBS, cells/tissues were incubated with appropriate secondary antibodies or other 
fluorescent probes (see Table 2-2) in PBS, 0.1 M L-lysine and 0.1% TX-100 for 40-60 
minutes in the dark. After three 10 minute washes with PBS specimens were mounted 
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on coverslips with anti-fade medium (Vectashield, Vectorlabs) containing 4',6-
diamidino-2-phenylindole (DAPI) to stain nuclei, and sealed with nail varnish. 
Immunofluorescent samples were examined and imaged using a Zeiss Meta 
confocal laser scanning microscope with 20x (dry), 40x (oil) and 63x (oil and water) 
objectives. The fluorochromes Alexa 488 (excitation/emission 496/519 nm), Alexa 555 
(ex/em 555/565 nm), rhodamine (ex/em 550/570 nm), Alexa 633 (ex/em 632/647 nm) 
and DAPI (ex/em 358/461 nm) were excited by wavelengths of 488, 568, 633 and 364 
nm laser lines. Images were recorded by single- or sequential dual/triple-channel 
scanning. Z-series stacks were taken at ~1 µm intervals and transformed into projections 
of maximum pixel intensity. Settings for laser power, pinhole and photomultiplier tube 
were kept constant for comparative experiments. 
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Protein 
 
Type; host Concentration Source Antibody # 
Acetylated 
tubulin 
Monoclonal; 
mouse 
1:1000 Sigma T6793 
Alpha tubulin Monoclonal; 
mouse 
1:400 Invitrogen 32-2500 
Ca2+-ATPase Monoclonal; 
mouse 
1:200 Sigma A7952 
Claudin-11 Polyclonal; 
rabbit 
1:200 Invitrogen 36-4500 
Cx26 Monoclonal; 
mouse 
1:400 Invitrogen 33-5800 
Cx26 Polyclonal; 
rabbit 
1:200 W. H. Evans, Univ. of 
Wales, Cardiff, UK 
GAP28H 
Cx30 Polyclonal; 
rabbit 
1:400 Invitrogen 71-2200 
Cx31 Polyclonal; 
rabbit 
1:100 D. P. Kelsell, Queen Mary, 
Univ. of London, UK 
N/A 
Cx43 Polyclonal; 
rabbit 
1:400 Sigma C6219 
GLUT-1 Polyclonal; 
rabbit 
1:300 Sigma SAB4502803 
GM130 Monoclonal; 
mouse 
1:400 BD Biosciences 610823 
KCNQ1 Goat; 
polyclonal 
1:200 Santa Cruz Sc-10646 
Kir4.1 Polyclonal; 
rabbit 
1:400 Alomone Labs APC-035 
Na+,K+,ATPase Monoclonal; 
mouse 
1:300 Sigma A-275 
NKCC1 Monoclonal; 
mouse 
1:300 C. Lytle, Developmental 
Studies Hybridoma Bank, 
Univeristy of Iowa 
N/A 
S100 alpha Polyclonal; 
rabbit 
1:200 Abcam ab11428 
Vimentin Monoclonal; 
mouse 
1:400 Sigma V2258 
 
Table 2-1. Primary antibodies used for immuno-labelling 
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Table 2-2. Secondary antibodies and other fluorescently-conjugated probes. 
Secondary antibody 
& other conjugated 
fluorophores 
Host Concentration Source Antibody # 
Anti-goat Alexa 
Fluor 633 
Donkey 1:200 Invitrogen A21082 
Anti-mouse Alexa 
Fluor 555 
Goat 1:200 Invitrogen A21422 
Anti-mouse Alexa 
Fluor 633 
Goat 1:200 Invitrogen A21050 
Anti-rabbit Alexa 
Fluor 488 
Goat 1:200 Invitrogen A11008 
Anti-rabbit 
Rhodamine 
Goat 1:200 Chemicon 
(Millipore) 
AP132R 
Phalloidin Alexa 
Fluor 633 
N/A 1:400 Invitrogen A22284 
Streptavidin Alexa 
Fluor 555 
N/A 1:1000 Invitrogen S32355 
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2.6 Reverse transcription PCR 
Cells were grown to full confluency in 25 cm
2
 flasks and RNA extracted using the 
RNeasy kit (Qiagen), with additional DNAse treatment, according to manufacturer’s 
instructions. For positive control reactions, RNA was extracted from guinea-pig brain, 
and cochlea tissue using a rotor-stator homogeniser. RNA concentrations were recorded 
using a Nanodrop 1000 spectrophotometer (Thermo Scientific) and then reverse 
transcribed into complementary DNA (cDNA) using the Quantitect Reverse 
Trancription kit (Qiagen). cDNA concentrations were recorded and specific sequences 
amplified by polymerase chain reaction (PCR) using the Taq DNA polymerase kit 
(Qiagen) as described.  
Specific primers for the following connexin sequences were designed with the aid 
of Primer3 (http://frodo.wi.mit.edu/primer3/). All primers were obtained from guinea-
pig (Cavia porcellus) coding DNA, with the exception of Cx30; the guinea-pig 
sequence was not available at the time so primers were designed from mouse (Mus 
musculus) coding DNA. The functionality of mCx30 primers was confirmed by 
amplification of Cx30 from guinea-pig cochlear cDNA. Primer sequences (including 
coding DNA accession numbers): guinea-pig Cx26 (gCx26, NM_001172823.1) 
(forward: 5’- ACCGGAAGCATGAGAAGAAA-3’; reverse: 5’- 
CAAGCATTGCATTTCACCAG-3’), mCx30 (NM_001010937.1) (forward: 5’-
AGGAAGTGTGGGGTGATGAG-3’; reverse: 5’-AGGTAACACAACTCGGCCAC-
3’), gCx31 (ENSCPOT00000010722) (forward: 5’-TATACGTGGTGGCTGCAGAG-
3’; reverse: 5’-TGCTCACCGTACTTCTGACG-3’), gCx43 (NM_001172748.1) 
(forward: 5’-AGGAGGAGCTCAAGGTAGCC-3’; reverse: 5’-
GACCGACTTGAAGAGGATGC-3’). All connexin primer sequences were checked 
using the BLAST tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi) to rule out cross-
reactivity with other connexin types. Glyceraldehyde-3-phosphate dehydrogenase 
(gGAPDH, NM_001172951.1) (forward: 5'-GTCGGTTGTGGATCTGACCT-3'; 
reverse: 5'-TGCTGTAGCCGAACTCATTG-3') served as a positive control. Primers 
were purchased from Sigma-Aldrich and re-suspended at 100 µM in ddH2O. PCR 
reactions were set up as follows: 1x PCR buffer, 1.5 mM MgCl2, 200 µM of each 
dNTP, 2.5 units Taq DNA polymerase, 0.2 µM of each primer and 1 µg template DNA, 
made up to 20 µl with dH20, per 20 µl reaction. Samples from reverse transcriptase 
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reactions without enzyme or dH2O replaced the template DNA for negative control 
reactions. Optimal annealing temperatures for each primer pair were determined by a 
temperature gradient. Thermal cycling was performed using an Eppendorf Mastercycler 
Gradient under the following conditions:  
1) Initial denaturation 94 C 5 minutes 
2) Denaturation  94 C 30 seconds 
3) Annealing  60
o
C (Cx26 primers) 63
o
C (all other primers) 1 minute  
4) Extension  72 C 1 minute 
5) Repeat steps 2-4, 35 times 
6) Final extension 72 C 10 minutes 
7) Hold   4
o
C Indefinitely 
PCR products were run on a 2% agarose gel as described in section 2.8.3 
2.7 Quantitative real-time PCR 
Whole stria vascularis strips were isolated and pooled from each cochlea of age-
matched Cx30
+/+
 and Cx30
–/–
 mice and transferred into RNAlater (Qiagen). RNA was 
extracted using the RNeasy kit (Qiagen) and reverse transcribed as mentioned in section 
2.6. Gene expression was determined by quantitative real-time PCR (qPCR) using a 
Kir4.1 gene expression assay (Applied Biosystems; Mm00445028_m1). Reactions were 
multiplexed with a primer-limited eukaryotic 18S rRNA endogenous control (Applied 
Biosystems; Mm03928990_g1). Each reaction was performed in triplicates or 
quadruplicates and amplified on a SDS7500 real-time PCR System (Applied 
Biosystems). Relative quantification analysis was performed with SDS1.2.1 software 
(Applied Biosystems). 
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2.8 Connexin 30 transgenic mice 
2.8.1 Generation of Cx30 knockout mice 
Connexin 30
 
knockout (Cx30
–/–
) frozen embryos (EM:00323) were purchased 
from the European Mutant Mouse Archive (EMMA), CNR, Consiglio Nazionale delle 
Ricerche, Monterotondo Scalo, Roma, Italy. The re-derivation process was carried out 
by Ms. K. Gardner at the Transgenic Laboratory, Neural Development Unit, Institute of 
Child Health, UCL. The procedure returned three healthy Cx30
–/– 
female mice which 
were then backcrossed with C57BL/6 wild-type mice to produce heterozygote litters 
and then intercrossed to produce homozygous Cx30
–/– 
mice.  
 The Cx30
–/– mice were originally created by Prof. K. Willecke’s group at the 
Institute of Genetics, University of Bonn (Teubner et al., 2003a). Briefly, the coding 
region of the mouse Gjb6 gene was replaced with the coding sequence of the E. Coli 
galactosidase reporter gene (lacZ) along with a nuclear localisation signal (NLS) 
neomycin resistance (neo) cassette ( 
 
 
Image deleted due to copyright. 
 
 
 
Figure 2-1. Generation of Cx30
–/– 
mice. 
(A) The targeting vector containing the nuclear localisation sequence (NLS), lacZ 
reporter gene and the neo resistance cassette. Grey filled bars, Cx30 coding sequences 
homologous to wild-type DNA; thin line, vector backbone. (B) Wild-type Cx30 gene. 
Thick line, genomic DNA. (C) Resulting allele after homologous recombination. 
Arrows represent primers used for genotyping. H, HindIII; N, NotI; S, SacI restriction 
sites. Adapted from Teubner et al. (2003). 
 
    56 
 
Image deleted due to copyright. 
 
 
 
Figure 2-1). The NLS and neo sequences in the targeting vector were flanked by 
corresponding Cx30 sequences ( 
 
Image deleted due to copyright. 
 
 
 
Figure 2-1, grey bars) which allowed for homologous recombination into genomic DNA 
(indicated by X). The targeting vector was linearised and electroporated into HM1 
mouse embryonic stem cells, as described by (Theis et al., 2000). Cells that 
incorporated the targeting vector were selected for with geniticin (G418) and checked 
for homologous recombination by southern blot analysis. The cells were then injected 
into C57BL/6 blastocytes and implanted into pseudopregnant NMRI foster mothers. 
Chimeric mice were then backcrossed to C57BL/6 mice. 
2.8.2 Genotyping 
Genomic DNA was isolated from ear punches (live animals) or tail tips (sacrificed 
animals) using the Extract-N-Amp™ Tissue PCR Kit according to manufacturer’s 
instructions. Custom made DNA oligo primers were designed to detect the presence of 
both wild-type Cx30 (Cx30
+/+
) and lacZ genes: Cx30 (forward: 5’-
ATTGGTCAGATAATTCTGAGG-3’; reverse: 5’-AAACTTGTGATTGCATTCTGGC 
CAC); lacZ (reverse: 5’-AGCGAGTAACAACCCGTCGGATTC-3’). The forward 
primer lies outside of the Cx30 coding region and the reverse primers of both Cx30 and 
lacZ are located within the respective genes (Figure 2-1). Cx30
+/+ 
mice produce band 
sizes of 850 base-pairs, whereas Cx30
–/– 
mice produce band sizes of 450bp (see Figure 
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2-2). Heterozygous mice (Cx30
+/–) contain bands of both sizes. Each 20 μl PCR reaction 
was set up as follows: 
Extract-N-Amp PCR reaction mix (containing 
JumpStart Taq antibody for hot-start amplification) 
10 μl 
Tissue extract 5 μl 
Cx30 wild-type 5’ forward primer 1 μl (1 μM final conc.) 
Cx30 wild-type 3’ reverse primer 1 μl (1 μM final conc.) 
Cx30 lacZ 3’ reverse primer 1 μl (1 μM final conc.) 
PCR grade water 2μl 
 
Thermal cycling was performed using an Eppendorf Mastercycler Gradient under the 
following conditions:  
1) Initial denaturation 95 C 5 minutes 
2) Denaturation  95 C 30 seconds 
3) Annealing  57
o
C 30 seconds  
4) Extension  72 C 45 seconds 
5) Repeat steps 2-4, 35 times 
6) Final extension 72 C 10 minutes 
7) Hold   4
o
C Indefinitely 
 
2.8.3 Agarose Gel Electrophoresis 
Samples were loaded with 1x blue/orange DNA loading dye (Promega) and 
electrophoresed on a 1.3% agarose gel prepared with 1x TAE (2.0 M Tris, 1 M Glacial 
acetic acid, 50 mM EDTA, pH 8.0) buffer containing 0.25 g/ml ethidium bromide. A 
100 bp DNA ladder (Promega) was used as a molecular marker. DNA was viewed in a 
GelDoc-It 3UVTM Transilluminator Imaging system (Jencons-PLS) at 302nm (UV-B). 
Image acquisition and analysis was performed with LabWorksTM software (UVP 
BioImaging Systems). 
 
Figure 2-2. Cx30 genotyped samples. 
Lane 1, 100 bp DNA ladder with size 
markers; lane 2, no template control; lane 3, 
a band at 850 bp (Cx30
+/+
, wild-type); lane 
4, a band at 450bp (Cx30
–/–
, homozygous 
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2.9 Cochlear Preparations 
2.9.1 Cryosectioning 
After removing a small piece of bone from the very apical point of the cochlea, 
4% PFA was gently perfused through the round and oval windows. Whole cochleae 
were then immersed in fixative and left on a rotor for a 1 hour at room temperature. 
PFA fixed mouse/rat cochleae were decalcified in 4.13% EDTA in PBS for 2-4 days at 
4
o
C. For cryoprotection, cochleae were rinsed in PBS and incubated in 30% sucrose in 
PBS overnight at 4
o
C. Cochleae were embedded in low-gelling temperature agarose 
(Type VII) containing18% sucrose in PBS and 0.01% sodium azide (NaN3). Gel was 
poured into 35 mm petri dishes and cochleae orientated so that the oval window was 
facing upwards and then allowed to set at room temperature. Dishes were sealed with 
Parafilm
TM
 and stored at 4
o
C until required. Specimens were mounted onto cryostat 
chucks with a small amount of Tissue Tek OCT compound (Sakura, Netherlands) and 
frozen rapidly in liquid nitrogen. Tissue blocks were allowed to equilibrate to the 
temperature inside a Leica CM1900 cryostat (-20
o
C) for 30 mins. Sections were cut at a 
thickness of 15 µm and mounted on poly-L-lysine coated slides (VWR, UK) and stored 
at -20
o
C. 
2.9.2 Cochlear slice preparation  
Sprague Dawley rats aged P0 to P7 were used for live slices and P0 to adult for 
fixed slices. Rats were killed as described above. The developing bullae were excised, 
and the cochlear bones were exposed. Additional dissection was performed in cold 
artificial perilymph (in mM: 150 NaCl, 4 KCl, 2 MgCl2, 1.3 CaCl2, and 5 glucose, pH 
adjusted to 7.3 with NaOH). The cochlear bone was mounted on a vibratome block 
using cyanoacrylate glue (Roti-Coll 1; Carl Roth, Karlsruhe, Germany). Slices were cut 
at 200–400 µm on a semi-automatic vibratome (Vibratome 1000+; TPI, St. Louis, MO), 
fitted with a razor blade (Wilkinson Sword, High Wycombe, UK). The vibratome was 
adjusted to allow a very slow blade advance (<0.1 mm/s). 
For fixed cochlear slices: cochleae were fixed with 4% PFA for 1 hour at room 
temperature and decalcified as described for cryosectioning and then mounted and 
sliced as described above. 
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2.10 Whole-cell patch clamp recordings/dye transfer  
Live cochlear slices were stored in artificial perilymph (in mM: 145 NaCl, 4 
KCl, 2 MgCl2, 1.3 CaCl2, and 5 glucose, pH adjusted to 7.3 with NaOH) on ice until 
use. For patching, slices were placed in a recording chamber (~400 µl) on an upright 
microscope (Axioskop; Zeiss, Oberkochen, Germany) and superfused with artifical 
perilymph. The flow rate (2-4 ml/min) was controlled by a peristaltic pump and slices 
secured with short lengths of platinum wire. All experiments were carried out at room 
temperature (20 – 24oC). To view individual cells for patch-clamp recordings, the tissue 
was visualized with near-infrared videomicroscopy (as described in Jagger et al., 2000), 
using a CCD video camera (ICD 42E; Ikegami, Tokyo, Japan) and light from a 100W 
halogen bulb filtered at 750 nm (centre wavelength, ±10 nm). 
2.10.1 Dye transfer in cochlear slices 
Dye transfer and patch-clamp recordings in cochlear slices have been 
successfully used in our lab previously (Jagger and Forge, 2006). A 10 min whole-cell 
recording has been shown as sufficient time for Neurobiotin
TM
 Tracer (NBN, Vector 
Laboratories, Burlingame, CA) dye to pass throughout Köllicker’s organ, which is the 
standard duration used for these experiments. Recordings were performed using a patch-
clamp amplifier (Axopatch 200B; Axon Instruments, Union City, CA) and a Digidata 
board (Axon Instruments) under the control of computer software (pClamp version 8; 
Axon Instruments). Patch pipettes were fabricated on a vertical puller (P30; Sutter 
Instruments, Novato, CA) from capillary glass (GC120TF-10; Harvard Apparatus, 
Edenbridge, UK). Pipettes were filled with a potassium chloride intracellular solution 
(in mM: 140 KCl, 10 NaCl, 2 MgCl2, 5 HEPES, 5 EGTA, and 5 glucose, pH adjusted to 
7.3 with KOH). For dye transfer experiments, the pipette solution was supplemented 
with 1 mg/ml NBN (MW, 287 Da; charge +1) and either 2 mg/ml Lucifer yellow (LY; 
di-lithium salt; MW, 443 Da; charge -2, Sigma) or 2 mg/ml fluorescein-conjugated 
dextran (FD; anionic, lysine fixable; MW 10,000 Da; Invitrogen). These dyes have 
different permeabilities depending on the connexin composition of gap junction 
channels. NBN has been shown to pass through all functional gap junction channels, 
whereas LY is permeable to Cx26 homotypic channels, but not Cx30 homotypic or 
Cx26/Cx30 heterotypic channels (Jagger and Forge, 2006). FD is impermeable to gap 
junctions due to its high molecular weight and is useful for identifying patched cells and 
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studying cell morphology. Pipette solutions were filtered at 0.22 µm and centrifuged to 
remove insoluble debris. Pipettes had an access resistance of 2-4 MΩ, measured in 
artificial perilymph. A small amount of positive pressure was applied to the pipette tip 
to keep it free from blockages before the patch formation. Once a giga-seal was formed 
suction was applied to create the whole-cell configuration. The input resistance was 
measured during 10 mV hyperpolarizing pulses (10 ms duration). After 10 mins the 
pipette was gently removed to form a tight seal, which was confirmed by the formation 
of a high-resistance membrane patch. Upon removal of the pipette, slices were fixed in 
4% PFA at room temperature for 30 mins.  
2.10.2 Dye transfer in HeLa and fibrocyte cell lines 
Essentially the same technique as described above was used for dye transfer in 
HeLa and fibrocyte cell lines grown to 85-95% confluency on 9 mm coverslips. For 
BFA experiments, cells were incubated in media containing 5 µg/ml BFA (or 0.01% 
(v/v) ethanol for control purposes) for 6-7 hours prior to dye injection. Cells were then 
fixed, NBN visualised by staining with streptavidin-conjugated to an Alexa Fluor 555 
probe (as described in section 2.5) and imaged using a Zeiss LSM 510 confocal 
microscope. All image settings were kept constant between coverslips. To prevent bias, 
each coverslip was randomly assigned a letter by D. Jagger before imaging. Therefore, 
each image was counted blind. Counts were performed using ImageJ software and only 
included cells with NBN present in the cytoplasm and nucleus. Data was collated, 
presented as mean ± standard error of the mean (SEM) and statistically analysed using 
the Student’s T-test in GraphPad Prism4.  
2.10.3 Inward-rectifying potassium channel recordings 
  For Kir4.1 recordings the intracellular pipette solution was supplemented with 3 
mM ATP-Na2. In some experiments, BaCl2 or fluoxetine hydrochloride was added to 
artificial perilymph to block inward-rectifying K
+
 channels. BaCl2 was made up as a 1M 
stock solution in sterilised ddH20 and diluted to 2 mM in artificial perilymph before the 
experiment. Fluoxetine hydrochloride was made up as a 10 mM stock in sterilised 
ddH20 and diluted to 100 µM in artificial perilymph. For the [K
+
] test, artificial 
perilymph solutions were made by adjusting KCl and NaCl concentrations 
appropriately: 1 mM KCl, 148 mM NaCl; 10 mM KCl, 139 mM NaCl; 40 mM KCl, 
109 mM NaCl.  
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2.11 Stria vascularis measurements 
2.11.1 Stria vascularis thickness measurements 
Measurements of stria vascularis thickness were taken from thin sections, 
imaged by TEM and cryosections, imaged by confocal microscopy. The thickness was 
calculated as the distance between the endolymphatic surface of marginal cells to the 
apical surface of basal cells directly abutting the spiral ligament. Three measurements 
were taken for each turn of the cochlea. Basal measurements were pooled together as 
were apical measurements (according to the animal’s age) and averaged to obtain a 
mean thickness. Data are presented as mean ± SEM and were statistically analysed 
using Student’s t-test in GraphPad Prism 4 software. Differences were considered 
significant when p<0.05.  
2.11.2 Dimensions of marginal cell nuclei 
Marginal cell nuclei dimensions were calculated by measuring the distance from 
one end of DAPI stained nuclei to the other (length) and divided by the height measured 
at the mid-point of the length. Distances were measured using Zeiss LSM Image 
Browser software (http://www.zeiss.de/micro). Measurements were taken from mid-
modiolar cochlear cryosections and pooled according to age and genotype. Data are 
presented as mean ± SEM and were statistically analysed using Student’s t-test in 
GraphPad Prism 4 software. Differences were considered significant when p<0.05. 
2.12 Vascular permeability studies 
2.12.1 FITC-conjugated bovine serum albumin tail-vein injections 
Adult (P21+) Cx30
+/+
, Cx30
+/–
 and Cx30
–/–
 mice were used for tail-vein 
injections. The animals were warmed in a 39
o
C incubator for 5 minutes and held in a 
mouse restrainer so that the tail was accessible and the vein visible. A 50µl aliquot of 
5% (w/v) FITC-conjugated bovine serum albumin (BSA-FITC) made up in sterilized 
PBS was injected into each mouse. The mice were left for 30-60 minutes at room 
temperature to allow the BSA-FITC to permeate all capillaries and to allow for any 
vessel leakage. The mice were then killed via CO2 inhalation and cochleae excised as 
described above. For live whole-mount imaging the cochlear bone was removed and 
stria vascularis (SV) segments dissected onto a microscope slide with Vectashield tissue 
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mounting media. The segments were immediately imaged under a Zeiss epifluorescence 
microscope. For fixed SV imaging the cochleae were prepared and cryosections cut as 
described in section 2.9.1. Sections were immunolabelled for Cx30 (counter-stain) and 
viewed under a Zeiss LSM laser-scanning confocal microscope. 
2.12.2 Semi-quantitative fluorescence analysis 
All images were acquired using a Zeiss LSM 510 confocal microscope using the 
same detection settings for wild-type and transgenic samples. Images were taken from 
single plane sections, or combined stacks at the same thickness, as noted in figure 
legends. The green BSA-FITC channel was converted to greyscale and analysed using 
ImageJ software (http://rsbweb.nih.gov/ij/). Each 8-bit image could produce a maximum 
greyscale level of 256. Single line profile plots were measured along the width of the 
stria, traversing each capillary, in cochlear sections. For whole-mounts, line distances 
were kept the same and plotted in regions of highest fluorescence intensity. Pixel 
intensities measured along the line profiles were transferred to GraphPad Prism 4 
software for further analysis. Graphs were plotted as distance vs fluorescence intensity 
or total average fluorescence intensity. 
2.12.3 Diuretic injections 
Adult (P21+), age-matched Cx30
+/+
 and Cx30
–/–
 mice were given a single 
subcutaneous intraperitoneal injection of a clinical preparation of the loop diuretic, 
bumetanide (Burinex injection, Leo-Pharma) at 0.05 mg/g. Animals were killed and 
cochlea tissue obtained 24 hours later. 
2.12.4 Thin sections and transmission electron microscopy 
Cochleae were perfused with, and then immersed in 2.5% gluataraldehyde in 
0.1M cacodylate buffer (pH 7.3) with 3 mM CaCl2. Fixation was continued for a 
minimum of 2 hrs at room temperature. The cochleae were then post-fixed in 1% OsO4 
(osmium tetroxide) in 1 mM cacodylate buffer for 2 hrs at room temperature. The 
cochleae were then decalcified in 4.13% EDTA in cacodylate buffer (pH7.3) for 48-72h 
at 4°C. The cochleae were partially dehydrated in an ethanol series to 70% ethanol, then 
immersed in saturated uranyl acetate in 70% ethanol overnight at 4°C to “en bloc” stain 
the tissues. Dehydration was continued to 100% ethanol before embedding the entire 
cochlea in plastic (Epon). Sections parallel to the modiolus were cut at 1 µm thickness 
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and stained with toluidine blue for visualisation by light microscopy. A series of thin 
sections for transmission electron microscopy (TEM) were then cut (80-100 nm thick). 
This procedure was carried out by Mr. G. Nevill. TEM images were collected digitally 
using a Gatan camera. 
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3 TRAFFICKING PATHWAYS OF INNER EAR CONNEXINS 
3.1 Introduction 
The large number of possible configurations and the wide-spread expression of 
connexins in the mammalian system suggest specific functions for gap junctions in 
particular cells or tissues. Mutations in connexins cause up to 10 different diseases, 
including hearing loss, skin disease, cataracts and heart disease, amongst others 
(reviewed by Laird, 2010). It is therefore, imperative to understand how gap junctions 
are regulated and how connexin composition influences intercellular communication. In 
the inner ear, Cx26 and Cx30 are vital for hearing. The loss of either one of these 
connexins cannot be compensated for by the other, suggesting a functional requirement 
for heteromeric/heterotypic gap junction configurations. Mutations in the genes coding 
for Cx26 and Cx30 can lead to truncated proteins, oligomerisation defects, trafficking 
defects, non-functional channels or channels with aberrant permeabilities (reviewed by 
Martinez et al., 2009). In addition, dominant-negative mutations in either connexin can 
lead to cochlear dysfunction. Of interest are the many Cx26 (Martinez et al 2010) and 
Cx30 (Common et al 2002) mutations that impair trafficking of connexons to the 
plasma membrane, which lead to syndromic (associated with other diseases, i.e. skin 
disease) or non-syndromic hearing loss.  
It is not clear how the co-assembly of Cx26 and Cx30 is regulated both 
temporally and spatially in the cochlea. In light of mutation-specific treatments for 
cystic fibrosis (discussed below) and for connexin-mutation specific therapies in the 
future, it is vital to investigate the molecular assembly, trafficking and life-cycle of 
Cx26/Cx30 gap junctions. At the time of this study, there had been conflicting data 
regarding the Cx26 trafficking pathway, whereas the Cx30 pathway had not been 
investigated. For Cx26, some studies suggest a trafficking route through the Golgi 
apparatus, termed the ‘conventional secretory (trafficking) pathway’, whereas others 
suggest a route that by-passes the Golgi, termed the ‘non-conventional trafficking 
pathway’ (discussed further in section 3.1.3). Since Cx26 and Cx30 bind together to 
form heteromeric channels in the cochlea, it seems likely that both connexins follow 
similar trafficking pathways. Therefore, this project set out initially to investigate the 
intracellular trafficking pathways of Cx26 and Cx30 in vitro, with particular attention to 
Golgi interactions. In the long-term, it would be beneficial to elucidate where in the cell 
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these proteins oligomerise into heteromeric connexons. This is with the future aim of 
identifying possible therapeutic substances that can rescue trafficking-defective 
mutations, as has been described for cystic fibrosis (see section 3.1.2). This section 
introduces the field of protein trafficking, the two general secretory pathways and our 
current knowledge about connexin trafficking. 
3.1.1 The conventional secretory pathway 
 Most membrane-spanning proteins are transported from their site of translation 
to the cell surface via the conventional secretory (“trafficking”) pathway. This process, 
originally described by George Palade (1975), involves insertion of nascent proteins 
into the endoplasmic reticulum (ER) membrane through binding of a signal-peptide 
recognition particle. From here proteins undergo folding, oligomerisation, addition of 
oligosaccharide chains and packaging into budding vesicles at ER exit sites (ERES). To 
continue transport along the secretory pathway these vesicles require binding of coat 
protein complex II (COPII), which directs the cargo to the cis-Golgi via the ER-Golgi 
intermediate compartment (ERGIC). The proteins are then modified, processed and 
sorted whilst being directed towards the trans-Golgi network (TGN) where they then 
bud off and fuse with the plasma membrane (PM). This process has been well 
documented (Rothman, 1994; Mellman and Warren, 2000; Lee et al., 2004) and was 
once thought to be the common pathway for all transmembrane proteins and secretory 
molecules (Palade, 1975). 
3.1.2 Discovery of non-conventional secretory pathways 
 The discoveries of alternative trafficking pathways have only emerged in the last 
20 years. The non-conventional secretory pathway has been described as a transport 
system for proteins that do not enter or pass through the ER and/or Golgi apparatus en 
route to the PM, and that do not contain post-translational modifications specific for 
these compartments (reviewed by Nickel and Seedorf, 2008). Originally, evidence for 
non-conventional secretion was shown for interleukin 1β (Rubartelli et al., 1990) and 
galectin-1 (Cooper and Barondes, 1990). These cytoplasmic and nuclear proteins lack 
an ER-signal peptide and have been shown to exit cells through ER- and Golgi-
independent pathways. Since their discovery these molecules have been joined by other 
similar proteins such as fibroblast growth factors (FGF1 and 2), galectin-3, β-
galactosidase-specific lectins and engrailed homeoprotein, amongst others, with up to 
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20 different soluble proteins making up this group. These proteins are often referred to 
as “soluble” or “cytoplasmic” proteins and are involved in various physiological 
processes, such as inflammation, angiogenesis, cell differentiation, or proliferation 
(reviewed by Nickel and Seedorf, 2008; Nickel and Rabouille, 2009). 
 An alternative group of proteins that traffic non-conventionally start their 
journey in the ER and transport to the cell surface in a COPII and/or Golgi-independent 
manner. Proteins that do not require COPII-coat components include yeast heat-shock 
protein Hsp150 (Fatal et al., 2004), Kv4 voltage-sensitive potassium channels (Hasdemir 
et al., 2005), EDEM1 and OS-9 (Zuber et al., 2007; Cali et al., 2008) – both of which 
are regulators of ER-associated degradation (ERAD). These pathways would most 
likely require novel coat complexes or have the ability to directly insert into the PM 
from ER-exit sites (for PM targeted proteins). 
 Various techniques have been used to show that the remaining non-conventional 
group of proteins bypass the Golgi apparatus (reviewed by Grieve and Rabouille, 2011): 
i) Brefeldin-A (BFA) treatment to destabilise the Golgi stacks and prevent ER-to-Golgi 
transport (discussed in chapter 3.1.4); ii) glycosylation state as detected by 
Endoglycosidase H (Medzihradszky, 2005); and iii) knock-down of Golgi SNARE 
(soluble N-ethylmaleimide-sensitive-factor attachment protein receptor) proteins 
required for vesicle docking. Examples of proteins identified to traffic non-
conventionally using these techniques are described briefly.  
 Cystic fibrosis transmembrane conductance regulator (CFTR) is the most 
documented example of Golgi bypass. Although the general consensus is that CFTR 
exits the ER via COPII vesicles (Wang et al., 2004), Golgi bypass still occurs in baby 
hamster kidney (BHK) and Chinese hamster ovary (CHO) cells (Yoo et al., 2002). 
However, the authors suggest that CFTR trafficking may be cell-type specific, since 
Golgi bypass was not shown for HeLa or 293T cells. The predicted trafficking pathway 
is thought to incorporate fusion with endosomes or the TGN prior to PM insertion, thus 
bypassing the cis and medial Golgi stacks (Yoo et al., 2002). Understanding the protein 
trafficking pathway of CFTR has been instrumental in developing cystic fibrosis clinical 
trials. Recently, research has focused on the most common mutation, ΔF508-CFTR, 
which fails to fold correctly in the ER and is rapidly degraded via the proteasome. In 
addition, the mutation confers reduced capacity to transport Cl
-
 ions and decreases the 
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PM half-life (reviewed by Guggino and Stanton, 2006). Interest in the field stems from 
the discovery that certain chemicals and drugs can rescue, to an extent, the trafficking 
and functions of ΔF508-CFTR. Curcumin, a component of the spice turmeric, and S-
nitrosoglutathione, a bronchodilator normally expressed in healthy lungs, can induce 
transport of this mutant to the PM (Zaman et al., 2001; Egan et al., 2004). Therefore, 
these compounds could potentially be used alongside drugs that increase ΔF508-CFTR 
activity. One such drug that is being investigated is a flavinoid called Genistein, which 
has been shown to activate both ΔF508-CFTR and another human mutation, G551D-
CFTR. In combination, these drugs and compounds could be used to help reduce the 
symptoms of cystic fibrosis (Guggino and Stanton, 2006).  
 CD45 is a protein tyrosine phosphatase that has the ability to traffic to the PM in 
a BFA-insensitive manner. In T-cells, it has been shown that two glycosylated forms of 
CD45 reach the cell surface as detected by Endoglycosidase H (EndoH) sensitivity. 
EndoH functions by detecting proteins with a high mannose oligosaccharide core. The 
addition of high mannose oligosaccharides usually occurs within the ER. Upon entry 
into the Golgi apparatus, these sugars are modified to an extent where they are no longer 
a substrate for EndoH. Therefore, EndoH-resistant forms are thought to traffic through 
the Golgi, whereas EndoH-sensitive proteins are thought to bypass the Golgi. The pool 
of CD45 EndoH-sensitive proteins also traffic to the PM three times faster than the 
resistant form, leading to speculation that divergent trafficking pathways act as a control 
mechanism in regulating protein modifications and activity (Baldwin and Ostergaard, 
2002). 
 Ist2 is a Saccharomyces cerevisae (yeast) integral PM protein that is synthesised 
from mRNA at localised, specific ER domains. Evidence suggests a novel trafficking 
pathway whereby Ist2 is directly transported from cortical ER exit sites into the PM, 
thus bypassing the Golgi apparatus and components of the conventional secretory 
pathway (Juschke et al., 2004; Franz et al., 2007). 
3.1.3 Connexin trafficking pathways 
 Connexins, along with most integral membrane proteins are synthesised by 
bound ribosomes and are co-translationally inserted into the ER membrane. 
insertion into the PM, connexin subunits must oligomerise into hexameric 
Within the ER most connexins are sorted, assembled into connexons and trafficked 
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the conventional secretory pathway (Yeager et al., 1998; Segretain and Falk, 2004; 
Thomas et al., 2005; Laird, 2006). The exact intracellular location of connexon 
assembly may be unique to the connexin and cell type, with some studies 
oligomerisation in the ER (Falk et al., 1997; Ahmad et al., 1999; Maza et al., 2005) 
ERGIC (Diez et al., 1999). Other studies, however, have shown that Cx43 and 
present in their monomeric form in the Golgi apparatus and oligomerise in the 
(Musil and Goodenough, 1993; Koval et al., 1997; Maza et al., 2003; Das et al., 
Both pathways are summarised in  
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Figure 3-1. A recent study has also argued against Cx32 oligomerisation in the ER and 
suggested instead that connexon formation occurs at a post-ER site, likely to be the 
TGN (Vanslyke et al., 2009).  
 Cx43 is the most widely distributed connexin in the body and has roles in many 
organs, including the heart, skin, eye and brain (as reviewed by Laird, 2006). The 
trafficking pathway of Cx43 has been well characterised, with the common 
understanding that it traffics via the Golgi apparatus and oligomerises into connexons 
before insertion into the PM (Musil and Goodenough, 1993; Laird et al., 1995; Martin et 
al., 2001a; Thomas et al., 2005). These studies found that both endogenous and green 
fluorescent protein (GFP)-tagged Cx43 were sensitive to BFA treatment in a variety of 
mammalian cell lines. After a 6 hour incubation, gap junction plaques were removed 
from the cell surface and intracellular staining exhibited an ER-like localisation, 
suggesting that Cx43 required a functional Golgi unit for trafficking to the PM. Similar 
results were also found for tagged (Cx26-YFP) and Cx26-untagged protein trafficking 
in stably transfected mammary-tumour (BICR-M1Rk) and normal rat kidney (NRK) 
cell lines. In further support of this finding, Cx26 and Cx43 ER-to-Golgi transport was 
inhibited by expression of a dominant-negative form of Sar1 (secretion-associated and 
Ras-related protein 1), a guanine triphosphatase (GTPase) that is required for COPII 
coat formation on budding ER vesicles (Thomas et al., 2005). In addition, Cx43-GFP 
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delivery and gap junction regeneration was inhibited by the microtubule disrupting drug 
nocodazole, whereas Cx26-GFP trafficking was unaffected. These data point towards a 
conventional secretory pathway for both Cx26 and Cx43, and a microtubule-dependent 
pathway for Cx43, but not Cx26. 
 The studies mentioned in the previous paragraph suggest that Cx26 follows the 
same conventional trafficking pathway as Cx43 through the Golgi apparatus. However, 
Cx26 homomeric connexons have also been suggested to insert directly into PMs via a 
pathway that does not implicate the Golgi apparatus (Diez et al., 1999). In support of 
this finding, connexons composed of Cx26 have been demonstrated to traffic to the PM 
in the presence of BFA (George et al., 1999; Martin et al., 2001a; Martin et al., 2001b). 
In addition, Cx26 can also post-translationally insert into ER membranes, and possibly 
plasma membranes, in a cell-free translation system – a process that is rarely seen in 
eukaryotes and one that contrasts with the usual co-translational integration into ER 
membranes seen with most other proteins (Ahmad et al., 1999; Ahmad and Evans, 
2002). These data suggest that Cx26 has the potential to reach the PM via a Golgi-
independent pathway. In contrast to the study by Thomas et al. (2005), data presented 
by Martin et al. (2001a) also suggest that connexons composed of Cx26, but not those 
of Cx43, require microtubules to traffic to the PM. These contradictory results have 
raised many questions about the influence of cell type and exogenous expression 
systems used in the study of connexin trafficking. 
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Figure 3-1. Oligomerisation and trafficking pathways of Cx32 and Cx43. 
Evidence suggests that connexins have the potential to oligomerise in the ER (in over-
expression systems), ERGIC (Cx32, green) or the TGN (Cx43, mauve). Both these 
pathways include trafficking through the Golgi apparatus before insertion in the PM. 
From here, connexons dock with compatible connexons on the opposing PM to form 
gap junction channels, which cluster together to form semi-crystalline arrays known as 
gap junction plaques. Adapted from Koval, 2006. 
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3.1.4 Trafficking routes of Cx26 and Cx30 in vitro 
 Since gap junctions in the cochlea are often composed of Cx26/Cx30 
heteromeric gap junctions (Forge et al., 2003b; Yum et al., 2007), it would seem likely 
that they oligomerise prior to insertion in the PM. Thus it would seem likely that Cx26 
and Cx30 trafficking pathways show common features. The reports described in the 
previous section have revealed conflicting data regarding whether Cx26 travels through 
the Golgi apparatus en route to the PM. At the time of study, the trafficking pathway of 
Cx30 had not been investigated.  
 This chapter investigates the trafficking of rodent Cx26 and Cx30 in vitro, with 
particular attention to potential Golgi interactions. Immunofluorescence labelling was 
used to determine intracellular localisation and dye transfer studies to determine the 
extent of functional gap junctional coupling. The Golgi-disrupting drug Brefeldin-A 
(BFA) and temperature manipulation are commonly used to disrupt Golgi-dependent 
protein trafficking to the PM. The techniques and mechanisms are described briefly 
below.  
3.1.4.1 Brefeldin-A 
 BFA is a fungal metabolite often used in protein trafficking studies due to its 
unique ability to disrupt protein trafficking from the ER to Golgi, and its relatively non-
cytotoxic effects (Misumi et al., 1986; Klausner et al., 1992). It functions by inhibiting a 
guanosine triphosphate exchange factor (GEF) that catalyses the activation of a small 
GTPase called Arf1p on Golgi membranes. This process is essential for recruitment of 
coat proteins (COPs) to the membrane and subsequent formation of transport vesicles 
(Helms and Rothman, 1992; Nebenfuhr et al., 2002). In most cells, BFA treatment 
results in the absorption of the Golgi membrane into the ER (Lippincott-Schwartz et al., 
1990). The discovery of unconventional protein secretion has been largely attributed to 
the effects of BFA on cultured cells. In recent years, research has suggested that PM 
cargo may segregate early in the secretory pathway, either in the ER, ERGIC or earliest 
Golgi cisternae and that these proteins traffic to the PM via unconventional (Golgi-
independent) trafficking routes (Prydz et al., 2008; Nickel and Rabouille, 2009; Tveit et 
al., 2009).  
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3.1.4.2 Temperature regulation of trafficking pathways 
 Temperature manipulation is a common technique used to halt the transport of 
proteins in specific intracellular compartments. One of the first experiments to show 
temperature-dependent trafficking through the Golgi was carried out by Matlin and 
Simons (1983). They showed that influenza virus hemagglutinin was terminally 
glycosylated in the Golgi apparatus and trafficked to the cell surface via the TGN. 
Incubation at 20
o
C resulted in continued glycosylation, but a lack of hemagglutinin 
detection at the cell surface, suggesting an accumulation in the Golgi apparatus. This 
process was reversible when the temperature was returned to 37 
o
C. Other studies have 
also used this technique to entrap proteins trafficking through the common secretory 
pathway in the TGN (Griffiths et al., 1989; Sato et al., 2009). Further studies have also 
established a lower temperature block of protein accumulation in the ERGIC. At 15
o
C 
proteins exit the ER but fail to enter the Golgi stacks and accumulate in pre-Golgi 
vacuolar compartments (Saraste and Kuismanen, 1984; Lippincott-Schwartz et al., 
1990; Klumperman et al., 1998; Martinez-Alonso et al., 2005). Using temperature 
manipulation, Musil and Goodenough (1993) were the first to show that Cx43 
oligomerisation occurred within the TGN (at 20
o
C), rather than in the ER (at 15
o
C).  
For the questions being asked here, temperature-blocking of Cx26 and Cx30 at 
20
o
C was utilised as a way of determining whether these proteins pass through the Golgi 
apparatus. At these lower temperatures one would expect an accumulation of protein 
within the Golgi stacks if trafficking is halted at the TGN. If the trafficking is Golgi-
independent then temperature blocking at 20
o
C should have no effect since these 
proteins are presumed to not pass through the TGN. 
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3.2 Results 
3.2.1 Connexin 43 co-localises with the Golgi apparatus 
 Using BFA to disrupt the Golgi apparatus, previous reports have shown Cx43 
traffics through the Golgi before inserting into the PM (Laird et al., 1995). For 
comparative reasons and to standardise our technique, HeLa cells stably expressing 
Cx43 were used to assess Cx43 intracellular localisation and the effect of BFA on gap 
junction formation.  
 Control Cx43-HeLa cells immunolabelled for Cx43 showed an abundance of 
gap junction plaques between cells and intracellular cytoplasmic accumulations (Figure 
3-2Ai). Co-labelling with the cis-Golgi marker GM130 (Figure 3-2Aii) revealed co-
localisation with the Cx43 cytoplasmic accumulations, as depicted by yellow pixels 
(Figure 3-2Aiii). To disrupt ER-Golgi trafficking, cultured cells were treated with 5 
μg/ml BFA for 7 hours prior to fixation. This time was seen as sufficient to allow 
reduction of gap junction numbers, since most gap junctions have a half-life of 1.5-5 
hours at the PM (Fallon and Goodenough, 1981; Laird et al., 1991).  After 7 hours, the 
intracellular localisation Cx43 was diffuse throughout all cells (Figure 3-2Bi). The 
Golgi apparatus was completely disrupted and small GM130-labelled punctae were 
spread throughout the cell cytoplasm (Figure 3-2Bii). This labelling pattern was 
expected since disruption of COPII coat formation by BFA is known to disrupt the 
Golgi structure and cause regression of Golgi membranes into ER/ERGIC 
compartments (as described previously). Therefore, the expression patterns of GM130 
and Cx43 after BFA treatment are likely due to ER localisation (Figure 3-2Biii). 
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Figure 3-2. Cx43 co-localises with the cis-Golgi and is disrupted by BFA.  
(Ai) Control HeLa cells stably expressing Cx43 (red) formed gap junction plaques at 
cell-cell boundaries (closed arrows). (Aii) Staining with anti-GM130 showed the 
structure of the cis-Golgi (green). (Aiii) Cx43 co-localised with GM130 in control cells 
(yellow, open arrows). Nuclei were counter-stained with DAPI (blue). (Bi) Cx43 
localisation was diffuse throughout the cell along with an apparent reduction in gap 
junction numbers after treatment with BFA for 7 hrs. (Bii) Confirmation of Golgi 
apparatus disruption (note the dispersed green staining). (Biii) Cx43 no longer 
accumulated in a specific sub-cellular region after Golgi dispersal. Insets show detail in 
regions delineated by dashed boxes. Scale bars 20 µm. 
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3.2.2 Connexin 26 localises to the Golgi apparatus 
 HeLa cells stably expressing Cx26 showed less intracellular staining compared 
with Cx43-HeLa cells, and had only small Cx26 punctae within the cell cytoplasm 
(Figure 3-3Ai). Co-labelling with GM130 did not reveal any direct co-localisation, as 
determined by yellow pixels (Figure 3-3Aii-iii). However, upon closer inspection, many 
of the Cx26-labelled granules were localised to the vicinity surrounding the cis-Golgi 
cisternae (Figure 3-3Aiii, inset). After 7 hours of BFA treatment, Cx26 appeared 
dispersed throughout the cells’ cytoplasm (Figure 3-3Bi), in a similar, but not identical 
pattern to the disrupted GM130 labelling (Figure 3-3Bii-iii). These data suggest that 
Cx26 is localised to the Golgi region and possibly locates to an ER-like compartment 
upon BFA treatment. It is difficult to determine conclusively that Cx26 was localised 
within the Golgi compartment due to a lack of direct co-localisation with GM130 (i.e. 
lack of yellow pixels). However, the Cx26-labelled granules that localised specifically 
around the GM130 marker could represent budding vesicles from the cis- or medial-
Golgi stacks. 
To further investigate whether Cx26 traffics through the Golgi apparatus, normal 
HeLa cells were transiently transfected with two mutant constructs that confer 
syndromic hearing loss (i.e. also cause skin disease). These were developed previously 
by Marziano et al. (2003), and contain a single dominant mutation in the GJB2 gene 
(G59A and D66H). D66H does not traffic to the PM and instead accumulates in an 
intracellular compartment localised to the perinuclear region. G59A also accumulates in 
an intracellular compartment, but a proportion can traffic to the PM to form non-
functional gap junctions (Marziano et al., 2003; Thomas et al., 2004). These mutations 
were used to determine whether accumulation occurs in the cis-Golgi compartment. 
HeLa cells transfected with D66H-eGFP showed accumulation in the cis-Golgi 
apparatus as shown by the strong co-localisation (yellow pixels) with GM130, and did 
not form gap junction plaques (Figure 3-3Ci-iii). The G59A-eGFP mutant formed small, 
gap junction plaques and also accumulated in the cis-Golgi apparatus as shown by its 
co-localisation with GM130 (Figure 3-3Di-iii). It is evident that the trafficking of these 
two Cx26 mutants accumulates (G59A) and stalls (D66H) at the cis-Golgi apparatus. 
These data suggest further that Cx26 must travel through the Golgi before reaching the 
PM and that mutations in this gene can affect the normal trafficking route through the 
secretory pathway. 
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Figure 3-3. Connexin 26 mutants co-localise with the cis- Golgi  
(Ai-iii) HeLa cells stably expressing Cx26 (red) show Cx26-labelled granules 
surrounding the cis-Golgi marker GM130 (green). Arrow, enlarged region within the 
inset. Nuclei were counterstained with DAPI (blue). (Bi-iii) Cx26 was dispersed along 
with the Golgi apparatus after 7 hrs BFA treatment. (Ci-iii, Di-iii) HeLa cells were 
transiently transfected with two different constructs that contain a single, dominant 
mutation in the GJB2 gene (D66H and G59A) – both of which cause syndromic 
deafness. Both mutations show co-localisation with the cis-Golgi compartment 
(yellow). Scale bars 10µm. 
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3.2.3 Connexin 30 does not co-localise with the Golgi apparatus 
 At the time of study, no other publications had reported the trafficking pathway 
of Cx30. Immunofluorescent labelling was investigated in HeLa cells stably expressing 
Cx30. The cells displayed distinct gap junction plaques, but, in contrast to Cx26 and 
Cx43, had no discernible intracellular labelling when the detection levels were 
comparable to those used for Cx26 (Figure 3-4Ai-iii). However, when the detector gain 
levels were increased so that immunofluorescence levels were saturated, some Cx30 
intracellular localisation became apparent (Figure 3-4Bi-iii). Although both Cx30 and 
GM130 labelling were localised in similar regions of the cell, they did not exhibit any 
direct co-labelling (determined by yellow pixels) and appeared to segregate into 
separate compartments. Gap junction plaques were still visible after treatment with BFA 
for 7 hours, and some intracellular Cx30 vesicle-like structures were apparent in the 
cytosol (Figure 3-4Ci-iii). The Cx30-labelled vesicles were distinct from GM130-
labelled punctae and could have been formed by endocytosis from gap junction plaques. 
Thus, Cx30 intracellular labelling, although present at much lower levels, exhibited 
different patterns to both Cx26 and Cx43 and did not co-localise with the cis-Golgi 
compartment. 
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Figure 3-4. Connexin 30 does not co-localise with the Golgi apparatus.  
(Ai-iii) Immunostaining of HeLa cells stably expressing Cx30 (red) did not show 
intracellular localisation in the cytoplasm or in the cis-Golgi (green) when the detector 
levels were comparable to those used for Cx26 (Figure 3-3A). Nuclei were 
counterstained with DAPI (blue). (Bi-iii) However, faint intracellular localisation was 
visible when focused on one cell and with the detector of the red channel raised to a 
saturation level. Insets show a more detailed image of the cis-Golgi region and revealed 
that the faint Cx30-labelling was distinct from GM130 labelling (arrow). Note the lack 
of yellow pixelation. (Ci-iii) Cells treated with BFA for 7 hours revealed similar gap 
junction plaques (bright red patches) and possibly more Cx30 positive granules in the 
cytoplasm. Scale bars 5 µm. 
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3.2.4 BFA effect on dye transfer in Cx43, Cx26 and Cx30-HeLa cells 
Injection of small molecular dyes and subsequent intercellular transfer can be a 
useful technique for determining the presence of functional gap junctions between cells 
in culture or in situ (Jagger and Forge, 2006). This technique was used here to quantify 
the extent of gap junctional intercellular communication (GJIC) in Cx-HeLa cells before 
and after BFA treatment. HeLa cells were used for in vitro studies since these cells do 
not express any known connexins (Eckert et al., 1993; Elfgang et al., 1995), which 
permits the use of dye transfer as a quantitative way of measuring functional gap 
junction coupling. Cells were plated onto 9 mm glass coverslips and grown to a 
monolayer confluency of 85-95%. Intracellular recording solution containing the gap 
junction permeable dye neurobiotin (NBN; charge, +1; MW, 287 Da) was introduced 
into a single cell using the whole-cell patch clamp method. Previous studies have shown 
that a 10 minute period is sufficient to permit extensive dye spread (Jagger and Forge, 
2006). After this period, cells were fixed and fluorescently labelled (as described in 
materials and methods). For BFA treatment, cells were incubated with media containing 
5 µg/ml BFA for 6-7 hours before whole-cell dye injections were performed. BFA was 
also included in the bath solution to maintain Golgi disruption.  
In control Cx43-HeLa cells, NBN introduced into a single cell spread 
extensively between gap junction-coupled cells (average of ~150 cells, Figure 3-5Ai-
iii). Incubation with BFA for 7 hours caused a 60% decrease in the number of cells 
containing NBN (average of ~60 cells), suggesting a strong reduction in the number of 
gap junctions. These data, taken together with the immunofluorescence labelling, agree 
with previous reports that Cx43 traffics through the Golgi apparatus en route to the PM, 
and standardises our experimental technique for investigating Cx26 and Cx30 
trafficking. Control Cx26-HeLa cells exhibited wide-spread NBN transfer (average of 
~290 cells) after 10 minutes of dye injection (Figure 3-5Bi-iii). The amount of dye 
spread was reduced by 86% (to ~40 cells) after 7 hour incubation with BFA. These data, 
along with the Cx26-HeLa immunofluorescence labelling and mutant transfections, 
strongly indicate that Cx26 traffics through some component of the Golgi apparatus en 
route to the PM in HeLa cells. Immunofluorescence labelling did not yield definitive 
results regarding Cx30 localisation at the Golgi. Dye transfer studies have, however, 
helped to elucidate that Cx30 may traffic to the PM via a Golgi-independent route. 
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There was no significant difference between the number of cells containing NBN after 7 
hours BFA treatment (~60 cells) in comparison to control cells (~65 cells, Figure 3-5Ci-
iii), suggesting that Cx30 trafficking is not dependent on an intact Golgi apparatus in 
HeLa cells. 
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Figure 3-5. Dye transfer in Cx30-HeLa cells is not inhibited by BFA. 
Neurobiotin (NBN, red) was introduced into single Cx43 (Ai), Cx26 (Bi) and Cx30 (Ci) 
HeLa cells via a patch pipette and allowed to diffuse through gap junctions for 10 
minutes before fixation. Nuclei were labelled with DAPI (blue). Representative images 
of NBN transfer in Cx43 (Aii), Cx26 (Bii) and Cx30 (Cii) HeLa cells after 7 hrs BFA 
treatment. (Aiii) BFA caused a significant reduction (P<0.0001) in the number of 
Cx43-HeLa cells containing NBN. (Biii) BFA also significantly reduced (P<0.0001) 
NBN transfer in Cx26-HeLa cells. (Ciii) There was no significant difference 
(P=0.6562) in the number of Cx30-HeLa cells containing NBN after BFA treatment. n 
= number of dye injections. Scale bars 50 µm. 
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3.2.5 Cx26 and Cx30 do not accumulate in the Golgi apparatus when TGN exit is 
blocked 
Incubation of cells at temperatures of 15-20
o
C have been used to block 
trafficking at certain points along the secretory pathway. Cells cultured at 15
o
C 
accumulate newly synthesised proteins in the ER/ERGIC (Klumperman et al., 1998; 
Martinez-Alonso et al., 2005), whereas cells incubated at 19-20
o
C permit exit from the 
ERGIC into the Golgi stack, but block release from the TGN (Matlin and Simons, 1983; 
Saraste and Kuismanen, 1984; Griffiths et al., 1989; Lippincott-Schwartz et al., 1990). 
Temperature manipulation was used here to try and elucidate whether Cx26 and Cx30 
traffic through the Golgi apparatus. The aim of the experiment was to determine 
whether either connexin accumulates in the Golgi stack upon temperature reduction.  
Transfected HeLa cells stably expressing Cx26 or Cx30 were incubated at 19
o
C 
for 2, 4 and 8 hours before fixation and immuno-staining. In control cells (37
o
C), gap 
junction plaques were visible between cell-cell contacts, but intracellular staining was 
minimal (Figure 3-6A, E). After 2 hour incubation at 19
o
C, the cis-Golgi apparatus in 
both cell lines appeared to condense and lose its tubular structure. However, no 
accumulation or co-localisation with the GM130 marker was noticeable for Cx26 or 
Cx30 (Figure 3-6B, F). Increasing the incubation times to 4 (Figure 3-6C, G) and 8 
(Figure 3-6D, H) hours at 19
o
C did not induce any changes in connexin localisation. In 
addition, most cells were still connected by large gap junction plaque.  Consequently, 
there was no apparent accumulation of Cx26 or Cx30 in the Golgi at 19
o
C.  
 These data are difficult to interpret. For Cx26, which is BFA-sensitive, it was 
expected that blocking TGN exit at 19
o
C would lead to an accumulation in some part of 
the Golgi compartment and a stark reduction in gap junction plaques after 8 hours. In 
comparison, Cx30 was not expected to accumulate in the Golgi if it is trafficked to the 
PM in a Golgi-bypass manner. It could be that the amount of time required for 
significant Cx26 accumulation to occur in the Golgi is longer than the incubation times 
used. Therefore, Cx26 accretion would not be apparent with immuno-localisation 
studies. It is also possible that Cx26 buds off from cis or medial- Golgi compartments, 
rather than trafficking through to the TGN.  This would explain why Cx26 is sensitive 
to BFA, yet does not show any localisation within the Golgi stack. Cx30 on the other 
hand might not accumulate in any of the Golgi stacks due to its possible Golgi-bypass 
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route. A positive control that shows protein accumulation in the Golgi is required to 
determine whether TGN exit was significantly blocked in these cells. Cx43-HeLa cells 
were not used as a positive control since they localise strongly to the Golgi complex in 
normal conditions, therefore, immuno-labelling would not yield informative results. 
Ideally dye transfer experiments would have been implemented to allow quantification 
of the extent of gap junctional coupling. Connexins that traffic through the Golgi and 
are blocked from TGN exit would, in theory, have a reduction in the number of gap 
junctions, thus reducing the extent of gap junctional intercellular communication. This 
experiment was not possible due to problems of maintaining the cells at 19
o
C on the 
electrophysiology rig. 
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3.2.6 Trafficking routes of native Cx26 and Cx30: the quest for endogenous 
Cx26/Cx30 expressing cells  
Stably-transfected cell lines are useful models for trafficking experiments as 
these systems allow the researcher to directly regulate the expression of genes of 
interest. There are, however, conflicting results in the literature (especially for Cx26) 
when using in vitro techniques (for example, Martin et al., 2001a; Thomas et al., 2005). 
With this in mind, and to verify results obtained from heterologous expression systems, 
cell lines were also created from both adult guinea-pig and rat cochlear lateral wall 
fibrocyte cultures. These cells express significant amounts of Cx26 and Cx30 in vivo. 
Five different fibrocyte subtypes have been classified in the lateral wall according to 
their immunohistochemical expression and localisation within the spiral ligament (see 
Table 3-1). This profile was used to ascertain which subtype had been cultured, with the 
view of using these cells to repeat the trafficking experiments. Given that fibrocytes 
express both Cx26 and Cx30 in vivo these cells would represent an excellent model 
system to assess whether the trafficking properties of these connexins match those in 
vitro or change when expressed simultaneously in the same cell type. These cells were 
also identified as a possible model to investigate the intracellular location of Cx26/30 
oligomerisation.  
In vitro techniques have been invaluable for studying protein trafficking and 
intracellular localisation, but they may not represent the true in vivo expression pattern. 
Accordingly it would be beneficial to confirm the trafficking results seen so far by 
repeating the experiments on a cell line that endogenously express Cx26 and Cx30. 
Most of the fibrocytes in the lateral wall express both these connexins and can be 
cultured readily (Gratton et al., 1996; Yoshida et al., 1999; Suko et al., 2000; Shen et 
al., 2004). However, connexin expression in cultured fibrocytes has not been reported 
previously. This was investigated here using adult guinea-pig preparations. Lateral wall 
sections were plated onto collagen coated coverslips and cultured as described in 
material and methods (Figure 3-7A-C). Healthy cell lines were maintained for up to ~20 
passages. 
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Immunohistochemical Profile of Lateral Wall Fibrocytes (in vivo expression 
data) 
Antigen Type I Type II Type III Type IV Type V 
Vimentin + - + + - 
Cytokeratins - - - - - 
Carbonic anhydrase II + - + + + 
Creatine Kinase-BB + - + + + 
Ca-ATPase + - - - - 
Na-K-ATPase - + - + + 
Caldesmon + + + N/D N/D 
S-100 + +/- - + + 
Aquaporin-1 - - + - - 
 
Table 3-1. Immunohistochemical profile of lateral wall fibrocytes. 
Cultured fibrocytes can be classed into subgroups depending on their location in the 
lateral wall (Spicer and Schulte, 1991) and by the expression of the above proteins (in 
vivo). From Gratton et al., 1996, Suko et al., 2000, Liang et al., 2003 Qu et al., 2007 
Mutai et al., 2009. See Figure 3-7 for a diagram of fibrocyte locations in the lateral wall. 
N/D, not described. 
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 Immunofluorescence experiments on subcultured fibrocytes showed labelling 
for both S-100 (Figure 3-7D) and vimentin (Figure 3-7E), but not for Na
+
-K
+
-ATPase 
(Figure 3-7F). This indicated that the cells mostly resembled type I fibrocytes 
(according to the immunohistochemical profile in table 1), and would be expected to 
express both Cx26 and Cx30. However, neither the mRNA (data not shown) nor the 
protein of Cx26 (Figure 3-7G) or Cx30 (Figure 3-7H) were detected in these cells. Gap 
junctional intercellular communication was confirmed though by dye injection of NBN 
and Lucifer Yellow (LY), both of which transferred between numerous fibrocytes 
(Figure 3-7I). Accordingly, the connexin expression of the fibrocytes was investigated.  
 Reverse-transcription PCR (RT-PCR) confirmed the absence of Cx26 and Cx30 
mRNA (data not shown), but revealed bands for both Cx43 (167 bp) and Cx31 (232 bp) 
in cultured fibrocytes (Figure 3-8A, C). Immunofluorescence labelling of Cx43 revealed 
extensive staining at cell-cell boundaries and strong co-localisation with the Golgi 
apparatus (Figure 3-8B) in a similar pattern to that in Cx43-HeLa cells. Cx31 staining 
was not as uniform compared to Cx43, but did reveal strong intracellular and possible 
PM localisation (Figure 3-8D). Consequently the fibrocytes did not express endogenous 
Cx26 or Cx30 in culture and so could not be used for trafficking experiments. Similar 
results were obtained with cultured rat fibrocytes (data not shown). 
88 
 
  
Figure 3-7. Cultured fibrocytes express type I markers, but not Cx26 or Cx30 in 
vitro. 
(A) Lateral wall fibrocytes are classified into five subgroups according to their protein 
expression (see Table 1) and location. (B) Primary cell cultures were obtained from 
lateral wall dissections and (C) subcultured onto coverslips. Secondary cultures labelled 
for S-100 (D, red) and vimentin (E, green), but not Na
+
-K
+
-ATPase (F) indicating that 
these cells were most likely type I fibrocytes. Cx26 (G) and Cx30 (H) protein 
expression was absent, despite being ubiquitously expressed by type I fibrocytes in 
vivo. (I) Following a whole-cell patch clamp recording, NBN and Lucifer Yellow dyes 
were detected in numerous fibrocytes, suggesting the presence of gap junctions (NBN, 
red; LY green). Scale bars; D-F, 50 μm; G, H, 10 μm; I, 100 μm. 
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Figure 3-8. Cultured fibrocytes express Cx43 and Cx31.  
(A) RT- PCR of cultured fibrocyte lysates revealed the presence of Cx43 (lane 3, 167 
bp) and Cx31 (lane 6, 232 bp) mRNA. Lanes 1 + 4, water controls; lanes 2 + 5, no 
reverse transcriptase controls. (B) Cx43 expression (red) was confirmed by 
immunofluorescence labelling and was localised at cell-cell boundaries. (B’) In 
addition, Cx43 strongly co-localised with the cis-Golgi marker, GM130. (D) Cx31 was 
detected by a polyclonal antibody raised against human Cx31 (from Prof. D. Kelsell). 
(D’) Merged image, counterstained with alpha-tubulin. Cx31 was evident intracellulary 
and at cell-cell boundaries. Nuclei were counterstained with DAPI (blue). Scale bars 20 
μm.  
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3.3 Discussion 
Our understanding of the life-cycle of Cx26 and Cx30 proteins and gap junction 
regulation in the inner ear is lacking. This chapter has investigated the in vitro 
trafficking pathways of Cx26 and Cx30, with the future aim of understanding how and 
where these connexins oligomerise within the cell. Stably transfected Cx26-, Cx30- and 
Cx43-HeLa cells were immuno-stained to determine the intracellular localisation of 
connexins. BFA was used to disrupt the Golgi apparatus and thus block ER-to-Golgi 
transport and dye transfer studies were used to quantify the effect of BFA on gap 
junctional coupling. The results indicated a Golgi-dependent pathway for Cx26 and 
Cx43 transport to the PM, whereas Cx30 data suggested a Golgi-independent pathway. 
These data were unexpected since Cx26 and Cx30 form heteromeric connexons and so, 
were expected to follow similar pathways. These findings are discussed below. 
Attempts were also made to culture a cell line that would express native Cx26 and 
Cx30, and thus avoid possible issues with connexin overexpression. 
3.3.1 Cx26 and Cx43 are trafficked via the Golgi apparatus 
 Proteins that travel along the conventional secretory pathway are transferred 
from the ER via ER exit sites to the cis-Golgi, through the Golgi stacks and then 
onwards to the PM via small vesicles that bud off from the trans-Golgi network 
(Rothman, 1994; Lee et al., 2004; Nakano and Luini, 2010). Trafficking of Cx43 is 
well-documented, and has been shown to transport through the Golgi apparatus, with 
oligomerisation occurring in the TGN before insertion into the PM (Musil and 
Goodenough, 1993; Koval et al., 1997). Considering the short half-life (1-2 hours) of 
Cx43 at the PM (Laird et al., 1991; Beardslee et al., 1998), it would seem likely that a 
continual production line of Cx43 protein, passing from the cis- to trans-Golgi 
compartments, is required to maintain gap junction formation. This was apparent in the 
immunofluorescence labelling shown in Figure 3-2. In addition, BFA treatment 
dispersed Cx43-labelling within the cytoplasm and caused a significant reduction in dye 
transfer. Consequently Cx43-HeLa cells were a useful model system for BFA 
sensitivity experiments, and results matched those of others (Musil and Goodenough, 
1993; Laird et al., 1995; Martin et al., 2001a; Thomas et al., 2005). 
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 As suggested elsewhere (Thomas et al., 2005), data presented here indicates that 
Cx26 trafficking depends on a functional Golgi apparatus. In comparison to Cx43, there 
was no direct overlap in expression (co-localisation) with the cis-Golgi marker GM130. 
There was also a lack of condensed intracellular accumulation, however small Cx26-
positive granules were clearly visible and were concentrated around the cis-Golgi 
compartment. This localisation may represent Cx26-vesicle budding from early Golgi 
stacks before they reach the TGN. Budding and trafficking of vesicles to the PM before 
entering the TGN would represent a unique trafficking pathway for Cx26 and one that 
would require less time to reach the PM. These ideas are discussed in more detail 
below. In addition, since Cx26 labelling was only found in small granules, these regions 
may represent areas of Cx26 oligomerisation. The close proximity and clustering of 
connexins during this process may enhance the immunofluorescence signal and may 
explain why Cx26 fluorescence was not observed in the rest of the Golgi stack. 
However, it cannot be ruled out that differences in the intracellular localisation of 
connexins (i.e. Cx43 v Cx26) in these transfected cell lines may be due to differences in 
the amount of protein expression.  
 One explanation for the lack of direct co-localisation with the cis-Golgi marker 
GM130 could be that Cx26 spends less time within the Golgi or might not actually enter 
the late Golgi compartments (Figure 3-9). Diez et al. (1999) show in liver subcellular 
fractions that Cx26 is present in much lower amounts in the Golgi heavy fraction 
(compared to Cx32), but is present in the ER and ER-Golgi-intermediate compartment 
(ERGIC). The authors suggest that oligomerisation may occur in the ER or ERGIC (as 
in agreement with Falk et al., 1994) since these fractions contain monomeric and 
oligomeric configurations and that these have the potential to traffic to the PM via a 
pathway that does not implicate the Golgi apparatus. In contrast, the dye transfer 
experiments presented here showed that Cx26 trafficking was sensitive to BFA 
treatment, as in agreement with (Thomas et al., 2005), which suggests a reduction of 
Cx26 gap junction plaques at the PM. Cx26 immuno-labelling revealed small vesicles 
surrounding the cis-Golgi, which could represent regions of Cx26 oligomerisation 
before budding off and transporting to the PM. Alternatively, oligomerisation could 
occur within the ER/ERGIC compartment and then transfer to the cis-Golgi. From this 
point connexons could rapidly bud off from the stack, thus preventing a build-up of 
Cx26 in the Golgi apparatus (Figure 3-9). This observation can be supported by a study 
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by George et al. (George et al., 1999) which showed that Cx26 delivery to the PM 
occurred within 5 minutes. In contrast Cx43 (10 mins) and Cx32 (15 mins), which both 
traffic to the TGN, had slower rates of appearance at the PM. Therefore, Cx26 could be 
adapted to traffic via a pathway that is less time-limiting, which may involve budding 
from the classical secretory pathway before trafficking to the TGN. This hypothesis 
would fit with the data shown here since Cx26 immuno-labelling did not directly co-
localise or accumulate with GM130-labelled compartments. In addition, Cx26 did not 
accumulate at a temperature that blocks TGN exit (19
o
C), yet gap junctional 
communication was dependent on a functional Golgi apparatus as seen by its sensitivity 
to BFA.  
 The debate regarding the Cx26 trafficking pathway persists. The disparity 
between different studies could be due to various experimental conditions and systems 
used. For example, exogenous over-expression of connexins can induce changes in their 
trafficking and/or oligomerisation. A recent study by Van Slyke et al. (2009) found that 
Cx43, Cx32 and Cx26 subunit assembly into connexons can be influenced to take place 
in the ER of cells by strong over-expression. In contrast, the authors suggest that with 
endogenous levels of expression, oligomerisation occurs in the Golgi apparatus. 
Therefore, the number of over-expressed connexin 26 units in those studies that suggest 
Cx26 is BFA-insensitive, could have influenced the site of oligomerisation and their 
finding of direct trafficking to the PM from the ER (George et al., 1999; Martin et al., 
2001a; Martin et al., 2001b).  
Variations in protein trafficking can also be dependent on cell type (reviewed by 
Nickel and Rabouille, 2009). One example where this has been shown involves the 
cystic fibrosis trans-membrane conductance regulator (CFTR). CFTR has been shown 
to bypass the Golgi in a non-conventional pathway in both baby hamster kidney (BHK) 
and Chinese hamster ovary (CHO) cells (Yoo et al., 2002; Okiyoneda et al., 2004; 
Wang et al., 2004). However, the same results were not found in HeLa or 293T cells 
(Yoo et al., 2002). The authors note that CFTR transport from the ER is cell-type 
specific, which has also been shown by cAMP stimulating CFTR vesicle trafficking to 
the cell surface in some cell types, but not others. Consequently it is essential to note 
that in vitro experiments utilising genetic expression vectors may not replicate the in 
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vivo state. It would be advisable to repeat future experiments on other cell lines or use 
systems that express the protein/s of interest endogenously. 
The results with Cx26 seen by Thomas et al. (2005) tend to agree with the 
results shown here, which suggest that Cx26 is sensitive to BFA and, therefore, passes 
through some component of the Golgi apparatus en route to the PM. Thomas et al. use 
normal rat kidney (NRK) and rat mammary BICRM1Rk tumour cells for their 
experiments, both of which express Cx43 endogenously. Expression of untagged and 
GFP/YFP-tagged Cx26 had almost identical results to Cx43 in both of these cells lines. 
Cx26 trafficking was disrupted upon treatment with BFA, and revealed results similar to 
those seen here, with noticeable Cx26 immuno-labelled vesicles surrounding the 
apparent cis-Golgi localisation. The influence of endogenous Cx43 on Cx26 should be 
minimal since Cx26 belongs to the β group of connexins and Cx43 to the α group. 
There is no evidence of co-assembly between connexins of different families – apart 
from point mutations that lead to a gain-of-function effect (Rouan et al., 2001). A 
separate study by Thomas et al. (2004) also suggests that Cx26 traffics all the way 
through the Golgi apparatus to the TGN. This is based on their finding that when cells 
transfected with Cx26-D66H (Golgi localised) were treated with BFA, a small 
compartment labelled by BODIPY did not retract into the ER. BODIPY is a dye used to 
label all parts of the Golgi network. The cis-Golgi, labelled with GM130, retracted into 
the ER system along with the Cx26-D66H contained in these compartments, leaving the 
remaining BODIPY structures (presumed TGN) co-labelled with Cx26-D66H intact. 
This would contradict the hypothesis that Cx26 buds off from the Golgi stacks before 
reaching the TGN. However, since this is a mutant protein which fails to leave the 
Golgi, the resultant accumulation could be expected to spread between all 
compartments.  
Together, the data presented here points towards a Golgi-dependent trafficking 
pathway for Cx26 transport to the PM.  
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Figure 3-9. A preliminary summary of potential Cx26 and Cx30 trafficking 
pathways.  
Based on the data shown here, and in combination with other studies, there are four 
likely candidates for Cx26 and Cx30 trafficking to the PM. 1) Evidence points 
towards a Golgi bypass route for Cx30 since there was no co-localisation with the 
cis-Golgi and BFA did not reduce GJIC. In addition, impermissible exit from the 
TGN at 19 
o
C did not result in Cx30 accumulation in the Golgi. 2) and 3) Cx26 
transport to the ERGIC is dependent on COPII formation at the ER (Thomas et al., 
2005). Cx26 is also highly sensitive to BFA, suggesting that it traffics through some 
part of the ERGIC/Golgi system. Since immuno-labelling revealed distinct Cx26 
punctae surrounding the cis-Golgi and incubation at 19 
o
C did not induce 
intracellular accumulation, one could postulate that Cx26 buds off from the ERGIC 
or early Golgi compartments without passing through to the TGN. 4) Alternatively, 
Cx26 may traffic conventionally to the TGN; however, the lack of Cx26 
accumulation at reduced temperature shifts suggests that this pathway is questionable 
(faded connexons). 
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3.3.2 Cx30 trafficking may bypass the Golgi apparatus 
 At the time of study, the trafficking pathway of Cx30 had not been examined 
previously. To elucidate whether Cx30 traffics through the Golgi apparatus HeLa cells 
stably expressing Cx30 were treated with BFA and processed for immunofluorescence-
localisation or dye transfer as discussed above. Immuno-labelling initially revealed 
extensive gap junction-like plaques at cell-cell boundaries with very little discernible 
intracellular staining. There was no apparent localisation in Golgi structures, nor were 
there any Cx30-containing vesicles emanating from the Golgi stacks. However, when 
the detection levels were increased so that gap junctions were saturated, faint 
intracellular labelling became visible in some cells. The pattern of staining was 
unexpected since it did not show co-localisation with GM130 and was not vesiculated 
as seen with Cx26. Instead, the pattern appeared to follow a tubular, organelle-like 
labelling that was distinct from the cis-Golgi. This pattern of labelling could represent 
the ERGIC or ER compartments and could be tested by co-labelling with ER or 
ERGIC-specific markers. Upon BFA treatment, gap junctions persisted at the PM and 
some Cx30-labelled vesicles could be seen in the cell’s cytoplasm. These vesicles did 
not co-localise with the vesiculated GM130-labelled Golgi membranes, and could 
represent endocytosed regions of the PM containing Cx30 gap junctions. 
 Cx30-HeLa dye transfer experiments revealed a stark difference in the extent of 
NBN transfer after BFA treatment, compared with Cx26 and Cx43. The number of cells 
containing NBN after 7 hours BFA did not change in comparison to untreated cells and 
actually showed a small (but insignificant) increase. This suggests that connexons were 
transported to the PM in a pathway that was unaffected by BFA treatment. This was 
somewhat unexpected since Cx26 and Cx30 have been shown to co-assemble into 
heteromeric connexons, which would suggest that the trafficking pathways follow 
similar routes. 
 During the course of this study, and in agreement with the results shown here, a 
publication by Qu et al. (2009) also showed that Cx30 gap junctions were insensitive to 
BFA treatment. The authors showed that the percentage of Cx30 gap junction-paired 
cells versus the total paired Cx30-expressing cells did not differ between control and 
BFA treated cells (5 μg/ml, 5 hours). In comparison, cells treated with cytochalasin B, a 
drug that disrupts actin filaments by blocking monomer addition at the fast-growing 
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end, caused a marked decrease in the percentage of gap junction-paired cells (from 70% 
to 10%). The observed insensitivity of Cx30 to BFA treatment supports the data shown 
here. In addition, cytochalasin B sensitivity suggests that actin filaments play a role in 
anchoring and stabilising Cx30 gap junctions at the PM. The authors also propose that a 
portion of Cx30 may traffic a short-distance directly from the ER to the PM in an actin-
dependent manner (Figure 3-9). In addition, the presence of ER-plasma membrane 
“bridges” (Levine and Rabouille, 2005), may allow direct transportation of Cx30 
connexons from the ER to the plasma membrane without passing through the Golgi 
apparatus (Qu et al., 2009). 
3.3.3 Alternative explanations for Cx30 BFA-insensitivity 
 Cx30 turnover dynamics have not yet been studied. Even though most gap 
junctions have a half-life of 1.5-5 hours at the PM (Fallon and Goodenough, 1981; 
Traub et al., 1987; Laird et al., 1995; Darrow et al., 1995; Laing and Beyer, 1995; 
Beardslee et al., 1998), the possibility that Cx30 may have an unusually long half-life 
cannot be ruled out. If this is the case then trafficking of Cx30 may appear to be BFA-
insensitive. A recent study has shown that pannexins (Panx) are insensitive to BFA, yet 
evidence also points towards a conventional trafficking route. Penuela et al. (2007) have 
shown that cell surface expression of Panx1 and Panx3 was unaffected by 6 hours of 
BFA (5 μg/ml) treatment, whereas Cx43 expression was lost from the PM with a 
concomitant increase in intracellular labelling. These data indicate that pannexins may 
be able to traffic to the membrane unconventionally. However, in the same study, 
treatment with cycloheximide (CHX), which is a potent inhibitor of protein synthesis, 
for up to 8 hours did not affect the amount of Panx1 protein, whereas Cx43 levels were 
decreased. If pannexins had a short half-life (like connexins) it would be expected that 
the protein level would decrease with time during CHX treatment. These data suggest 
that pannexins have distinct properties from Cx43 in that they have much slower turn-
over kinetics and a longer half-life. An unusually long half-life at the PM could also 
explain why Cx30 was not affected by BFA treatment. CHX could be a useful tool for 
future experiments to determine the half-life of Cx30 protein at the PM in HeLa cells.  
 Alternatively, Cx30 may have the capacity to recycle via endosomal structures. 
Instead of internalised gap junctions being degraded, the vesicles may be transported to 
the endosome and then recycled back to the cell surface. Although this process has not 
97 
 
been shown for connexins, studies of other proteins have shown endosomal recycling 
(Maxfield and McGraw, 2004).  
 To verify these hypotheses, an ideal experiment would be to look at the turn-
over rate and trafficking of Cx30 using live-cell fluorescence imaging. To do this, a 
fluorescently tagged connexin construct would be required and would need to be 
expressed in a cell line such as HeLa. Fluorescence recovery after photobleaching 
(FRAP) on a gap junction plaque could then be used to distinguish the rate of turnover 
of Cx30 homotypic gap junctions. Alternatively, a system implementing the bi-arsenical 
labelling of connexins would give a more accurate determination of half-life (Gaietta et 
al., 2002). This system would involve creating recombinant connexin proteins 
containing a tetracysteine (TC) motif (Cys-Cys-Pro-Gly-Cys-Cys) either at the C- or N-
terminus. Visualisation of transient gap junction plaques during live cell imaging would 
be accomplished by incubating the cells in media containing a cell permeable, bi-
arsenical reagent called FlAsH. Upon interaction with the TC motif, the fluorescein 
derivative emits green fluorescence, thus “lighting up” any connexin-TC proteins. Once 
FlAsH is bound, excess reagent can be washed off and changed for media containing a 
red-fluorescent bi-arsenical derivative called ReAsH. Any new connexin-TC proteins 
that form will then incorporate ReAsH. This process will enable the researcher to 
measure the time it takes for the green pre-existing gap junction plaque to be replaced 
by the red connexon units, thus giving a very accurate measurement of turn-over rates. 
BFA experiments could also be repeated using this system, allowing the researcher to 
disrupt the Golgi apparatus before tracking the transport of newly synthesised 
connexins. This will help to elucidate whether the extensive dye transfer seen in Cx30 
HeLa cells during BFA treatment was a result of connexins that traffic via a Golgi-
independent pathway, or whether Cx30 has a much longer half-life at the PM. If the 
latter is true, then Cx30 could function as a “stabilising” connexin. Some of the largest 
gap junction plaques in the mammalian system are found in cochlear regions where both 
Cx26 and Cx30 are co-expressed (Forge et al., 2003a). Thus, Cx30 could have a role in 
extending the life of cochlear gap junctions.  
Either way, it appears that the functional properties of Cx30 are remarkably 
different in comparison to other connexin isoforms. 
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3.3.4 The on-going quest for endogenous Cx26/Cx30 expression 
 Most gap junction studies use cell lines devoid of connexin expression (e.g. 
HeLa cells), thus allowing the researcher to regulate specific connexin subtypes. This 
system is extremely useful for looking at protein dynamics and live-cell imaging, but 
exogenous over-expression may affect normal protein behaviour (as discussed in 
section 3.3.1). Consequently, in vitro trafficking results can vary quite significantly 
between different groups, as is the case with Cx26. To answer the questions of connexin 
trafficking one would ideally want to use cell lines that already express connexins 
endogenously. Unfortunately there are no known cell lines that express just Cx30 or 
both Cx26 and Cx30 endogenously, making these studies difficult. Keratinocytes were 
explored as a possible model, since these cells express both Cx26 and Cx30 and can be 
readily cultured. However, keratinocytes also express Cx30.3, Cx31, Cx31.1 and Cx43 
(Di et al., 2001). The binding of these connexins may alter trafficking routes and would 
pose a problem for dye transfer experiments. Additionally, it has been noted that 
cultured keratinocytes have much lower expression of Cx26 and Cx30, making 
immuno-labelling difficult (personal communication, Dr. D. Becker, UCL). Another 
possible alternative presents in the form of cultured astrocyte cells, which express Cx26, 
Cx30 and Cx43 in vivo. Although some studies suggest the presence of Cx30 in cultured 
glial cells (Kunzelmann et al., 1999), others show that expression of Cx26 or Cx30 were 
almost undetectable (personal communication, Prof. B. Barres, Stanford). In addition 
the glial cultures that did express Cx30 were not uniform throughout - with 
measurements by Kunzelmann et al. (1999) suggesting up to only 15% of cells might 
express Cx30. This low expression number would pose problems for dye transfer 
experiments; therefore it was not viable to culture these cells. 
 Fibrocytes of the cochlear lateral wall were identified as a potential source for 
endogenous expression and were cultured according to Gratton et al. (1996). Cultures 
grew well and immunofluorescence labelling suggested that the cells resembled type I 
fibrocytes. These were expected to express both Cx26 and Cx30 since type I fibrocytes 
express both connexins in vivo. Disappointingly, immunostaining and RT-PCR revealed 
no expression of Cx26 or Cx30. Interestingly however, Cx43 and Cx31 mRNA were 
detected with RT-PCR. Immunostaining revealed distinct Cx43 and possible Cx31-
labelled gap junctions. This finding is intriguing as it suggests that cultured fibrocytes 
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do not maintain the same profile in vitro as they do in vivo. It may suggest that cochlear 
fibrocytes undergo a de-differentiation step to a more primitive, fibroblast-like state 
when in culture. Alternatively the extra space or culture conditions might activate the 
expression of other connexins, whilst down-regulating both Cx26 and Cx30. Another 
explanation could be that a small sub-population of Cx43/Cx31 expressing fibrocytes 
was cultured. For example, type III fibrocytes express Cx43 (Forge et al., 2003a), and 
type II/IV fibrocytes express Cx31 (Xia et al., 2000; Forge et al., 2003a). Consequently, 
cultured fibrocytes, although interesting for their apparent “switch” in connexin 
expression, were not useful for Cx26/Cx30 trafficking studies. 
 Much of the work was spent trying to find and produce a cell line that expressed 
both Cx26 and Cx30 endogenously to address the issues noted. From the cell lines 
researched and cell lines created here, it would appear that Cx26 and Cx30 are down-
regulated in dividing, cultured cells, as is the case with keratinocytes and astrocytes. 
There are some cell lines that either express or can be induced to express Cx26 in 
culture. These include rat liver hepatocytes and a porcine kidney epithelial cell line 
(LLC-PK1-CL-4). In primary hepatocyte cell cultures Cx26 expression is reduced. 
However, addition of S-Adenosylmethionine (Yamaji et al., 2010) or glucagon (Kojima 
et al., 1995) to the culture media can induce both Cx26 mRNA and protein expression. 
On the contrary, both authors point out that PM localisation and GJIC is not increased 
after these treatments, leading to the question of whether these Cx26 subunits are 
functional? The study by Kojima et al. (1995) showed an apparent increase in Cx26-
containing gap junction plaques, so it may be possible to use these cells to study 
endogenous Cx26 trafficking pathways. However, the co-expression of Cx32 in these 
cells may affect intracellular transport and dye transfer studies. Alternatively the LLC-
PK1-CL-4 cell line has been shown to express Cx26 mRNA (D'Souza et al., 2008), but 
to date, no journal publication has shown functional Cx26 gap junctional coupling in 
these cells. These cell types may provide some options for studying endogenous Cx26 
trafficking in the future. To my knowledge, there are no cultured cell lines that express 
Cx30 endogenously, at least to a level required for these experiments. 
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3.4 Conclusion 
 The divergence of trafficking pathways could be an evolutionary mechanism 
designed to prevent certain proteins inter-mixing or a process that allows differential 
trafficking routes and turn-over rates for proteins in particular cell types. The work 
outlined in this chapter seems to point towards separate trafficking pathways for Cx26 
(Golgi-dependent) and Cx30 (Golgi-independent). However, due to the issues and 
problems noted with in vitro techniques these results need to be clarified. If these 
findings prove to be correct, it raises an interesting question as to where in the cell these 
connexins oligomerise into heteromeric connexons. It is possible that in separate 
expression systems homomeric connexons have distinct trafficking properties. Upon 
inter-mixing, Cx26 or Cx30 might have the potential to over-ride a certain trafficking 
pathway dependent upon the hexameric conformation and/or ratios of Cx26 to Cx30. If 
these were true, it would reveal a unique and novel way of regulating many properties 
of the gap junction life cycle, including: turn-over rate, homomeric/heterotypic/ 
heteromeric gap junction configurations and regulation of intermixing between different 
connexin subtypes. Various mutations in Cx26 and Cx30 cause syndromic or non-
syndromic deafness. Changes in trafficking, heteromeric ratios and intermixing as 
caused by mutation may explain why some cases of deafness are non-syndromic 
whereas others associate with syndromic phenotypes i.e. skin disease. 
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4 DEVELOPMENT OF GAP JUNCTIONAL INTERCELLULAR 
COMMUNICATION WITHIN THE LATERAL WALL OF THE 
RAT COCHLEA 
4.1 Introduction 
Functional gap junctions are vital for cochlea function. The previous chapter 
highlighted the possibility that altered trafficking pathways could help regulate 
connexin-intermixing. This effect, and those of mutations, could have consequences on 
gap junctional intercellular communication (GJIC) in both the epithelial and connective 
tissue gap junction networks of the cochlea. It has already been shown that the 
physiological properties of Cx26/Cx30 gap junctions vary depending on their connexin 
composition. In heterologous expression systems, dyes of varying charge and size, such 
as NBN (NBN) (charge, +1; MW, 287 Da) and Lucifer yellow (LY) (charge, -2; MW, 
443 Da), have been used to investigate the permeabilities of gap junctions composed of 
Cx26 alone, Cx30 alone or Cx26 and Cx30 (Manthey et al., 2001; Marziano et al., 
2003). Cx26 homotypic gap junctions are permeable to both LY and NBN, whereas 
Cx30 homotypic gap junctions are permeable to NBN, but not LY. Similarly, 
Cx26/Cx30 heteromeric gap junctions permit NBN transfer, but are impermeable to LY. 
Utilising slices of the rat cochlea, similar techniques have identified areas of 
compartmentalised gap junctional coupling between cells of the epithelial gap junction 
system (Jagger and Forge, 2006). In the hearing cochlea, these compartments are 
separated into medial and lateral GJIC pathways between supporting cells surrounding 
inner and outer hair cells, respectively. These pathways are formed progressively 
through postnatal development and are likely to be involved in buffering or cycling 
excess K
+
 away from the vicinity of hair cells. Importantly, changes in gap junction 
selectivity and conductance during postnatal development correspond to changes in 
Cx26/Cx30 protein expression and gap junction plaque distribution.  
4.1.1 Cochlear fluid compartments 
The mammalian cochlea is composed of three tube-like structures; the scala 
tympani, scala media and scala vestibuli (see Image deleted due to copyright. 
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Figure 4-1), each of which are filled with extracellular fluid. The scala tympani 
and scala vestibuli are filled with perilymph, and scala media with an unusual fluid 
termed endolymph. The mechano-sensitive hair cells in the organ of Corti epithelium 
are bathed in both of these extracellular fluids; endolymph at the apical surface and 
perilymph surrounding the baso-lateral surface.  
Endolymph is a unique extracellular fluid found only in the inner ear. K
+
 
represents the main cation, with an unusually high concentration of ~150 mM, whereas 
Na
+
 (~1-2 mM) and Ca
2+
 (~20 µM) in comparison are unusually low in concentration. 
In contrast, perilymph has an ionic balance that resembles most other extracellular 
fluids in the body, such as plasma and cerebrospinal fluid. This fluid fills the scala 
tympani and vestibuli compartments and any other extracellular space (excluding the 
intrastrial space). Na
+
 represents the main cation in perilymph, with a concentration of 
~145 mM, [Ca
2+
] is also elevated (0.6-1.3 mM), whereas [K
+
] is significantly lower  (4-
6 mM) in comparison to endolymph (reviewed by Wangemann and Schacht, 1996; 
Wangemann, 2006). The intrastrial space represents a third extracellular fluid within the 
cochlea and fills the small extracellular spaces between basal, intermediate and marginal 
cells of the stria vascularis. This tightly packed compartment has a very low [K
+
] (1-2 
mM), and slightly lowered [Na
+
] (~85 mM) in comparison to endolymph and perilymph 
respectively (Salt et al., 1987). 
Auditory transduction depends on the flow of K
+
 from endolymph into hair cells 
via mechano-sensory transducer channels located within hair cell stereocilia. Thus, the 
cochlear partition between endolymph and perilymph is essential for sensory 
transduction. Leakage of perilymph into endolymph, and vice versa, disrupts normal K
+
 
homeostasis and results in hair cell death (Nakano et al., 2009).  
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4.1.2 The endocochlear potential 
Other than differences in ion composition, endolymph differs from perilymph in 
that it generates a very large, positive extracellular potential of around +80-100 mV, in 
respect to perilymph. This positive potential, termed the endocochlear potential (EP), 
was first measured by Georg von Békésy (von Békésy, 1952). The EP, along with the 
high endolymphatic [K
+
], increases the driving force for K
+
 entry into hair cells upon 
mechanical deflection of hair bundles (reviewed by Dallos, 1978). The ionic 
composition of endolymph and development of the EP have been shown to arise 
independently and in succession during cochlear maturation. Before the onset of hearing 
in rats (usually around postnatal day 12, P12), EP has been measured below +20 mV 
(Bosher and Warren, 1971; Rybak et al., 1992). Around P10-P12 there is a rapid 
upswing of the measured value of EP, which increases to a mature level of around +80-
90 mV by P16. Importantly, the ionic composition of endolymph within scala media is 
established earlier in development. The [K
+
] and [Na
+
] reach near mature levels by P7 
(Bosher and Warren, 1971). Comparable development has been observed for the mouse 
cochlea (Yamasaki et al., 2000). 
The source of the EP generating machinery was identified as the stria vascularis 
in 1959 (Tasaki and Spyropoulos, 1959). It comprises of a tripartite structure of 
mesenchyme-derived basal cells, neural crest-derived intermediate cells (melanocytes) 
and epithelial marginal cells (Forge and Wright, 2002). Studies have since found a 
plethora of ion channels, transporters and junctional proteins within both the stria 
vascularis and spiral ligament that are important for maintaining both EP and high 
endolymphatic [K
+
] (Wangemann, 2006; Zdebik et al., 2009; Hibino et al., 2010).  
The potassium channel Kir4.1 and tight junction proteins between apical surfaces 
of basal cells and marginal cells are two components that are essential for EP 
generation. The inwardly-rectifying Kir4.1 channel was first detected in stria vascularis 
tissue by Hibino and colleagues (Hibino et al., 1997) and was thought to localise to 
epithelial marginal cells. However, the correct localisation to intermediate cells was 
later discovered by Ando and Takeuchi (Ando and Takeuchi, 1999), who suggested a 
role for Kir4.1 in K
+
 secretion into the intrastrial space. Knock-out of Kir4.1 (Marcus et 
al., 2002) or treatment with Ba
2+ 
(Marcus et al., 1985; Nin et al., 2008) - a reversible Kir 
channel blocker - both abolish the EP and reduce endolymphatic [K
+
]. Incidentally, the 
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expression profile of Kir4.1 within intermediate cells coincides with development of EP 
from postnatal day 8 onwards (Hibino et al., 1997). These data taken together confirm 
an essential role for Kir4.1 channels in production of the EP and suggest that the 
potential is formed across the intermediate cell membrane. 
Tight junctions between basal cells have also been shown to correlate temporally 
with the period of onset and rise of EP (Souter and Forge, 1998). Claudin-11 is the only 
tight junction protein detected in basal cells, and mice with a deletion of this gene do 
not develop an EP (Gow et al., 2004; Kitajiri et al., 2004). This finding confirms the 
importance of sealing between basal cells and electrical isolation of the intrastrial 
compartment from perilymph. Consequently, the intrastrial space can generate a 
potential of ~+90-100 mV in respect to perilymph, termed the intrastrial potential.  
4.1.3 K+ recycling pathway 
To maintain the EP and high endolymphatic [K
+
] and to prevent pathological 
build-up of K
+
 ions around hair cells, it has been postulated that supporting cells 
spiral ligament fibrocytes play a role in recycling extracellular K
+
 away from the 
of Corti to the stria vascularis (Weber et al., 2001; Wangemann, 2006). The 
proposal for K
+
 circulation arose from observations that radioactive K
+
 was more 
readily detected in endolymph after application to perilymph rather than blood 
(Konishi et al., 1978; Sterkers et al., 1982). In addition, perilymphatic, but not 
perfusion of K
+
-free solution severely suppressed the EP (Wada et al., 1979; 
al., 1981). The authors therefore suggest that the source of K
+
 is more likely to 
from perilymph via a recirculation pathway, rather than from the vasculature. 
proposed pathway consists of gap junction coupled supporting cells within the 
gap junction network and connective tissue gap junction network (Kikuchi et al., 
The expression of certain ion transporters within these networks adds further 
for a trans-cellular K
+
 pathway (see Image deleted due to copyright. 
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Figure 4-1).  
The proposed mechanism for K
+
 cycling has been described in detail elsewhere 
(Kikuchi et al., 2000; Wangemann, 2006; Hibino and Kurachi, 2006; Mistrik and 
Ashmore, 2009; Zdebik et al., 2009; Hibino et al., 2010), but is described only briefly 
here. The general consensus for K
+
 cycling supports the following model: 1) K
+
 from 
endolymph enters hair cells through the stereocilia MET channel in response to sound 
stimulation. Excess K
+
 is extruded into the extracellular space (sometimes referred to as 
cortilymph) from hair cells most likely via KCNQ4 (Kharkovets et al., 2006) and Ca
2+
-
activated BK channels located in their basolateral membrane. 2) Supporting Deiters’ 
cells immediately siphon extracellular K
+
 to prevent hair cell depolarisation and toxic 
K
+
 accumulation. This process likely occurs through K
+
,Cl
- 
co-transporters (Kcc3 and 
Kcc4, Boettger et al., 2002; Boettger et al., 2003) and inwardly rectifying Kir4.1 
channels. 3) K
+
 diffuses between supporting cells through the Cx26/Cx30 epithelial gap 
junction system towards outer sulcus cells. Root cell processes then release K
+
 into the 
perilymphatic space of the spiral ligament most likely via Kir4.1 channels (Jagger et al., 
2010). 4) Type II fibrocytes that surround root cell processes absorb K
+
 from the 
extracellular space through two K
+
-uptake apparatuses; Na
+
,K
+
-ATPase and Na
+
,K
+
-
2Cl
-
 co-transporter (NKCC1). Expression of Kir5.1 in these cells is thought to 
negatively regulate cochlear circulation and prevent its overshoot (Hibino et al., 2004). 
K
+
 then passes through the connective tissue gap junction network towards stria 
vascularis. 5) Kir4.1 channels in intermediate cells continuously secrete K
+
 down its 
electrochemical gradient into the intrastrial space, which is then absorbed through 
Na
+
,K
+
-ATPase and NKCC1 at the basolateral membranes of marginal cells. This 
process maintains a low [K
+
] in the fluid of the intrastrial space and thus facilitates K
+
 
diffusion through Kir4.1 channels. The intrastrial potential has been recorded at +90-100 
mV in respect to perilymph (Salt et al., 1987), which then decreases by ~10 mV across 
the apical membrane of marginal cells, resulting in a potential of +80-90 mV in 
endolymph (Prazma, 1975; Melichar and Syka, 1987). K
+
 absorbed by marginal cells is 
finally secreted back into endolymph via Kv channels composed of KCNQ1 and 
KCNE1 subunits, thus completing the K
+
 cycle. 
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Figure 4-1. Illustration demonstrating the potassium circulation model and 
formation of endocochlear potential.  
(A) K+ is taken up by cochlear hair cells upon deflection of stereocilia and then 
extruded into “cortilymph”. Deiters’ cells absorb excess K+ and transfer it through the 
epithelial gap junction network to outer sulcus/root cells. K+ is extruded and taken up 
by spiral ligament fibrocytes and transferred to the stria vascularis through gap junction 
channels (see detail in B). (B) K+ and Na+ transporters (Na
+
,K
+
-ATPase and NKCC1) 
absorb excess K+ in extracellular space surrounding root cell processes (outer sulcus 
cells). GJIC (purple channels) permits movement of K+ towards basal cells and 
penultimately into intermediate cells. From here, Kir4.1 channels release K+ into the 
intrastrial space. Ion transporters (Na
+
,K
+
-ATPase and NKCC1) located in the 
basolateral membranes of marginal cells siphon excess K+. KCNQ1/KCNE1 channels 
secrete K+ back into the endolymph. Electrical isolation of the stria vascularis from 
perilymph and endolymph, thus permitting high endocochlear and intrastrial potentials, 
is maintained by tight junctions (TJ) between marginal cells and between basal cells. 
Image reproduced from Hibino and Kurachi, 2006. 
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The connective tissue gap junction network is composed of spiral ligament 
fibrocytes, and basal and intermediate cells of the stria vascularis. All these cells are 
inter-connected via gap junction plaques, which are constructed mostly from Cx26 
and/or Cx30 subunits (Ahmad et al., 2003; Forge et al., 2003a; Forge et al., 2003b; Sun 
et al., 2005; Jagger and Forge, 2006; Nickel et al., 2009). Mutations within the genes for 
Cx26 (GJB2) and Cx30 (GJB6) cause inherited hearing loss in humans (Kelsell et al., 
1997; Kelsell et al., 2001; Nickel and Forge, 2008), thus it appears likely that deficits in 
GJIC within the connective tissue gap junction network may contribute to this 
impairment. In addition, fibrocyte degeneration is a cause of one form of hereditary 
deafness (DFN3) (Minowa et al., 1999) and is a major cause of presbyacusis and loss of 
EP (Hequembourg and Liberman, 2001; Wu and Marcus, 2003). Consequently, 
fibrocytes are essential for cochlear homeostasis and normal hearing (Furness et al., 
2009). 
4.1.4 Cochlear slice preparation 
Slices of the viable cochlea represent a unique way of identifying and recording 
changes in cochlea tissue during postnatal development. Cross sections through the 
modiolus provide access to cells in the lateral wall for patch clamping and dye 
experiments. This technique was originally developed in the neonatal rat (postnatal 
4-14) and was successfully used to record from a variety of cochlear cells (Jagger et 
2000). It has since been used for numerous studies investigating properties of 
supporting cells in the organ of Corti (Jagger and Forge, 2006), fibrocytes of the 
ligament and limbus (Furness et al., 2009) and root cells (Jagger et al., 2010). The 
advantage of using the cochlear slice technique over other preparations is that cell 
morphology and structure can be readily distinguished using infrared video-
(Image deleted due to copyright. 
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Figure 4-2). The technique also permits live cell imaging of intracellular 
fluorescent dye injections.  
The rat cochlea undergoes extensive morphological development between birth 
and hearing onset (around P12). At P0, cochlear landmarks such as hair cells and 
supporting cells in the sensory epithelium, adjacent Kölliker’s organ and overlying 
tectorial membrane were all clearly distinguishable (Image deleted due to 
copyright. 
 
 
 
 
 
Figure 4-2A). Within the lateral wall, marginal cells formed an epithelial layer at 
the lumenal border facing scala media. At this young age, other cell-types in the 
posterior region of the lateral wall were hard to identify. Cells immediately 
abutting the marginal cell epithelium originate from the mesenchyme, and 
appeared rounded and tightly packed together (Image deleted due to copyright. 
 
 
 
 
 
Figure 4-2B). This region is henceforth referred to as the “condensing 
mesenchyme” up until ~P5-P7, when characteristic fibrocyte morphologies appear.  
Around the onset of hearing, cochlear tissues have fully matured; Kölliker’s organ 
organ has receded, the spaces within the organ of Corti have opened and stria 
is clearly identifiable (Image deleted due to copyright. 
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Figure 4-2C). Lateral wall type I fibrocytes are clearly distinguishable from the 
stria vascularis, of which, three separate layers have formed, surrounding a 
network of fine capillaries (Image deleted due to copyright. 
 
 
 
 
 
Figure 4-2D). Between the fibrocytes, numerous dense fibrillar strands were 
apparent, running parallel to stria vascularis (Spicer and Schulte, 1996). 
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Image deleted due to copyright. 
 
 
 
 
 
Figure 4-2. Postnatal development of cochlear tissues.  
(A) Differential interference contrast (DIC) photomicrograph of a mid-turn of a fixed 
vibratome slice cut from the cochlea of a P0 rat. Various tissues and structures are 
highlighted: spiral limbus (lim), Reissner’s membrane (rm), Kölliker’s organ (Ko), scala 
media (sm), lateral wall (lw), and otic capsule (oc). Hair cells and surrounding 
supporting cells were evident in the sensory epithelium (arrow). (B) Detail of the lateral 
wall at P0. A single layer of marginal cells (mc) are clearly distinguishable lining the 
lumenal border. Posterior to the marginal cells are a mass of mesenchyme derived cells 
which do not have a clearly definable morphology. This region is termed the 
“condensing mesenchyme”. (C) DIC mid-turn of a P15 rat cochlea. Kölliker’s organ 
had retracted, spaces within the organ of Corti had opened and the stria vascularis (sv) 
was visible. The approximate locations of fibrocyte subtype (fc1-fc5) are labelled. (D) 
Detail of the lateral wall at P15. Marginal cells, intermediate cells (ic) and basal cells 
(bc) of the stria vascularis were identified. Posterior to the basal cell layer, type I 
fibrocytes were distinguishable within the spiral ligament. Numerous, dense fibrillar 
strands running parallel to stria vascularis were apparent between fibrocytes. Scale bars, 
20 µm. Image from Kelly et al., 2011. 
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4.1.5 Functional GJIC between fibrocytes and basal/intermediate cells 
This chapter investigates the development of GJIC in the connective tissue gap 
junction system of the lateral wall during postnatal development, using 
immunofluorescence, dye injection and whole-cell patch clamp recordings. The 
majority of the data presented here has been published in the journal Neuroscience 
(Kelly et al., 2011). The data described in this sub-section (4.1.5 and Figure 4-3) was 
acquired by D. Jagger before the start of this project.  
GJIC, as determined by neurobiotin (NBN) injection, was evident throughout the 
connective tissue gap junction network by post-natal day 7 (Figure 4-3A), suggesting a 
continuous syncytium throughout the lateral wall. NBN injected into type V fibrocytes 
was detected in distant regions such as in the cells lining the scala vestibuli (Figure 
4-3B). NBN injected into type I fibrocytes was detected throughout the lateral wall and 
within intermediate cells counter-stained for Kir4.1 (Figure 4-3C-D). Dye transfer to 
marginal cells was not detected in any of these experiments, confirming the absence of 
gap junctions in these cells (Forge et al., 2003a). These data reveal that GJIC matures in 
advance of hearing onset in rats (~P12). Therefore, a detailed examination of GJIC 
during earlier stages of development (before maturity) was carried out. 
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Image deleted due to copyright.  
Figure 4-3. GJIC between lateral wall fibrocytes and stria vascularis.  
(A-D) Dye transfer carried out in P7-P8 cochlear slice preparations. (A) NBN (red) 
injection into a type I fibrocyte cell in a basal turn region of a P7 cochlear slice. Dye 
was detected in almost all fibrocyte types within the lateral wall. (B) In a P8 apical turn 
slice, NBN injected into a type V fibrocyte could be detected in cells lining the scala 
vestibuli. (C) In a P10 slice, NBN injected into a type I fibrocyte was detected 
throughout the lateral wall syncytium and within intermediate cells (labelled for Kir4.1; 
green). (Di-iii) In a separate experiment, NBN injected into a type I fibrocyte was 
detected in many other type I cells (fc1). Kir 4.1 labelling of intermediate cells is shown 
again (green). The overlay of both images revealed NBN in strial basal cells (bc) and 
intermediate cells (ic). Scale bars, 20 µm. Image from Kelly et al., 2011. 
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4.2 Results 
4.2.1 Development of gap junction plaques within the cochlear lateral wall 
Gap junction plaques were detected using antibodies specific for Cx26 
(GAP28H) and Cx30. This immuno-labelling was important to demonstrate the 
development of gap junctional intercellular communication (GJIC) during postnatal 
cochlear development. The following subsections then display dye transfer studies to 
show that these cells are functionally connected by gap junction channels. 
Cx26 and Cx30 are the two predominant connexin isotypes expressed in the 
adult cochlea. Other studies have investigated co-localisation of these connexins during 
cochlear development (Lautermann et al., 1998; Lautermann et al., 1999; Ahmad et al., 
2003; Forge et al., 2003a; Sun et al., 2005) and so are not described in detail here. The 
developmental expression of Cx30 (Figure 4-4A-D) and Cx26 (Figure 4-4Ai-Di) from 
post-natal day 0 (P0) to P12 was detected in rat cochlear slices using polyclonal anti-
Cx30 and polyclonal GAP28H anti-Cx26 antibodies.  
In the P0 cochlea (Figure 4-4A, Ai), Cx26 and Cx30 gap junction plaques were 
most prominent in Kölliker’s organ. These cells are dye-coupled extensively at this age 
(Jagger and Forge, 2006). Smaller puncta were present in the spiral limbus and apical 
regions of Claudius and outer sulcus cells. Within the lateral wall, small puncta were 
visible in the suprastrial region (arrow head), close to where Reissner’s membrane 
attaches to the lateral wall and within the condensing mesenchyme lateral to marginal 
cells. By P4, expression of both Cx26 and Cx30 was up-regulated in the condensing 
mesenchyme and also between cells within the stria vascularis (Figure 4-4B, Bi). The 
extent of Cx26 and Cx30 immunofluorescence was increased further by P8 (Figure 
4-4C, Ci). Numerous gap junction plaques were detected between spiral limbus 
fibrocytes and between supporting cells extending to the outer sulcus. There was a 
marked increase in labelling for both Cx26 and Cx30 in the region around the 
developing basal cell layer of the stria vascularis, with smaller puncta scattered 
throughout the lateral wall. By P12 (corresponding to the onset of hearing in rats), both 
connexins were detected throughout the spiral ligament (Figure 4-4D, Di). Large and 
numerous gap junction plaques were present between type I, II and V fibrocytes and 
smaller plaques in the region where basal and intermediate cells of the stria vascularis 
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reside. These events reveal the progressive nature of connexin expression through 
postnatal development and compare closely to that discovered in the murine cochlea 
(Sun et al., 2005).  
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4.2.2 Functional GJIC in the early postnatal cochlear lateral wall (P2) 
GJIC communication in the supporting cell region of the organ of Corti has been 
investigated previously using the whole cell patch clamp technique (Forge et al., 2003b; 
Jagger and Forge, 2006). This method is useful for dye transfer studies (as described in 
the preceding chapter) and simultaneous electrophysiological recordings. These 
techniques were used here to functionally determine the pattern and extent of GJIC 
during early postnatal lateral wall development.  
The pattern of dye transfer in P2 live cochlear slice preparations varied 
depending on the location of the injected cell in the lateral wall. Cells within the 
condensing mesenchyme were clearly defined using infra-red DIC video-microscopy 
and could be distinguished from the marginal cells (Figure 4-5A). NBN injected into a 
single cell within this region passed to many cells in all directions, but was confined to a 
distinct, crescent-shaped zone (Figure 4-5B-D; n=8 injections). All cells within this 
zone were labelled for Cx30 (excluding marginal cells), indicating the presence of gap 
junction plaques. In agreement with the absence of gap junction plaques between 
marginal cells, NBN did not spread into the epithelial layer, thus confirming the absence 
of GJIC between these cells and mesenchymal cells. Simultaneous whole-cell current 
responses to 10 mV hyperpolarising steps (Figure 4-5Ci-Di) measured a very low input 
resistance, consistent with functional GJIC (Jagger and Forge, 2006). The pattern of dye 
spread was consistent between apical (Figure 4-5A-C) and basal (Figure 4-5D) turns. 
Single cell recordings were then performed in the superior and inferior regions 
of the lateral wall outside of the main condensing mesenchyme zone where Cx30 
immunofluorescence was restricted to small, sparse intercellular puncta. Immature cells 
within the superior region, located near to the attachment point of Reissner’s membrane 
could be distinguished (Figure 4-6A). Live cell video-microscopy revealed a distinct 
column of Lucifer yellow transfer in a direction inferior to the patched cell and posterior 
to the condensing mesenchyme (Figure 4-6B). After processing the slice for 
immunofluorescent labelling, NBN had spread to a greater number of cells, but was still 
confined in a distinct columnar pattern (Figure 4-6C). Dye did not pass laterally to cells 
within the condensing mesenchyme. The input resistance (Figure 4-6D) was similar in 
comparison to recordings from cells within the condensing mesenchyme. 
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Cells injected in the developing type II fibrocyte region, inferior to the 
condensing mesenchyme, also revealed dye coupling in characteristic columns of 10-30 
spindle-shaped cells (Figure 4-7A,D; n=9 injections). These columns were located 
parallel to the rear border of the condensing mesenchyme and towards the root cell 
processes adjacent to the outer sulcus. A more detailed image including fluorescein-
dextran revealed characteristic spindle-shaped morphologies (Figure 4-7B,E). Processes 
extended from the polar ends and wrapped around cells above and below the injected 
cell. As a consequence, NBN spread between cells in a columnar direction and was not 
readily detected within the condensing mesenchyme. The input resistances measured 
from the two cells (asterisks) recorded in separate slices (Figure 4-7C, F) indicated a 
similar extent of GJIC in comparison to cells in the condensing mesenchyme. In five 
recordings at P2, there was a higher input resistance (50-500 MΩ) and a low membrane 
capacitance (3-20 pF), consistent with an absence of GJIC. After these recordings NBN 
was detected in single, spindle-shaped cells.  
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Figure 4-5. GJIC in the condensing mesenchyme of P2 cochlear slice preparations. 
 
(A) Infra-red differential interference contrast (IR-DIC) video micrograph taken during 
a whole-cell patch clamp recording. The patch pipette is visible in the lower part of the 
micrograph whilst recording from a cell in the condensing mesenchyme (cm), behind 
the marginal cells (mc). (B) A confocal projection (10 µm depth) reveals the extent of 
NBN spread (red) following the recording in (A). The slice was counterstained for Cx30 
(green) and DAPI (blue). (C) A magnified image from (B) showing detailed gap 
junction plaques between cells containing NBN. (Ci) Whole-cell current recording 
corresponding to (C) in response to 10 mV hyperpolarising pulses (input resistance, 10 
MΩ). (D, Di) Extensive spread of NBN throughout the condensing mesenchyme in a 
different slice and the corresponding whole-cell recording (input resistance, 10M Ω). 
Scale bars, 20 µm. 
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Figure 4-6. GJIC between developing type V/I fibrocytes of a P2 cochlear slice.  
 
(A) Infra-red differential interference contrast (IR-DIC) video micrograph taken during 
a whole-cell patch clamp recording in the developing type V fibrocyte region (fcV). 
Reissner’s membrane, Rm; condensing mesenchyme, cm. (B) Live fluorescent image of 
lucifer yellow (LY) showed directional coupling in a column of cells inferior to the 
patched cell and posterior to the cm. (C) A confocal projection (10 µm depth) labelled 
for Cx30 (green) and DAPI (blue) revealed further spread of NBN (red) in a discrete 
column of cells behind the condensing mesenchyme. (D) Whole-cell current recording 
in response to 10 mV hyperpolarising pulses (input resistance, 18 MΩ). Scale bars, 20 
µm. 
 
122 
 
  
Figure 4-7. GJIC between developing type II fibrocytes in P2 cochlear slices.  
(A) NBN (red) transfer from a patched cell (asterisk) in the developing type II fibrocyte 
region (fcII), posterior to the condensing mesenchyme (cm). Marginal cells (mc) 
indicate the apical surface of the stria vascularis. NBN was detected in a column of 
spindle-shaped cells, but not in the condensing mesenchyme. Slices were counterstained 
for Cx30 (green). (B) Detail of the injection in (A). Fluorescein-dextran (green), a GJ 
impermeable dye, did not spread from the patched cell and revealed long spindle-like 
processes contacting coupled cells. (C) Whole-cell current recording in response to 10 
mV hyperpolarising pulses (input resistance, 19 MΩ). (D-F) Similar patterns of dye-
transfer were seen consistently between slices from other P2 animals, with only slight 
variations in the extent of coupling. Scale bars, 20 µm. 
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4.2.3 Functional GJIC in the postnatal cochlear lateral wall (P5) 
In P5 rat cochlear slices, the columns of dye-coupled fibrocytes seen at P2 were 
no longer observed. Cells injected in the type V fibrocyte region (Figure 4-8A) were 
dye-coupled to cells in the condensing mesenchyme/type I fibrocyte region, as 
demonstrated by extensive NBN transfer. In a more detailed image, Cx30 puncta were 
visibly aligned along the process of the injected cell (arrows, Figure 4-8B). As well as 
NBN, intracellular recording solutions were supplemented with fluorescein dextran, a 
gap junction impermeable dye, to reveal cell morphologies (Figure 4-8Bi). This dye 
does not pass through gap junction channels because of its high molecular weight (~10 
kDa), which is useful for delineating the injected cell. It also confirmed that dye transfer 
occurred via gap junctional coupling, as opposed to other mechanisms, such as 
cytoplasmic bridging. The low input resistance recorded (Figure 4-8C) was consistent 
with the increase in GJIC. NBN spread within the type II fibrocyte region was multi-
directional, though locally restricted, and corresponded with sparser anti-Cx30 labelling 
(Figure 4-8D-E). Fluorescein dextran co-injection revealed the morphology of the 
patched cell. Extensive projections extended to distant cells containing transferred NBN 
and had the appearance of wrapping around what could be a root cell process (Figure 
4-8Ei), though this has not been verified. The input resistance measured (Figure 4-8F) 
corresponded with the extent of NBN transfer.  
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As described, co-injection of fluorescein dextran during recordings enabled the 
assessment of GJIC, whilst also describing the morphology of the injected cell. A 
comparison of the morphology of different fibrocyte subtypes from P5-P6 cochlear 
slices is shown in Figure 4-9. Fluorescence from a cell in the type II fibrocyte region 
revealed a multi-polar morphology that had numerous cytoplasmic extensions 
contacting cells some distance away from the cell body (Figure 4-9A). Similar to the 
cell shown in Figure 4-8Ei, the projections give the impression of wrapping around 
what could be the shape of a root cell process (located inferior to the cell body). 
Morphologies from other subtypes were also revealed. Type I fibrocytes were 
monopolar or bipolar spindle-shaped cells (Figure 4-9B), whereas some type V 
fibrocytes had a multi-polar morphology with numerous large diameter processes 
extending from the cell body (Figure 4-9C).  
  
Figure 4-9. Characteristic morphology of fibrocyte subtypes in the postnatal spiral 
ligament.  
(A-C) Neurobiotin fills of uncoupled fibrocytes in P5-P6 cochlear slices. (A) Multipolar 
cell in the type II fibrocyte region lateral to the outer sulcus. (B) Monopolar cell in the 
type I fibrocyte region to the rear of stria vascularis. (C) Multipolar cell in the type V 
fibrocyte region superior to where Reissner’s membrane attaches to the lateral wall. 
Scale bars, 20 µm. 
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4.2.4 Fibrocytes in the early postnatal lateral wall have fluoxetine-sensitive, weakly 
rectifying currents 
Single-cell lateral wall fibrocytes were determined by the lack of dye spread 
(using live IR-DIC video-microscopy), high input resistance (>50MΩ) and low 
membrane capacitance (3-20 pF, estimated from the patch clamp amplifier). These 
uncoupled cells permitted recordings of current-voltage (I-V) relationships during dye 
injection in the whole-cell patch clamp configuration. Previous studies have suggested 
that type I fibrocytes (cultured from gerbil lateral wall explants) have a K
+
 membrane 
conductance that is mediated by BK channels (Liang et al., 2003; Shen et al., 2004). 
The authors propose that these channels are important in regulating the electrochemical 
gradient inside the lateral wall, which in turn is vital for K
+
 recycling. The present study 
examined single, uncoupled fibrocytes to determine whether any voltage-dependent 
currents were present in early postnatal development. 
During whole-cell recordings from single cells in P2 rat slices, the majority of 
fibrocytes had resting membrane potentials of -70 to -75 mV. I-V relationships were 
recorded in response to a voltage step command (Figure 4-10A). The corresponding 
recording (Figure 4-10B) is shown as a representative of several recordings in the P2 
lateral wall (n=6). In response to both hyperpolarising and depolarising steps, inward 
and outward currents were activated respectively. The steady-state currents were plotted 
to produce an I-V curve that showed weak inward-rectification (Figure 4-10C). Inward 
rectification usually indicates that the main conductance is mediated by Kir channels. To 
determine whether the membrane potential (Em) was dependent on K
+
, Em was recorded 
in zero-current clamp mode in response to increasing [K
+
]bath (Figure 4-10D). An 
increase in [K
+
]bath caused cell depolarisation, suggesting that K
+
 conductance is the 
major determinant of Em. 
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Figure 4-10. The resting potential of post-natal fibrocytes is dependent on K
+
.  
(A) Voltage (V) command used to record from a type II fibrocyte cell. The cell was 
voltage-clamped at -70mV in 4mM [K
+
]e artificial perilymph with 400-ms steps in 
10mV increments from -130mV to +20mV. (B) Current (I) trace in response to the 
voltage command. (C) I-V  plot reveals a weak inwardly rectifying current, indicative of 
a Kir channel. (D) The resting membrane potential (Em), in I=0 mode, is highly 
dependent on [K
+
]e. 
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Candidate ion channels responsible for the rectifying currents include members 
of the Kir family. However, there is no published evidence of inward-rectifying 
potassium channel expression in early (P0-P6) post-natal lateral wall fibrocytes. Kir4.1 
(KCNJ10) channel subunits, which conduct weakly inwardly rectifying currents in glia 
(Kofuji and Newman, 2004) and intermediate cells of the stria vascularis, are vital for 
generating the endocochlear potential (Takeuchi and Ando, 1998b; Takeuchi et al., 
2000). Expression of Kir4.1 in lateral wall fibrocytes, however, has not been reported. 
Alternatively, a study has shown the expression of Kir5.1 (KCNJ16) within type II and 
type V fibrocytes of the lateral wall (Hibino et al., 2004). Although the authors show no 
immuno-detectable protein before P10, there remains the possibility that undetectable 
amounts may be present at younger postnatal ages. Electrophysiological recordings 
suggest this might be the case (Figure 4-10). Consequently, expression of Kir4.1 was 
investigated in rat cochlear cryosections using a polyclonal anti-Kir4.1 antibody. P8 
cochlea sections revealed expression in cells within the sensory epithelium and less 
strongly in outer sulcus and intermediate cells (Figure 4-11A). In a more detailed image 
of the outer sulcus/type II fibrocyte region, Kir4.1 immuno-labelling was clearly visible 
in root cell processes and in puncta between type II fibrocytes (Figure 4-11B). By P12, 
intermediate cells strongly expressed Kir4.1 (Figure 4-11C) and, surprisingly, relatively 
high levels in both type II (Figure 4-11Di) and type V fibrocytes (Figure 4-11Dii). 
To further confirm that the currents were elicited by Kir channels, single cells 
demonstrating the characteristic weekly rectifying properties were treated with Ba
2+
 – a 
potent Kir channel blocker (Takeuchi and Ando, 1998b). Surprisingly, application of 2 
mM Ba
2+
 had no inhibitory effect and even caused a slight increase in the peak current 
(Figure 4-12). In contrast, cells exposed to the selective serotonin reuptake inhibitor 
(SSRI) fluoxetine – previously shown to inhibit Kir4.1 channels (Ohno et al., 2007) – 
had almost complete blockage of whole-cell currents (Figure 4-13). This effect was 
reversible after washout with fresh artificial perilymph. Fluoxetine also shifted the zero-
current potential (Vz) from -70 mV to -25 mV, which provides further evidence for a 
potassium channel conductance in the regulation of Em.  
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Figure 4-11. Kir4.1 immunofluorescence in P8 and P12 rat cochlea sections.  
(Ai-ii) Single confocal image from a P8 rat cochlear section labelled for Kir4.1 (green). Nuclei 
were counterstained with DAPI (blue). Expression of Kir4.1 was detected in supporting cells 
(sc), and less strongly in outer sulcus (os) and intermediate cells (ic). (Bi-ii) Confocal projection 
(3 µm depth) of the type II fibrocyte (fcII) region from (A) revealed diffuse staining in root cell 
processes (rc). Diffuse and small puncta labelling was also detected in type II fibrocytes. (Ci-ii) 
A montage of single confocal images from a P12 rat cochlear section. Expression of Kir4.1 was 
detected in intermediate cells, and fibrocytes in the type II and V (fcV) regions of the lateral 
wall. Detailed Kir4.1 expression detected in type II (Di) and type V fibrocytes (Dii). Scales 
bars, 50 µm. 
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Figure 4-12. Fibrocyte currents are resistant to Ba
2+
.  
Current trace from a single spindle-shaped fibrocyte in the developing type II fc region 
bathed in 4 mM [K
+
]o artificial perilymph (control, upper left panel) plus 2 mM Ba
2+
 
(lower left panel). The cell was voltage-clamped at -75 mV and currents recorded in 
response to the voltage command shown. I-V relationship (right panel) shows a weakly 
rectifying current (control, ●). Ba2+ did not inhibit the current, and even caused a slight 
increase in current amplitudes (▲). 
  
Figure 4-13. Fibrocyte currents are inhibited by fluoxetine.  
Current trace from a single spindle-shaped fibrocyte in the developing type II fc region 
bathed in 4 mM [K
+
]o artificial perilymph (control, upper left panel) or in response to 
100 µM fluoxetine (lower left panel). The cell was voltage-clamped at -70 mV and 
currents recorded in response to the voltage command shown. I-V relationship shows a 
weakly rectifying current (control, ●), which was inhibited by 100 µM fluoxetine (▲). 
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4.3 Discussion 
GJIC during development of the organ of Corti has been studied previously 
(Jagger and Forge, 2006). The results presented in this chapter reveal previously 
uncharacterised patterns of GJIC during early postnatal lateral wall development and 
document changes in the extent of GJIC up to the point of maturation (~P8). These data 
suggest that GJIC occurs in distinct compartments in the early stages of development 
and that by the end of the first postnatal week most of the fibrocytes are coupled by gap 
junctions. At this stage, there was also noticeable GJIC between fibrocytes and cells of 
the stria vascularis, indicating that lateral wall maturation is reached several days in 
advance of hearing onset. This study also utilised electrophysiogical recordings during 
whole-cell patch clamp mode in situ. These data suggest a previously undetermined role 
for weakly rectifying K
+
 channels during early postnatal development of fibrocytes.  
4.3.1 Morphological and functional maturation of the cochlear lateral wall 
Studies performed on altricial rodents including mice, rats and gerbils, have 
documented the maturation of cellular architecture in the lateral wall from birth up until 
the onset of hearing (Kikuchi and Hilding, 1966; Steel and Barkway, 1989; Rybak et al., 
1991; Souter and Forge, 1998). At birth, most of the structures and compartments 
within the lateral wall are ill-defined and immature. In the 7-12 days subsequent, there 
is a dramatic maturation of these compartments and differentiation into cell types 
equivalent of the mature form. The basic architecture noticeable at birth is that of the 
cuboidal epithelium of marginal cells, and cells derived from the periotic mesenchyme 
located posterior to the epithelium. At this stage the basolateral membrane infoldings of 
marginal cells do not extend beyond the basal lamina (Steel and Barkway, 1989). Na,K-
ATPase activity, essential for K
+
 uptake from the intrastrial space, can be detected in 
gerbil marginal cells by P2 (Souter and Forge, 1998). In addition, KCNQ1 expression is 
detected on the apical surface of marginal cells in rats at this developmental stage (D. 
Jagger, unpublished). Both proteins are essential for K
+
 secretion into endolymph and 
EP generation (Wangemann, 2006). 
Intermediate cells, which are melanocytes derived from the neural crest, are 
present in the lateral wall at P2, but have an immature morphology (Steel and Barkway, 
1989). Concurrently, there is vigorous mitotic activity within the condensing 
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mesenchyme (Mutai et al., 2009). Strial basal cells are derived postnatally from the 
fibroblasts via a mesenchyme-epithelial transition (Trowe et al., 2008). By the end of 
the first postnatal week the basal lamina has disintegrated and marginal cell infoldings 
begin to penetrate and lengthen towards the strial inner layers. At the same time, 
intermediate cells begin to interdigitate with marginal cell outfoldings. By P7-P8, stria 
vascularis has formed three distinct layers composed of marginal cells, intermediate 
cells and basal cells (Steel and Barkway, 1989; Souter and Forge, 1998). At this stage, 
intermediate cells express Kir4.1, which likely increases after the onset of hearing, as 
has been shown in the murine lateral wall (Singh and Wangemann, 2008). 
Dye injection into single fibrocytes of the lateral wall at P5-P6 revealed 
characteristic location-specific morphologies. Type II fibrocytes are multi-polar with 
extended processes that contact distant cells and wrap around what could be root cell 
projections. Type I fibrocytes have characteristic monopolar or bipolar, spindle-shaped 
morphologies and type V fibrocytes have multiple processes. This suggests that these 
cells have differentiated morphologically to carry out their roles in ion transport and 
neurotransmitter uptake (Spicer and Schulte, 1991; Spicer and Schulte, 1996; Furness et 
al., 2009; Jagger et al., 2010), around a week in advance of hearing onset. It has also 
been shown elsewhere that there is a rapid decrease in mitotic activity within the spiral 
ligament of rats between P7 and P10, suggesting that cells have matured before hearing 
onset. However, it remains possible that migration of differentiated cells within the 
ligament could occur during this period (Mutai et al., 2009). 
4.3.2 Functional GJIC in the neonatal lateral wall 
Previous studies have documented the immuno-reactive expression of Cx26 and 
Cx30 in the lateral wall during development of the cochlea (Lautermann et al., 1999; 
Sun et al., 2005). Functional GJIC studied here has revealed that otic fibrocytes are 
extensively coupled in the early postnatal period (P0-P7). In the early postnatal cochlea 
(P2), compartmentalised regions of GJIC were discovered. Cells within the condensing 
mesenchyme (posterior to the marginal cell layer) were coupled within a distinct, 
crescent-shaped zone. During this early stage, columns of dye transfer between spindle-
shaped cells in the region equivalent to the type II fibrocyte region were also 
discovered, and which had no apparent spread of dye into the condensing mesenchyme 
zone. This suggests that GJIC within the lateral wall develops in compartmentalised 
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regions as previously reported for supporting cells in the organ of Corti (Jagger and 
Forge, 2006). By P5, the pattern of GJIC between type II fibrocytes became more 
radial. The discreet columns of dye transfer were no longer seen, yet dye-coupling still 
did not extend into the type I fibrocytes. However, by P7, NBN had spread throughout 
the spiral ligament and into cells of the stria vascularis, suggesting that 
compartmentalisation is not a feature of the mature lateral wall. This finding contrasts to 
that found in the organ of Corti, in which GJIC maturation occurs around hearing onset 
(Jagger and Forge, 2006). The maturation of GJIC in the spiral ligament by P7 suggests 
that the connective tissue gap junction network is capable of re-circulating cytoplasmic 
K
+
 in advance of hearing onset, and so is primed for buffering K
+
 upon hair cell 
activation. 
It is not known whether GJIC is essential for proliferation and differentiation 
within developing fibrocytes. There have been no reports of gross morphological 
defects in fibrocytes of mouse mutants in which either Cx26 or Cx30 have been deleted 
or mutated (Cohen-Salmon et al., 2002; Kudo et al., 2003; Teubner et al., 2003b; Sun et 
al., 2009; Schutz et al., 2010). As early as P2 there was direct dye-coupling between 
cells within the condensing mesenchyme immediately abutting the basolateral 
membrane of marginal cells (possibly including developing intermediate cells). Gap-
junctional coupling during this period of development may be required for physiological 
signalling mechanisms. It has been shown elsewhere that cochlear gap junctions play a 
role in the intercellular transfer of metabolites such as IP3 (Beltramello et al., 2005), and 
glucose (Chang et al., 2008), and their impaired permeability may be the cause of 
human connexin-related deafness (Beltramello et al., 2005; Chang et al., 2009). These 
studies focused only on 1) cells of the epithelial gap junction system in neonatal rat 
pups (Beltramello et al., 2005), or 2) a variety of cells, including those within the 
connective tissue gap junction system, but only from P8 onwards (Chang et al., 2008). 
Future experiments could involve similar studies to investigate the contribution of GJIC 
to metabolite signalling in the lateral wall from P0 up to the point of GJIC maturity 
(~P7-P8).  
Previous studies have used molecular dyes of varying size and charge to 
investigate the selective permeability of gap junctions (Marziano et al., 2003). The 
permeability of gap junctions between supporting cells has been shown to vary through 
development. In particular, gap junctions between Deiters’ cells show a distinct increase 
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in selectivity beyond P12, which is thought to relate to changes in Cx26 and Cx30 
expression (Jagger and Forge, 2006). Cx26 and Cx30 are expressed extensively in the 
lateral wall and co-localise in most regions, therefore, the possibility of selective 
permeability in the spiral ligament may also exist. Hardening of the otic bone, coupled 
with an increase in extracellular stroma surrounding cells later in development (>P10), 
meant recordings from fibrocytes past this age were unreliable. Consequently a study of 
gap junction permeability was not conducted here. A possible alternative to this 
problem might be to use a sharp electrode to microinject dyes of varying size and 
charge, rather than the whole-cell patch clamp configuration. 
4.3.3 Dye coupling in the mature lateral wall supports K+ re-circulation 
The K
+
 recycling pathway is a proposed mechanism that involves recirculation 
of extruded K
+ 
from hair cells through gap junctions of the epithelial and connective 
tissue networks and pumped back into endolymph via the stria vascularis. It is a topic 
that is widely discussed in the hearing field (Kikuchi et al., 2000; Wangemann, 2006; 
Hibino and Kurachi, 2006; Zhao et al., 2006; Mistrik et al., 2009), yet no direct 
functional evidence exists to verify the hypotheses. There are, however, many indirect 
findings that support such a mechanism. These include observations of sub-cellular 
anatomical specialisations (Spicer and Schulte, 1996), protein expression patterns in 
vivo (Spicer and Schulte, 1991; Sakaguchi et al., 1998; Ando and Takeuchi, 1999; 
Hibino et al., 2004) and in vitro (Shen et al., 2004), and the compatible biophysical 
properties of cells located at key loci within the suggested pathway (Jagger et al., 2010). 
Together, the data presented in this chapter confirms the presence of a continuous gap 
junction pathway through the lateral wall and provides further support for the K
+
 
recycling hypothesis. Type II fibrocytes, which are predicted to absorb K
+
 secreted by 
root cell processes (Spicer and Schulte, 1996; Jagger et al., 2010), are connected to type 
I fibrocytes. In turn, type I fibrocytes are connected to basal cells of the stria vascularis, 
which are themselves coupled to intermediate cells. 
The endolymphatic [K
+
] in rats reaches almost adult levels by P7, and the ionic 
composition remains unchanged during the phase of rapid increase in EP (Bosher and 
Warren, 1971). This led to the suggestion that the ionic composition of endolymph and 
EP arise independently, and that they arise in succession during postnatal development. 
The fact that endolymphatic [K
+
] almost reaches adult levels by P7, yet the levels of 
135 
 
 
connexin expression continue to increase up to and beyond the onset of hearing, points 
further to surplus capacity in ion transport within the mature cochlear lateral wall 
(Schulte and Schmiedt, 1992; Jagger et al., 2011). Marginal cells mature well in 
advance of EP generation, whereas basal cells mature to express tight junctions just 
prior to the onset of EP (Souter and Forge, 1998). The observation that GJIC in the 
lateral wall is effectively mature by P7, and that intermediate cells are known to express 
Kir4.1, both suggest that endolymphatic K
+
 could be derived from the connective tissue 
gap junction network in advance of hearing onset. These data add further, indirect 
evidence, to other reports suggesting the presence of a K
+
 recirculation pathway. 
However, direct proof of such a mechanism is still lacking. Improvements in future 
techniques involving K
+
-specific fluorescent indicators and electrophysiological 
techniques are required before direct measurements can confirm transfer of K
+
 ions 
from the epithelial gap junction network to the connective tissue gap junctions network 
and consequently to the stria vascularis.  
4.3.4 Early postnatal lateral wall fibrocytes have weak inwardly-rectifying 
potassium currents 
Kunzelmann et al. (1999) have shown that Cx30 expression increases in rat 
hippocampal astrocytes during the first 3 weeks after birth and reaches fully mature 
levels by 4 weeks. The authors suggest that changes in the functional properties of 
astrocytes coincide with Cx30 expression, which may be important for meeting the 
demands of the maturing brain. These processes include spatial buffering, transfer of 
metabolites and second messengers or compounds that accumulate in extracellular 
space. Electrophysiological recordings also revealed inwardly rectifying K
+
 channels 
(Kir), which are indicative of mature astrocytes (Kunzelmann et al., 1999). Kir channels 
are up-regulated in a similar temporal pattern to Cx30 (Kressin et al., 1995). Here, 
similar changes were observed with the zero-current potential shift (~52 mV) in 
response to high [K
+
]o in early postnatal fibrocytes. This shift is close to that predicted 
by the Nernst equation for a K
+
 selective membrane and suggests that the channels are 
predominantly permeable to K
+
 ions. In addition, the conductance also increased in 
response to high [K
+
] (data not shown), which is typical of inward rectifying K
+
 
channels (Kressin et al., 1995). These channels are thought to play a vital role in K
+
 
buffering in the adult brain and, according to the spatial buffering hypothesis (Orkand et 
al., 1966), require cell-cell coupling via gap junctions (Kunzelmann et al., 1999). The 
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authors speculate that Cx30 is involved in K
+
 homeostasis of the neuronal 
microenvironment since the temporal expression of both Kir and Cx30 is highly co-
ordinated in astrocyte development.  
The findings presented here for postnatal fibrocytes show similarity to those of 
astrocytes. Like astrocytes, the expression of rectifying channels and gap junctions in 
fibrocytes might be important for early spatial buffering and/or the transfer of 
metabolites and second messengers during lateral wall development. Whether adult 
cochlear fibrocytes exhibit the same properties as early postnatal fibrocytes has yet to be 
determined. It has been suggested by that the resting membrane potential of adult 
fibrocytes is approximately ~-5 mV (Salt et al., 1987). This potential was recorded by 
advancing electrodes through the cochlear lateral wall in the horizontal plane towards 
stria vascularis and, therefore, may only be relevant for type I fibrocytes. As is now 
known, there are five main fibrocyte subtypes in the lateral wall and each subtype has 
different expression patterns of ion channels and transporters. In the recordings 
presented here, most of the developing fibrocytes were recorded from the developing 
type II region and had resting potentials of -70 to -75 mV. In agreement with the strong 
negative potentials found here, a study by Prazma (1975) also identified intracellular 
potentials of ~-80 mV in lateral wall fibrocytes in the region of the spiral prominence 
(type IIs). In type II fibrocytes expression of K
+
 ion transporters, such as Na
+
,K
+
-
ATPase, NKCC1 and Kir channels (which are not expressed in type I fibrocytes), may 
account for the differences seen in the reported resting potential.  
 The finding of weakly rectifying currents and expression of Kir4.1 in developing 
fibrocytes was surprising. Initially, expression of Kir channels in the cochlea was 
thought to occur in intermediate cells and supporting cells only. However, data in the 
last few years has revealed that Kir channels may have a wider role in cochlear 
physiology. For example, root cells express Kir4.1 subunits and have weak inwardly- 
rectifying currents, which may serve as a mechanism of K
+
 ion transport into the 
extracellular space (Jagger et al., 2010). In addition, Kir5.1 expression has been found 
in type II, IV and V lateral wall fibrocytes from P10 onwards (Hibino et al., 2004). The 
recordings presented here could be due to Kir5.1-expression (at levels undetected by 
immunofluorescence) in developing type II fibrocytes. In heterologous expression 
systems Kir5.1 homomeric channels are rapidly internalised from the plasma membrane 
and, consequently, do not form functional units (Tanemoto et al., 2002). Functional 
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channels would require heteromerization with another Kir subunit (such as Kir4.1) or 
binding to PSD-95 (Hibino et al., 2004). Whether Kir5.1 is expressed alone in cochlear 
fibrocytes, or in combination with Kir4.1/PSD-95, remains to be determined. PSD-95 is 
a PDZ-binding protein member of the membrane-associated guanylate kinase 
(MAGUK) family. These proteins are involved in clustering of ion channels, including 
Kir channels, at the membrane (Nehring et al., 2000). It is possible that the currents 
detected in early post-natal fibrocytes are formed from homomeric Kir5.1 channels, 
which would suggest that these cells also express PSD-95. Detection of PSD-95 has 
only been identified in inner and outer hair cells and afferent nerve terminals in the 
organ of Corti (Davies et al., 2001), but has not been examined in the lateral wall.  
Alternatively, the unexpected expression of Kir4.1 found in type II and V 
fibrocytes before hearing onset may account for the currents recorded here. These could 
be generated from heteromeric Kir4.1/Kir5.1 complexes, which have been shown to 
form functional inwardly-rectifying currents and are thought to be highly sensitive to 
internal pH levels (Tanemoto et al., 2000). An alternative mechanism for K
+
 uptake by 
type II fibrocytes could involve combinations of hetero- and homomeric Kir channels 
and pHi regulation. This can be explained using the Müller cell as a model system. 
Müller cells are a type of glial cell found in the retina and function in a similar way to 
astrocytes by siphoning extracellular K
+
 away from the neuronal microenvironment 
(Newman et al., 1984). A study by Ishii and colleagues (Ishii et al., 2003) suggested that 
Müller cells differentially utilize at least two types of Kir channel for K
+
 regulation; 
Kir4.1 homotetramers for K
+
 extrusion at Müller cell endfeet and Kir4.1/Kir5.1 
heterotetramers for pHi-dependent K
+
 uptake at the distal regions of Müller cells. The 
authors note that Kir4.1/Kir5.1 heteromeric channels are sensitive to physiological 
ranges of pH, whereas Kir4.1 homomeric channels are more resistant. This discrepancy 
is what allows the channels to function independently. The mechanism proposes that 
Müller cells possess an electrogenic Na
+
-HCO3
-
 co-transport system. An increase in 
extracellular K
+
 would depolarize the cell and increase the inward transport of Na
+
 and 
HCO3
-
. As a result of HCO3
-
 influx, the pHi would become more alkalinized. The 
authors propose that this would lead to an increase in the open probability of 
Kir4.1/Kir5.1 heteromeric channels and enhance K
+ uptake. Although it hasn’t been 
verified here, a similar mode of action could be applied to the junction between cells of 
the epithelial system and connective tissue system. It has been shown that root cell 
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processes express Kir4.1 and that this channel may be responsible for extruding K
+
 into 
the extracellular space between lateral wall fibrocytes (Jagger et al., 2010). Immuno-
labeling for Kir5.1 has been reported in type II fibrocytes (Hibino et al., 2004), which 
taken with the immuno-labeling for Kir4.1 shown here, may suggest the presence of 
Kir4.1/Kir5.1 heteromeric channels. It has also been shown that root cell processes 
express Pendrin, which is a member of the solute-carrier (SLC26A) family of anion 
transporters and has been suggested to secrete HCO3
-
 (Wangemann et al., 2004). In 
addition, type II fibrocytes have been shown to express a sodium bicarbonate co-
transporter (NBC3), which has the capacity to uptake Na
+
 and HCO3
-
 (Bok et al., 2003). 
Theoretically, the Müller cell model could then be applied: firstly, root cell processes 
may secrete K
+
 through Kir4.1 channels and HCO3
-
 through Pendrin transporters into the 
extracellular space. Type II fibrocytes could then take up HCO3
-
 through NBC3 co-
transporters and cause alkalization of the pHi. The change in pHi may then increase the 
open probability of Kir4.1/Kir5.1 heteromeric channels and enhance K
+
 uptake into the 
connective tissue gap junction system. Both NBC3 and Kir5.1 have been shown to bind 
PSD-95 through their PDZ binding domains. Therefore, PSD-95 could act as an 
intrinsic regulator of this process.  
This theory, however, is complicated somewhat by the observed insensitivity to 
high [Ba
2+
] exposure – a potent Kir channel blocker. In contrast, exposure of cochlear 
slices to fluoxetine caused a complete blockage of channel activity and depolarized the 
resting membrane potential. Although this drug has been shown to block Kir4.1 
channels (Ohno et al., 2007), it is not specific. These data are difficult to interpret. One 
explanation could be that a novel, Ba
2+
-resistant, Kir channel is expressed in postnatal 
fibrocytes or that Kir4.1/Kir5.1 heteromeric or Kir5.1 homomeric channels are resistant 
to Ba
2+
 in this system.  
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4.4 Conclusion 
The data presented in this chapter has revealed compartmentalized intercellular 
dye-coupling in the rat lateral wall between P2 and P5. By P7, there was extensive dye-
coupling throughout the connective tissue syncytium. Dye was detected in fibrocytes, 
basal cells and intermediate cells suggesting that lateral wall function matures several 
days in advance of hearing onset. Therefore, the lateral wall appears to be capable of re-
circulating cytoplasmic K
+
 as early as P7, and so is primed to receive and buffer K
+
 ions 
when the pathway is activated by air-borne sound. 
The detection of a negative resting potential sensitive to changes in [K
+
]o, 
weakly rectifying currents and immuno-labelling of Kir4.1 in developing lateral wall 
fibrocytes may suggest additional roles for K
+
 channels in the K
+
 cycling pathway. The 
combination of Kir channels and gap junction expression might also play a pivotal role 
in lateral wall maturation and EP generation. These data have only been studied in 
neonatal rat slices and need to be verified in the adult system.  
These data add further indirect evidence to the hypothesis of K
+
 recirculation in 
the cochlea. In despite of the growing support for recycling of K
+
 ions, there remains a 
lack of direct proof for such a system. Direct measurements of K
+
 flux from the 
epithelial gap junction network to the connective tissue gap junction network and to the 
stria vascularis will be required to finally deduce the existence of cochlear K
+
 cycling. 
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5 ROLE OF CX30 IN THE DEVELOPMENT OF COCHLEAR 
FUNCTION 
5.1 Introduction 
The previous chapter described GJIC during cochlear lateral wall development 
and showed that lateral wall cells are functionally coupled in the early stages of post-
natal development. This, together with previous work carried out in our lab (Jagger and 
Forge, 2006) suggests an important role for cell-cell communication before hearing 
onset. These studies, along with other clinical and functional analyses have helped to 
decipher some of the functions of inner ear connexins. However, our knowledge of the 
exact role of gap junctions in the inner ear and how connexin mutations specifically 
cause deafness is still lacking. This chapter discusses the genetics and animal models of 
connexin-related deafness and investigates the pathology and potential causes of EP loss 
in a Cx30-null (Cx30
–/–
) mouse model.  
5.1.1 Genetics of connexin-related hearing loss 
The requirement for functional gap junctions in the inner ear has been highlighted 
by the discoveries of mutations in genes encoding Cx26 (GJB2) (Kelsell et al., 1997), 
Cx30 (GJB6) (Grifa et al., 1999) and Cx31 (GJB3) (Xia et al., 1998), all of which cause 
hereditary deafness in humans (Ballana et al. 2011, http://davinci.crg.es/deafness/). In 
addition, other connexins linked to deafness include Cx29 (GJE1) (Yang et al., 2007) 
and Cx32 (GJB1) (Bergoffen et al., 1993), both of which cause peripheral neuropathies. 
There has also been a report linking sensorineural deafness with mutations in Cx43 
(GJA1) (Liu et al., 2001). This has since been shown to involve the pseudogene of Cx43 
(Paznekas et al., 2003), however a more recent study has suggested that mutations in 
both GJA1 and its pseudogene (pGJA1) may cause hearing loss (Hong et al., 2010). 
These types of deafness are associated with both recessive and dominant forms of 
inheritance and can cause deafness alone (non-syndromic) or present with other clinical 
problems (syndromic), such as skin disease (Rabionet et al., 2002). 
Around 70% of prelingual hereditary deafness is of the non-syndromic 
sensorineural type, of which autosomal recessive traits (DFNB) make up ~85% and 
dominant traits (DFNA) ~15% of cases (Denoyelle et al., 1998). To date, at least 70 
DFNB and 53 DFNA non-syndromic loci have been mapped. Of these loci, 41 genes 
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have been linked to DFNB and 25 genes to DFNA (Van Camp and Smith 2011, 
http://hereditaryhearingloss.org/).  
5.1.1.1 Non-syndromic deafness; GJB2 mutations  
Mutations at the DFNB1 locus account for up to 50% of all autosomal recessive 
non-syndromic hearing loss cases in many, but not all, populations studied (Bitner-
Glindzicz, 2002; Dodson et al., 2011). DFNB1 is located on chromosome 13q11-12 
(Guilford et al., 1994) and encompasses both the GJB2 (Kelsell et al., 1997) and GJB6 
(del Castillo et al., 2002) genes within 50 kb of each other (Ortolano et al., 2008). To 
date, more than 100 missense, nonsense, insertion, deletion and frame-shift mutations 
have been discovered in the GJB2 gene (Hoang et al., 2009). In European and North 
American populations the most common mutation is a recessive deletion of a single 
guanine nucleotide within a stretch of six guanines at position 35 of the GJB2 cDNA 
(termed 35delG). This causes a frameshift and subsequent premature termination of 
protein translation (Zelante et al., 1997). It has been proposed that the 35delG mutation 
may account for up to 70% of GJB2 mutant alleles and has a 1 in 50 carrier frequency in 
European populations, but is considerably higher in others (Bitner-Glindzicz, 2002). 
Additional GJB2 mutations are highly prevalent in other populations and account for 
most cases of autosomal recessive non-syndromic deafness. For example, the 167delT 
mutation, which causes a premature stop codon, has a carrier rate of 4% in the 
Ashkenazi Jewish population (Morell et al., 1998), whereas the most common deafness-
causing mutation in Japan is 235delC, with a carrier rate of ~1% (Abe et al., 2000; 
Kudo et al., 2000). A recent comprehensive review of various disease-causing Cx26 
mutations has estimated the carrier frequency to be 1-4% in many populations, making 
GJB2 one of the most common disease-linked genes in humans (Hoang et al., 2009). 
The high carrier frequency of certain GJB2 recessive mutations suggests there 
may be heterozygote advantage. For example, the most common recessive mutation 
found in the African population, R143W (Brobby et al., 1998), causes a thicker 
epidermis in both heterozygotes and homozygotes, which is thought to offer extra 
protection against pathogen invasion (Meyer et al., 2002). A separate study 
demonstrated that other non-syndromic GJB2 mutations increase cell survival, and thus, 
may explain the thicker epidermis (Common et al., 2004). In addition, organotypic skin 
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cultures engineered to express the Cx26R143W mutation were less susceptible to 
bacterial invasion (Man et al., 2007). 
Non-syndromic mutations are scattered throughout the Cx26 protein sequence 
(purple dots, Figure 5-1) and have been investigated using in vitro expression systems. 
Many of the recessive non-syndromic mutations have the ability to form gap junctions, 
but demonstrate a loss-of-function. These can include non-functional gap junctions 
(such as the R143W mutation), those with impaired electrical and biochemical coupling, 
and those with altered voltage gating (reviewed by Nickel and Forge, 2010). Others 
have impaired transcription due to large deletions of promoter elements or partial 
deletion of the gene itself (see section 5.1.1.3). The most common non-syndromic GJB2 
mutations mentioned above (35delG, 167delT and 235delC) are all caused by a single 
nucleotide deletion, which inserts a premature stop codon and thus leads to impaired 
translation. In addition to the common autosomal recessive non-syndromic forms of 
deafness, various dominant GJB2 mutations (DFNA3) have also been implicated in 
both non-syndromic and syndromic deafness (Nickel and Forge, 2008; Hoang et al., 
2009).  
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Image deleted due to copyright.  
Figure 5-1. Location of deafness and skin-disease causing Cx26 mutations.  
The Cx26 amino acid sequence is highlighted for mutations associated with deafness 
only (non-syndromic, purple dots) and those associated with deafness and skin 
disease (syndromic, orange dots). Reproduced from Laird 2006. 
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5.1.1.2 Syndromic deafness; GJB2 mutations 
Almost all Cx26 mutations discovered to date are associated with some degree 
of hearing loss. Interestingly, several Cx26 mutations have also been shown to cause 
deafness and skin-disease syndromes (Kelsell et al., 2001). In human skin, mRNA 
expression of 10 different connexins has been reported, including Cx26 and Cx30 (Di et 
al., 2001). It is likely then, that the high number of connexins and complex overlapping 
distributions found across the keratinocyte sub-populations can accommodate for 
recessive or loss-of-function Cx26 mutations. Dominant mutations in the GJB2 gene 
account for most forms of syndromic hearing loss. These mutations can associate with 
various skin disorders, including palmoplantar keratoderma (PPK), Vohwinkel 
syndrome (VS), Bart-Pumphrey syndrome (BPS), Keratitis-ichthyosis deafness (KID) 
syndrome and hystrix-like ichthyosis-deafness (HID) (reviewed in Nickel and Forge, 
2008; Scott and Kelsell, 2011).  
All dominant, syndromic GJB2 mutations discovered so far are located in the 
first third of the Cx26 molecule incorporating the amino-terminus and first extracellular 
loop (orange dots, Figure 5-1). It has been speculated that this region of the molecule is 
important for regulating Cx26 oligomerization with its wild-type counterpart or other 
connexin members and for correct transport to the plasma membrane (Thomas et al., 
2004; Laird, 2006). It has also been reported that some dominant Cx26 mutations can 
oligomerize with other connexins that do not normally form channels together. For 
example, R75W (Rouan et al., 2001) and G59A (Thomas et al., 2004) both of which 
have been linked to PPK; and D66H (Thomas et al., 2004) which causes VS, have all 
been shown to exert a trans-dominant effect on Cx43. In possible agreement with these 
findings, Cx26-R75W transgenic mice (Kudo et al., 2003) studied in our lab presented 
with cataracts (data not included in this thesis). In wild-type animals, alpha connexins 
Cx46 and Cx50 are expressed in the fibre cells and Cx43 and Cx50 in the epithelial 
cells of the lens and mutations in these connexins cause cataracts (Mathias et al., 2010). 
Ectopic R75W expression was found in all cataract lenses. Thus, expression of R75W 
under the control of the ubiquitous CAG promoter may be exerting a trans-dominant 
effect on alpha-connexins found in lens tissue (unpublished data). 
 In addition to trans-dominant effects, some dominant Cx26 mutations cause a 
gain-of-function effect. For example, G45E has been linked to a fatal form of KID 
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syndrome (Janecke et al., 2005). This mutation, along with others (Lee et al., 2009) has 
been implicated in cell death via ‘leaky’ hemichannels at the cell membrane. These 
studies highlight the complex nature of connexin biology and reveal a vast range of 
Cx26-linked pathologies associated with hearing loss and skin disease. 
5.1.1.3 GJB6 mutations and large deletions 
In addition to Cx26 mutations, studies have also identified mutations in the Cx30 
gene GJB6 that are linked to dominant and recessive forms of non-syndromic and 
syndromic (Clouston syndrome) hearing loss. Two deletions in the GJB6 gene have 
been linked to non-syndromic deafness at the DFNB1 locus. A 309 kb deletion, 
del(GJB6-D13S1830), is the second most common mutation after GJB2/35delG in 
certain populations (del Castillo et al., 2002). A separate study identified another GJB6 
deletion resulting in a loss of a 232 kb DNA fragment termed del(GJB6-D13S1854), 
which has a carrier frequency of 2% in the Spanish population (del Castillo et al., 2005). 
These deletions were initially discovered after screening GJB2 heterozygotes who 
presented with mild to severe hearing impairment (Lerer et al., 2001; Pallares-Ruiz et 
al., 2002). This has led to the prediction of a digenic mode of DFNB1 inheritance where 
the truncation of GJB6 augments the effects of a single copy GJB2 mutated allele in 
trans (del Castillo et al., 2005). In addition, the large deletions are predicted to remove 
regulatory elements important for Cx26 expression, which may act as a key factor in the 
severe deafness phenotype (Common et al., 2005). A more recent study by Feldmann et 
al. (2009) has reported the first known deletion of the GJB2 gene. In this instance a 
heterozygous deletion of a region spanning at least 920 kb was found in trans with a 
rare V84M GJB2 mutation leading to profound prelingual deafness. 
Thus far, only one missense mutation in the GJB6 (T5M) has been shown to cause 
non-syndromic hearing loss. This mutation has a dominant mode of inheritance and was 
the first Cx30 mutation linked to the DFNA3 locus (Grifa et al., 1999). In recombinant 
expression systems, Cx30T5M was localised to gap junction plaques at the plasma 
membrane and formed normal electrical coupling, but had  impaired permeability to dye 
tracers and IP3 (Common et al., 2002; Zhang et al., 2005). In addition, a mouse model 
engineered to express the Cx30T5M mutation has been suggested to have impaired ATP 
release through hemichannels during cochlear development (Schutz et al., 2010). 
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Dominant Cx30 mutations also cause a syndromic form of hearing loss associated 
with Clouston syndrome, also referred to as hidrotic ectodermal dysplasia (HED) 
(Lamartine et al., 2000; Smith et al., 2002). These mutations have impaired trafficking 
to the cell surface when expressed alone, but are rescued by co-expression of wild-type 
Cx30. The electrophysiological properties and dye transfer permeabilites differ only 
slightly between wild-type and mutant/wild-type channels. The mutations are thought to 
confer a gain-of-function, leading to ATP leak through hemichannels at the cell surface 
(Essenfelder et al., 2004). 
5.1.2 Mouse models of connexin-related deafness 
Mouse models of connexin-associated disease have proven to be valuable tools in 
the pursuit of understanding the complex nature of connexin biology. Deafness 
phenotypes associated with human connexin mutations correlate relatively well with 
mouse models of connexin-related deafness, although there are some differences 
between the two systems. To date, nine different Cx26 or Cx30 transgenic mouse lines 
have been developed with the aim of investigating the role of gap junctions in cochlear 
development and physiology. These include seven Cx26 and two Cx30 transgenic lines 
(see Table 5-1 for summary). One mutant mouse line (Cx26 double knockout) is 
embryonically lethal and causes death at around embryonic day 6. In contrast, patients 
homozygous for the 35delG mutation, who are effectively Cx26 knockouts, survive well 
and present with a non-syndromic form of hearing loss. The survival of these patients is 
due to inter-species variations in the placental syncytiotrophoblast layers. Humans have 
only one syncytiotrophoblast layer, whereas mice have two. Gap junctions composed of 
Cx26 are important for bridging the gap between the two layers in mice and permitting 
the transfer of glucose from the maternal side of the placenta to the foetal blood 
circulation. Deletion of Gjb2 leads to ~60% decrease of glucose transfer in mice 
(Gabriel et al., 1998). Therefore, homozygous Cx26-null mice are not viable and cannot 
be used for cochlear studies.  
5.1.2.1 Conditional Cx26 deletion and Cx26-point mutation mouse models 
An alternative system has been developed to overcome the problem of neonatal 
lethality in Cx26-null mice. Thus far, four different conditional Cx26 knockout (cCx26) 
mouse lines have been developed in an attempt to model the DFNB1 deafness seen in 
humans. All four mouse models utilise the Cx26
loxP/loxP
 mouse for tissue or cell-specific 
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Cx26 deletion via Cre-recombinase (Cohen-Salmon et al., 2002; Sun et al., 2009; Wang 
et al., 2009). In most of these studies the spatial or temporal deletion of the Gjb2 gene 
was limited to cells comprising the epithelial gap junction network. All mutants had 
profound-to-severe hearing loss as characterised by a significant increase in auditory 
brainstem response (ABR) thresholds, but no vestibular defects. Although all the mouse 
models were significantly deaf, there were some differences reported in the type of 
pathology associated with deafness. The original cCx26-null mouse (Cohen-Salmon et 
al., 2002) showed normal development of the inner ear up until the point of hearing 
onset (P14). From this stage onwards, the authors reported cell death of the inner hair 
cell (IHC) supporting cells initially, followed by other supporting cells and outer hair 
cells (OHCs). Spaces of Nuel and tunnel of Corti collapsed from P15-P16 onwards and 
this was coupled with a loss of integrity of the reticular lamina at the apical end of hair 
cells. In addition, there was a marked reduction in both the EP and endolymphatic [K
+
]. 
The authors propose that the onset of hearing around P14 triggers the death of IHC-
supporting cells by oxidative stress, generated in response to accumulated K
+
 interfering 
with the removal of the neurotransmitter glutamate (Cohen-Salmon et al., 2002). 
Three other cCx26 mouse lines also have severe hearing impairment, confirming 
the essential need for Cx26 protein for cochlear function (Sun et al., 2009; Wang et al., 
2009). Although these studies also showed supporting cell and OHC atrophy, the organ 
of Corti never fully developed in these mice. Nuel’s space around OHCs and the tunnel 
of Corti never opened during postnatal development, suggesting a role for Cx26 in the 
maturation of the cochlear sensory epithelium (Wang et al., 2009). In agreement, a 
mouse line engineered to express a dominant-negative Cx26R75W mutation (model for 
DFNA3) also demonstrated impaired postnatal development of the organ of Corti (Kudo 
et al., 2003; Inoshita et al., 2008). Delayed organ of Corti maturation may occur because 
loss of Cx26 gap junctions leads to a disruption in biochemical coupling between 
supporting cells and reduced supply of growth factors and nutrients (Inoshita et al., 
2008; Wang et al., 2009). In addition, Inoshita et al. (2008) also suggest decreased ATP 
release through connexin hemichannels in the Cx26R75W mouse may lead to disrupted 
development of both supporting cells and hair cells.  
Surprisingly, Cx26R75W mice develop a normal EP, despite expression of the 
dominant-negative mutation throughout the lateral wall (Kudo et al., 2003). This is in 
contrast to the original cCx26 knockout study (Cohen-Salmon et al., 2002), where both 
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the EP and endolymphatic [K
+
] were reduced in adult mice. The cCx26 models 
developed by Sun et al. (2009) and Wang et al. (2009) were not tested for EP or [K
+
]. 
The normal EP values in the Cx26R75W mouse indicate that Cx26 may not be 
important for stria vascularis function. However, this theory needs to be confirmed with 
targeted deletion of Cx26 from the connective tissue gap junction system. It could also 
be possible that excess amounts of Cx30 or endogenous Cx26 are able to compensate 
for the mutation in the spiral ligament.  
 A recent study has developed the first mouse model of syndromic hearing loss 
(Schutz et al., 2011). A dominant-negative mutation, S17F, in the Gjb2 gene causes 
sensorineural hearing loss and skin disease, recapitulating KID syndrome seen in 
humans (Richard et al., 2002). Homozygous mutants are not viable, but heterozygous 
mice display both symptoms, thus confirming the dominant effect of the mutation. 
Cx26S17F channels are non-functional and do not pass any current, contrary to the 
gain-of-function effect of increased hemichannel activity seen with other KID mutations 
(Lee et al., 2009). Heterozygous Cx26S17F mice have significantly elevated hearing 
thresholds and a reduced EP. Further detailed work is required to understand the 
mechanism of deafness in these mice, but it appears that cochlea development is not as 
severely affected in comparison to conditional knockouts. The authors propose that 
remaining wild-type Cx26 may be sufficient to stabilise Cx30 channels and partially 
maintain cochlear homeostasis (Schutz et al., 2011). 
5.1.2.2 Cx30 mouse models of deafness 
Cx30 is essential for hearing, and deletion of the GJB6 gene in humans causes 
severe deafness (del Castillo et al., 2002).  A Cx30 knockout (Cx30
–/–
) mouse model 
also causes profound deafness and recapitulates the non-syndromic form (DFNB1) seen 
in humans. These mice never develop an EP and initially have hearing thresholds over 
80 dB, despite apparently normal inner-ear development. In addition, the endolymphatic 
[K
+
] develops normally (~100 mM) up until the onset of hearing (P13-P14), but then 
reduces (to ~44 mM) in the adult mouse. At this point the hearing thresholds are 
elevated above 100 dB, indicating profound deafness. Hair cell loss was reported 
relatively soon after the onset of hearing and gradually spread over several months 
(Teubner et al., 2003b). A separate study also showed that OHCs died quicker than 
IHCs, and that by 6 months all OHCs had degenerated. Loss of IHCs in contrast was 
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relatively slow. Cell death was first observed at P21 in the basal turn, but even after 18 
months, many IHCs were still present in the middle and apical turns. In comparison 
with cCx26 mice, cell death was relatively slow and mild (Sun et al., 2009). 
Interestingly, it has been shown that Cx26 protein levels are significantly 
reduced in the cochlea of Cx30
–/–
 mice, even though mRNA levels remain unchanged 
(Ahmad et al., 2007). A large proportion of gap junctions in the cochlear duct are 
reported to consist of Cx26 and Cx30, which have been shown to form heteromeric 
channels (Lautermann et al., 1998; Ahmad et al., 2003; Forge et al., 2003b; Yum et al., 
2007). Reduced Cx26 content, yet normal mRNA levels, in Cx30
–/–
 mice suggests that 
homotypic Cx26 channels are relatively unstable at the cell surface, and that Cx30 in 
normal tissue may have a stabilising effect on functional cochlear gap junctions. Thus, 
loss of Cx30 is predicted to cause an overall reduction in gap junction numbers. In 
support of this hypothesis, an adapted Cx30
–/–
 mouse model engineered to express extra 
copies of the Cx26 allele completely rescued hearing sensitivity and prevented hair cell 
death (Ahmad et al., 2007).  The authors suggest that heteromeric Cx26/Cx30 channels 
are not essential for normal cochlear function. Although the instability and faster 
degradation of homotypic channels may account for cochlear pathology in cases where 
mutations lead to an inability to form heteromeric gap junctions, it does not account for 
deafness-causing connexin mutations that oligomerise into functional heteromeric gap 
junctions (Nickel and Forge, 2010). It may also be the case that particular cell types or 
regions of the cochlea express only Cx30 homotypic gap junctions and that over-
expression of Cx26 in those cells leads to restored GJIC, rather than an overall increase 
in gap junction numbers. 
A recent mouse model has been engineered to express the human non-syndromic 
Cx30T5M mutation under the control of the endogenous Cx30 promoter (Schutz et al., 
2010). These mice have reduced levels of both Cx26 and Cx30 protein, suggesting that 
the T5M mutation also leads to gap junction instability, in agreement with reduced 
Cx26 channel numbers seen in Cx30
–/–
 mice (Ahmad et al., 2007). Surprisingly, the 
Cx30T5M mice only exhibited a mild increase in hearing thresholds, up to ~15 dB 
across all frequencies (Schutz et al., 2010). This contrasts with the more severe, yet 
variable, deafness seen in human Cx30T5M carriers. Some  carriers have been shown to 
have a 20-50 dB decrease in hearing levels at frequencies of 2-8 kHz, whereas some 
showed profound sensorineural deafness (Grifa et al., 1999). Differences in biochemical 
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coupling and gap junction permeabilities between mice and humans, as analysed 
previously (Beltramello et al., 2003), are suggested to account for the differences 
between species (Schutz et al., 2010). In addition, Cx30T5M mice develop a normal EP 
and exhibit normal electrical coupling between non-sensory cells. However, a marked 
reduction in the ability to transfer the fluorescent tracer calcein and reduction in 
intercellular Ca
2+
 signalling via ATP release from hemichannels have been suggested. 
This has led to the authors suggesting that impaired biochemical coupling is the cause 
of deafness in these mutants (Schutz et al., 2010). 
That protein levels of both Cx26 and Cx30 are reduced in the T5M mouse 
model, yet hearing thresholds are not severely affected, may suggest that it is not 
necessarily reduced gap junction numbers in Cx30-mutant mice that cause deafness, as 
proposed by Ahmad et al. (2007). Instead, it seems likely that there are regions or cell 
types that express Cx30 specifically, which may be compensated for by over-expression 
of Cx26 in Cx30
–/–
 mice. For example, Deiters’ cells have been shown to express Cx30 
predominantly over Cx26 (Sun et al., 2005; Jagger and Forge, 2006), thus a complete 
lack of Cx30 may lead to deficient K
+
 homeostasis in this region. This may also explain 
why OHCs begin to degenerate after hearing onset and prior to IHCs in Cx30
–/–
 mice. 
The generation of EP is dependent on the intermediate cells of stria vascularis, 
and requires electrical isolation of the intrastrial compartment from the lumen of blood 
vessels, and both perilymph and endolymph (as discussed in the previous chapter). This 
isolation is conferred by tight junctions between endothelial cells, marginal cells and 
basal cells. A novel mechanism for the lack of EP in Cx30
–/–
 mice was proposed by 
Cohen-Salmon et al. (2007) who suggested that Cx30 deficiency causes disruption of 
the stria vascularis endothelial barrier. The authors came to this conclusion based on 
three experimental results. Firstly, they suggested that strial endothelial cells were 
abnormal in Cx30
–/–
 mice as observed using transmission electron microscopy. 
Secondly, albumin and IgG heavy and light chains (serum proteins that are usually 
impermeable across the endothelial barrier) were detected in the intrastrial space. 
Thirdly, qPCR analysis of strial tissue revealed changes in the transcriptional level of 
several genes involved in vascular physiology. The authors hypothesize that loss of 
Cx30 gap junctions or nonjunctional hemichannels may lead to an osmotic imbalance 
within stria vascularis. This in turn is thought to cause changes in transcriptional levels 
of certain genes downstream and an eventual build-up of homocysteine (a non-protein 
151 
 
 
sulphur amino acid) that is proposed to cause endothelial dysfunction. Loss of a tight 
endothelial barrier would then cause an electric shunt, thought to be sufficient to cause a 
loss of EP (Cohen-Salmon et al., 2007). Several queries arise in response to this 
interpretation. For example, neither Cx26 nor Cx30 are expressed in strial endothelial 
cells (Cohen-Salmon et al., 2007), making it difficult to understand how gap junction 
dysfunction can result in only endothelial damage. In addition, Hoang et al. (2009) raise 
the question as to why Cx26R75W mice do not present the same pathology considering 
the mutation is expressed throughout the lateral wall (Kudo et al., 2003) and is 
dominant-negative over wild-type Cx26 and Cx30 (Hoang et al., 2009). Although a 
hypothesised complex signalling pathway has been proposed, the exact mechanism of 
how the loss of Cx30 can lead to changes in transcriptional regulation of certain genes is 
unknown. It is also unknown as to whether Cx26/Cx30 hemichannels exist in the stria 
vascularis. 
This chapter focuses on the Cx30
–/–
 mouse model and investigates stria 
vascularis morphology and the expression of proteins involved in the generation and 
maintenance of endocochlear potential (EP). In addition, the endothelial breakage 
theory is addressed using alternative techniques to those used by Cohen-Salmon et al. 
(2007).  
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Cx 
(gene) 
Mutation Phenotype Hearing threshold 
(ABR) 
EP and 
endolymphatic [K
+
] 
(control vs mutant) 
Reference 
Cx26 
(Gjb2) 
Null (double 
knockout) 
Embryonic lethal at 
E6. 
N/A N/A Gabriel et 
al. 2008 
Conditional 
Cx26-null 
(Cx26
Otog/Cre
) 
Non-syndromic 
deafness. IHC-SC 
loss at P14. Loss of 
OHCs and SCs from 
P15-P16 onwards.  
Average thresholds 
elevated by 30-36 
dB for sensitive 
frequencies. 
P12-P13: EP, 56 vs 
58 mV; [K
+
], not 
recorded. Adult: 
EP, 110 vs 38 mV; 
[K
+
], 153 vs 85  mM. 
Cohen-
Salmon et 
al. 2002 
Conditional 
Cx26-null 
(Cx26
loxP/loxP
; 
Rosa26
CreER
) 
Non-syndromic 
deafness. Delayed 
postnatal 
development. 
Elevated by 30-50 
dB across 
frequencies. 
Not recorded. Sun et al. 
2009 
Conditional 
Cx26-null 
(foxg1-Cre 
and pax2-
Cre lines) 
Non-syndromic 
deafness. Delayed 
postnatal 
development. 
Supporting cell 
degeneration from 
P8 onwards. OHC 
death ~P13. 
Elevated by 30-50 
dB across all 
frequencies. 
Not recorded. Wang et 
al. 2009 
Cx26R75W Non-syndromic 
deafness. Delayed 
postnatal 
development. Hair 
cell degeneration 
by 7 weeks. 
Average threshold 
elevated by ~70 dB.  
16-21 weeks: EP, 
97.4 vs 87.7 mV; 
[K
+
] not recorded. 
 
Kudo et al. 
2003 
Cx26S17F Cx26
S17F/S17F
 
embryonic lethal. 
Cx26
+/S17F
 similar 
phenotype to KID 
syndrome 
(deafness and skin 
disease).  
Average threshold 
elevated by ~35-40 
dB.  
Adult: EP, reduced 
by 42 mV in 129Sv 
background, 
reduced by 25 mV 
in C57BL/6 
background; [K
+
] 
not recorded. 
Schutz et 
al. 2011 
Cx30 
(Gjb6) 
Null (double 
knockout) 
Non-syndromic 
deafness. Normal 
development up to 
P17. Gradual loss of 
sensory cells from 
P18. Extensive HC 
loss by 4 months. 
P17-P18 thresholds 
elevated from 31 
dB in controls to 84 
dB in mutant. Adult 
mutants had no 
detectable ABR up 
to 100 dB. 
P13-P14: EP; 74 vs 
0 mV, [K
+
]; 102 mM 
vs 100 mM. 
Adult: EP; 83 vs 3 
mV, [K
+
]; 148 vs 44 
mM. 
Teubner 
et al. 2003 
Cx30T5M Non-syndromic 
deafness. 
Mild, but significant 
elevation of ~15 dB 
for most freq. 
P21-P28: EP; 121.2 
vs 122.2 mV. 
Schutz et 
al. 2010 
Table 5-1. Summary of Cx26 and Cx30 mutant mouse models.  
ABR, auditory brainstem response; IHC/OHC, inner/outer hair cell; SC, supporting cell. 
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5.2 Results 
5.2.1 Stria vascularis morphology in Cx30–/– mice 
5.2.1.1 Stria vascularis is significantly thinner 
During the investigation into the role of Cx30 in the development of cochlea 
function, a noticeable and consistent thinning of stria vascularis tissue in Cx30 null 
(Cx30
–/–
) mice was observed - which has not been reported in previous Cx30
–/– 
studies. 
To quantify these findings, the distance between the apical surface of marginal cells and 
basal cells was measured in three locations along the width of the stria (Figure 5-2A) 
and then averaged, as implemented elsewhere (Wangemann et al., 2004). Representative 
fluorescence images show detailed measurements and confirm a statistically significant 
thinning of strial tissue in adult Cx30
–/–
 cryosections (Figure 5-2B,C). To avoid 
potential influences from tissue preparation and processing artefacts, thickness 
measurements were also analysed from thin section, transmission electron micrographs 
(TEM). Strial thickness measured from TEM sections of Cx30 wild-type (Cx30
+/+
) and 
Cx30
–/–
 mice aged between post-natal day 30 (P30) and P37 were all significantly 
reduced in mutant mice (Figure 5-2D). Older mice, aged between P57 and P67, also 
displayed significant stria vascularis thinning in basal and apical coils of the cochlea 
(Figure 5-2E). To determine whether this morphology could be a consequence or cause 
of hearing impairment in these mice strial measurements were recorded from 
fluorescently-labelled cryosections taken within the first week of hearing onset (P13-
P19). Strial thickness was significantly reduced in basal and apical turns of Cx30
–/–
 mice 
(Figure 5-2F). This suggests that the tissue never reaches the mature thickness seen in 
Cx30
+/+
 animals. Consistent with the TEM dimensions, aged Cx30
–/–
 mice (P38 to P51) 
also had a considerably thinner stria vascularis in comparison to wild-type (Figure 
5-2G). 
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Figure 5-2. Thinning of stria vascularis in Cx30
–/–
 (KO) mice.  
 
(A) Schematic showing the locations of stria vascularis (sv) measurements. Thickness 
was determined from the average of three measurements recorded perpendicular to the 
surface of marginal cells. (B-C) Representative immunofluorescence images  showing  
three distances measured from marginal cells (mc) to basal cells (bc) in Cx30
+/+
 (B) and 
Cx30
–/–
 (C) cochlear cryosections. Cx30 is labelled in green, nuclei in blue. (D-E) Strial 
thickness data pooled from P30 to P37 (D) and P57 to P67 mice (E) measured from 
transmission electron micrographs (WT, blue bars; KO, orange bars). (F-G) Strial 
thickness data pooled from P12 to P19 (F) and P38 to P51 mice (G) measured from 
immunofluorescent cochlear cryosections. Tissues for electron microscopy were 
prepared and processed by G. Nevill and A. Forge. Number above each column 
indicates the number of measurements. Each bar represents measurements from a 
minimum of 3 animals. Cx30
–/–
 strial thickness was significantly thinner in all age sets 
(** p<0.005;*** p<0.0005). 
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5.2.1.2 Marginal cell nuclei appear abnormal 
When measuring the thickness of the stria vascularis it also became apparent 
that, in most cases, the morphology of marginal cell nuclei in Cx30
–/–
 mice appeared 
abnormal in comparison to those of age-matched Cx30
+/+
 mice. This was consistent in 
both thin sections and cryosections of mutant cochleae. In mature (>P38) cochlear 
cryosections, control marginal cell nuclei were located at the apical surface facing scala 
media and appeared flattened and either ellipsoidal or plano-concave in shape (Figure 
5-3Ai-Aii). In comparison, many of the nuclei in Cx30
–/–
 marginal cells appeared more 
rounded and oval (Figure 5-3Bi-Bii) and were not ordered uniformly at the apical 
surface. To quantify these findings, the dimensions of marginal cell nuclei were 
calculated from magnified confocal images of cochlea cryosections. In both the younger 
(P17-P19) and older aged groups (P38-P51) the nuclear dimensions (calculated from the 
ratio of length to width) were significantly different in Cx30
–/–
 mice (Figure 5-3C). 
Cx30
+/+
 measurements for both age groups had dimensions in which the length of each 
nucleus was more than twice that of the width (P17-P19, 2.37 ±0.08; P38-P51, 2.37 
±0.15), giving a flattened appearance (as depicted in the figure key). In contrast, nuclei 
measured from Cx30
–/–
 mice had dimensions in which the length was relatively equal to 
the width (P17-P19, 1.37 ±0.08; P38-P51, 1.20 ±0.06), thus giving a more rounded 
appearance. Marginal cell nuclei that are atypical in shape have been reported in other 
examples of stria vascularis abnormalities (Jagger et al., 2011). In addition, marginal 
cell nuclei are large and irregular in shape during early postnatal development and 
flatten out at the apical surface before strial maturation (Steel and Barkway, 1989; 
Souter and Forge, 1998). The observation of atypically shaped marginal cell nuclei in  
Cx30
–/– 
mice may be consistent with those cells not reaching full maturity.  
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Figure 5-3. Abnormal marginal cell nuclei in Cx30
–/–
 (KO) mice.  
(Ai) A cryosection of the basal turn stria vascularis of a P42 Cx30
+/+ 
cochlea. Marginal 
cells (mc) were stained with an anti-NKCC1 antibody (green). Nuclei (blue) were 
stained with DAPI and were located at the apical surface of marginal cells. (Aii) A 
detailed view of the boxed area in (Ai) shows the characteristic flattened or ellipsoid-
shaped nuclei of normal marginal cells. (Bi) A corresponding image from the basal turn 
of a P38 Cx30
–/– 
cochlea. (Bii) A detailed view of the boxed area in (Bi) revealed 
abnormally shaped marginal cell nuclei, which appeared more rounded than ellipsoid in 
shape. (C) Marginal cell nuclei dimensions were quantified from young (P17-P19) and 
older (P38-P51) mice and displayed as a mean ratio of length/height. Number above 
each column indicates the number of measurements from 3 (P17-P19WT) or 2 animals 
(all other bars) respectively. Cx30
–/– 
marginal cell nuclei had significantly different 
ratios from Cx30
+/+
 in both age sets (*** p<0.0001). Scale bars, 10 µm. 
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5.2.2 Expression of strial cell proteins important in the generation of endocochlear 
potential 
Cx30
–/–
 mice do not generate an EP (Teubner et al., 2003b; Ahmad et al., 2007). 
The mice used in this study were obtained from the European Mouse Mutant Archive 
(www.emmanet.org, EM:00323) and originate from the same colony used in the studies 
where EP was recorded. All homozygous Cx30
–/–
 mice were deaf, as determined by a 
lack of preyer reflex and were genotyped to confirm the deletion of Gjb6 gene. It is 
important to note that EP was not measured here, but is assumed to be absent 
considering a lack of EP is sufficient to cause hearing loss and recordings from 
elsewhere have confirmed that Cx30
–/–
 mice do not develop an EP (Teubner et al., 
2003b; Ahmad et al., 2007). Stria vascularis is thinner in these animals (see 5.2.1.1), 
suggesting a lack of tissue maturation. Thus, the expression of genes and proteins 
involved in EP generation were investigated using immunofluorescence labelling and 
qPCR in both Cx30
+/+ 
and Cx30
–/–
 strial tissue. 
5.2.2.1 Reduced Kir4.1 expression in Cx30
–/–
 mice 
Kir4.1 is expressed in intermediate cells and is essential for EP generation (as 
described in the previous chapter) and is down regulated in various cochlear pathologies 
(Wangemann et al., 2004; Jin et al., 2008; Mustapha et al., 2009). Immunofluorescence 
labelling of adult Cx30
+/+
 mice revealed extensive labelling for Kir4.1 in intermediate 
cells of a basal turn cochlea (Figure 5-4A). In contrast, Kir4.1 fluorescence in 
intermediate cells was markedly decreased in the basal turn of an age-matched Cx30
–/–
 
cochlea (Figure 5-4B). This was somewhat surprising given that a previous report 
suggested Kir4.1 was not down-regulated in Cx30
–/–
 mice (Cohen-Salmon et al., 2007). 
All cryosections were processed at the same time with the same conditions and prepared 
so that both wild-type and Cx30
–/–
 cryosections were mounted on the same slide. This 
was to ensure that both genotypes were treated identically, including antibody 
concentrations and incubation times. In addition, all confocal imaging settings were 
constant between scans. This allowed for semi-quantitative comparison between 
samples. A line profile plotted along the width of the stria vascularis showed 
significantly higher peaks of pixel intensity in Cx30
+/+ 
compared to Cx30
–/–
 (Figure 
5-4C). The mean average of the recorded pixel intensities along the line profile was 
reduced by 63%, thus confirming a strong reduction of Kir4.1 fluorescence in Cx30
–/–
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stria (Figure 5-4D). Almost identical results were found in the apical region of the 
cochlea (Figure 5-4-H), indicating that the decrease in Kir4.1 immunofluorescence 
intensity was consistent throughout the cochlea. Similar results were also found in 
younger mice (P19) where the average Cx30
–/–
 Kir4.1 grey level was reduced by ~55% 
in comparison to the measurements from wild-type, age-matched mice (data not 
shown).  
In addition to immunofluorescence labelling, Kir4.1 mRNA levels were 
measured from isolated stria vascularis tissue by real-time qPCR (Figure 5-5). In 
comparison to age-matched Cx30
+/+ 
mice, Kir4.1 mRNA levels were 1.3 and 3.8-fold 
lower in P7 and P15 Cx30
–/–
 stria respectively. In older mice (P38) the level of mRNA 
in the Cx30
–/–
 stria had increased, but was still 1.3-fold lower in comparison to a P35 
Cx30
+/+
. These data appear correspond to the immunofluorescence data and indicate 
that mRNA and protein levels of Kir4.1 are reduced in Cx30
–/–
 mice. These data are 
preliminary experiments, of which one animal from each genotype was used for each 
age group. Therefore, statistical analyses were not performed. Although further 
experiments and animals are required for statistical significance, there does appear to be 
a general trend of reduced Kir4.1 mRNA levels in Cx30
–/–
 mice. In comparison to 
protein levels, these reductions may not appear to be significant. However, a study by 
Wangemann et al. (2004) has shown normal mRNA expression of Kir4.1 in strial tissue 
of a Pendred syndrome mouse model, but an absence of Kir4.1 protein, which would 
account for the observed loss of EP. The authors suggest that post-transcriptional 
regulation may have an effect on Kir4.1 protein levels, which may also be the case here. 
Kir4.1 is also expressed in the organ of Corti (Hibino et al., 1997) and is thought 
to be involved in uptake of extracellular K
+
 into supporting cells. Whether the loss of 
Cx30 affected Kir4.1 expression in these cells was also investigated. Kir4.1 
immunofluorescence was detected in many supporting cells including pillar cells, 
Deiters’ cells and Hensen’s cells in a Cx30+/+ apical turn (Figure 5-6Ai,ii). In contrast, 
supporting cells in a Cx30
–/–
 mid turn had a marked reduction in Kir4.1 fluorescence. 
Remnants of expression were only detectable in the inner pillar cells (Figure 5-6Bi,ii), 
suggesting that loss of Cx30 might also have an effect on cells in the organ of Corti. 
Notably, confocal images of spiral ganglion satellite cells had similar levels of Kir4.1 
immunofluorescence in both Cx30
+/+
 (Figure 5-6C) and Cx30
–/–
 (Figure 5-6D) mice. 
Thus, the reduction of Kir4.1 appeared to be sight-specific. 
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Figure 5-4. Reduced Kir4.1 protein expression in Cx30–/– (KO) mice.  
(A) Cryosection of the basal turn stria vascularis from a P42 Cx30+/+ (WT) mouse stained 
for Kir4.1 (green). Nuclei were counter-stained with DAPI (blue). Kir4.1 was strongly 
expressed in intermediate cells located between marginal cells (mc) and basal cells (bc). (B) 
A P38 Cx30–/– cryosection showed a marked reduction of Kir4.1 protein in the basal turn 
stria vascularis. (C) A semi-quantitative pixel intensity profile of Kir4.1 fluorescence 
plotted along the length of stria vascularis shows a strong reduction of Kir4.1 in the Cx30–/– 
mouse, confirmed also by the total average pixel intensity signal (D). Apical turns from 
Cx30+/+ (E) and Cx30–/– (F) cryosections also show a strong reduction in Kir4.1 expression. 
Pixel intensity plot (G) and average pixel intensity (H) both confirm the reduction of Kir4.1. 
All settings were kept the same for each experiment. Scale bars, 20 µm. 
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Figure 5-5. Reduction of Kir4.1 mRNA in Cx30
–/–
 strial tissue.  
Total mRNA was isolated from strips of stria vascularis from wild-type and Cx30
–/–
 
(KO) mice at the ages listed. At P1 expression of Kir4.1 was virtually absent, and was 
used as the calibrator.  Expression increased from P7 up to P35 in wild-type mice (blue 
bars). In comparison, Cx30
–/–
 mice of equivalent age had decreased levels of mRNA 
(orange bars), which was more pronounced at P15. For all experiments 18S rRNA was 
used as an endogenous control. Error bars represent 95% confidence intervals. These 
data are preliminary and represent data from one individual animal for each genotype 
and age, therefore statistical analyses were not performed. 
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Figure 5-6. Reduced Kir4.1 expression in Cx30
–/–
 supporting cells.   
(Ai,ii) A confocal projection (18.5 µm depth) of a mid-turn organ of Corti from the 
same Cx30
+/+
 cochlear cryosection as in Figure 5-4.  The section was labelled for Kir4.1 
(green), acetylated tubulin (red) and actin (white). Kir4.1 was detected in Deiters’ cells 
(dc), pillar cells (pc) and Hensen’s cells (hc) in the wild-type animal. The actin-rich 
stereocilia of outer hair cells (ohc) are also labelled. (Bi,ii) Kir4.1 was strongly reduced 
in the Cx30
–/–
 mid-turn organ of Corti (18.5 µm projection). Expression was only 
detectable in the inner pillar cells and not in Deiters’ cells or Hensen’s cells. (C) Control 
image from the same wild-type cryosection showing normal Kir4.1 expression in spiral 
ganglion satellite cells (green). Nuclei were counter-stained with DAPI (blue). (D) 
Kir4.1 levels in Cx30
–/–
 satellite cells were comparable to those of the wild-type. Scale 
bars, 20 µm. 
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5.2.2.2 Normal expression of other strial cell markers 
Since Kir4.1 expression was reduced in Cx30
–/–
 mice, it was important to 
determine whether any other components of the EP generating machinery were affected. 
An immunofluorescence-labelling study was performed on adult Cx30
+/+
 and Cx30
–/–
 
cryosections. Marginal cell proteins involved in K
+
 transport were analysed. NKCC1, a 
Na
+
-K
+
-Cl
-
 co-transporter (Figure 5-7A) and Na
+
-K
+
-ATPase (Figure 5-7B) labelled the 
numerous in-foldings of marginal cell basolateral membranes. KCNQ1, a component of 
the KCNQ1/KCNE1 potassium channel important for pumping K
+
 into endolymph, was 
expressed at the apical surface of marginal cells (Figure 5-7C). In comparison, 
expression of NKCC1 (Figure 5-7D), Na
+
-K
+
-ATPase (Figure 5-7E) and KCNQ1 
(Figure 5-7F) were comparable in Cx30
–/–
 mice. This suggests that even though 
marginal cell nuclei appeared atypical, expression of certain EP generating components 
appeared normal. Immunofluorescence analysis of other ion channels known to be 
expressed in marginal cells, including the Cl
-
 channel Barttin and H
+
-K
+
-ATPase have 
yet to be tested, although normal expression of the latter has been shown in a separate 
study (Cohen-Salmon et al., 2007). 
Proteins normally expressed in the basal cell layer were also investigated. The 
tight-junction protein Claudin-11 (Figure 5-7G), glucose transporter-1 GLUT-1 (Figure 
5-7H) and Cx26 (Figure 5-7I) were all expressed in Cx30
+/+ 
basal cells. Claudin-11 is 
the only known member of the claudin family found in the basal cell layer and is 
essential for stria vascularis integrity. Loss of claudin-11 in genetically engineered mice 
results in a loss of EP (Gow et al., 2004). In Cx30
–/–
 mice, claudin-11 was expressed in a 
similar fashion to that of Cx30
+/+
 mice (Figure 5-7J), suggesting that the basal cell tight-
junction barrier is intact. GLUT-1 is an important glucose transporter in stria vascularis 
and is expressed in endothelial cells as well as basal cells (Ando et al., 2008). 
Comparable immunofluorescence-labelling was seen between Cx30
+/+
 and Cx30
–/–
 stria 
vascularis (Figure 5-7K). Finally, it is known that gap junctions are present between 
adjacent basal cells, between basal cells and intermediate cells and between basal cells 
and fibrocytes (Forge, 1984). Comparable expression patterns of Cx26 were apparent in 
Cx30
–/–
 mice (Figure 5-7L), indicating that the basal layer is coupled to the underlying 
spiral ligament. Together, these data suggest that most of the proteins involved in 
generating the EP are normal in Cx30
–/–
 mice, and from the markers tested, only Kir4.1 
expression is altered. 
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Figure 5-7. Normal expression of marginal and basal cell markers in Cx30
–/–
 mice.  
(A-F) Marginal cell proteins (green) were labelled with antibodies for NKCC1 (A,D), 
Na
+
-K
+
-ATPase (B,E) and KCNQ1 (C,F). Nuclei were counter-stained with DAPI 
(blue). Expression patterns were comparable between Cx30 wild-type (A-C, +/+) and 
knock-out (D-F, –/–) P38 animals. (G-L) Basal cell proteins (green) were labelled with 
antibodies for claudin-11 (G,J), GLUT-1 (H,K) and Cx26 (I,L). Protein expression was 
similar in Cx30
+/+
 and Cx30
–/–
 basal cells. Scale bars, 20 µm. 
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5.2.3 Endothelial barrier is unaffected in Cx30–/– mice 
5.2.3.1 Tail-vein injection of a fluorescently-tagged bovine serum albumin conjugate  
Disruption of the endothelial barrier of capillaries supplying the stria vascularis 
has been proposed as a mechanism for lack of EP development in Cx30
–/–
 mice (Cohen-
Salmon et al., 2007). Loss of the endothelial barrier would result in leakage of ions and 
proteins into the intrastrial space and would disrupt the specific properties of the 
electrically isolated intrastrial space. Disruption of the ionic composition and potential 
leakage would then cause an electric shunt and a complete loss of EP. However, 
endothelial cells in the stria vascularis do not express Cx26 or Cx30 (Cohen-Salmon et 
al., 2007). Therefore, the following question arises: how does loss of Cx30 cause 
disruption of the endothelial barrier? Firstly, to investigate whether capillaries were 
leaky in our Cx30
–/–
 mice, a different approach to that of Cohen-Salmon et al. (2007) 
was implemented. Fluorescently tagged bovine serum albumin (BSA-FITC) was 
injected into the tail veins of both Cx30
+/+
 and Cx30
–/–
 mice. This protein is normally 
impermeant across the endothelial barrier and has been used elsewhere to investigate the 
leakiness of blood vessels in response to spinal cord injury (Cronin et al., 2008) and 
microvessel permeability in response to endothelin-1 (King-VanVlack et al., 2003). The 
potential for leakage of BSA-FITC into the intrastrial space was investigated. 
Fixed cochleae were dissected and whole-mount strial tissue strips were 
analysed by confocal microscopy. A basal turn strip of tissue from an adult Cx30
+/+
 
mouse showed BSA-FITC fluorescence within the complex network of strial capillaries 
(Figure 5-9A). To detect whether BSA-FITC had leaked into the intrastrial space grey 
level intensities were plotted along a line profile (Figure 5-9B). The grey level peaks 
were sharp and corresponded well to each capillary intersected along the line profile. 
The intrastrial space between capillaries had no detectable amounts of BSA-FITC 
suggesting that the protein did not leak through the endothelial barrier in Cx30
+/+
 mice. 
Equivalent images (Figure 5-9C) and grey level measurements (Figure 5-9D) in Cx30
–
/–
 mice were similar to those of Cx30
+/+
. Grey levels were confined to capillaries, with 
no BSA-FITC detected in the intrastrial space. The images shown were taken from 
tissue fixed prior to dissection. In addition, live strial whole mounts were prepared from 
both Cx30
+/+
 and Cx30
–/–
 mice, which also showed labelling within capillaries and not 
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within the intrastrial space (data not shown). This confirmed that BSA-FITC was not 
washed out of the stria vascularis during the fixation step. 
Cochlear cryosections were also prepared from BSA-FITC injected mice. BSA-
FITC in a basal turn image was confined to the capillaries and was not detected in the 
intrastrial space of Cx30
+/+
 mice (Figure 5-8Ai). The green channel was converted to a 
monochrome image (Figure 5-8Aii) and grey levels plotted along the width of the stria 
(Figure 5-8B). The fluorescent peaks corresponded well with the location of each 
capillary filled with BSA-FITC. In Cx30
–/– 
mice, a similar pattern was found. BSA-
FITC showed no signs of leakage into the intrastrial space (Figure 5-8Ci). A grey-scale 
image of BSA-FITC fluorescence and a line plot of pixel intensity confirmed a lack of 
fluorescence between capillaries (Figure 5-8Cii,D). If BSA-FITC was to leak into the 
intrastrial space, the profile peaks would be expected to appear broader and less sharp, 
indicating fluorescence between capillaries. However, this was not the case in any of the 
samples tested. These data suggest that the endothelial barrier is intact, and thus 
prevents leakage of fluorescently-tagged albumin into the intrastrial space. 
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Figure 5-8. BSA-FITC is confined to capillaries in stria vascularis whole-mounts. 
Adult mice were injected with BSA-FITC into the tail vein. Whole mounts of strial 
tissue were prepared post-fixation. Images are shown in monochrome format. (A) A 
face-on view of a basal turn coil from a Cx30
+/+
 mouse. BSA-FITC (white) was 
strongly present within the capillary network. (B) Grey levels plotted from the red line 
in (A) reveal tall, sharp peaks corresponding to each capillary cross-section. There was 
no fluorescence in the intrastrial space. (C) Basal turn stria from a Cx30
–/–
 mouse 
showed no obvious signs of leakage into the intrastrial space. (D) A line profile plot 
corresponding to (C) confirms that BSA-FITC was confined to strial capillaries. There 
was no detectable leakage into the intrastrial space. Grey levels were measured up to a 
maximum of 256 from an 8-bit image. Scale bars, 50 µm. 
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Figure 5-9. BSA-FITC is confined to capillaries and does not leak into the 
intrastrial space.  
Cochlear cryosections were obtained from adult mice. Each mouse was injected with 
FITC-conjugated bovine serum albumin (BSA-FITC, green) into their tail vein. (Ai) A 
basal turn section from a wild-type (+/+) mouse labelled for Cx30 (red) and nuclei 
(blue). BSA-FITC was confined to the strial capillaries. To quantify, the BSA-FITC 
channel was converted into monochrome (Ai) and grey level intensity measured along a 
line profile passing through each capillary (B). Peaks correspond to each capillary. 
There was no detectable fluorescence between capillaries. (Ci) A Cx30
–/–
 section, 
negative for Cx30 labelling (lack of red fluorescence), showed bright BSA-FITC 
fluorescence within strial capillaries. (Cii) Monochrome image used to detect grey 
levels (D) showed no leakage of BSA-FITC into the intrastrial space. Fluorescence was 
confined to sharp peaks corresponding to each capillary cross-section. Grey levels were 
measured up to a maximum of 256 from an 8-bit image. Scale bars, 20 µm. 
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5.2.3.2 Loop diuretic injection induces intrastrial oedema 
The data presented here seem at odds with the results of Cohen-Salmon et al. 
(2007). Therefore, it was decided to assess strial blood vessel permeability from an 
additional approach. Adult Cx30
+/+
 and Cx30
–/–
 mice were treated with a loop diuretic 
(bumetanide) via intraperitoneal injection. Loop diuretics cause an acute swelling 
(oedema) within the intrastrial space (Santi and Duvall, III, 1979), by blocking the 
NKCC1 transporter found in the basolateral surface of marginal cells (Crouch et al., 
1997; Azuma et al., 2002). Na
+
 ions accumulate in the intrastrial space since NKCC1 is 
the only ion transporter responsible for Na
+
 uptake into marginal cells (Wangemann and 
Schacht, 1996). The working hypothesis for this experiment suggests that if the 
endothelial barrier is intact, as it is in Cx30
+/+ 
mice, then ions will accumulate within the 
intrastrial space. In contrast, if the endothelial barrier is disrupted in Cx30
–/–
 mice then 
ions and solutes would be able to dissipate into the vasculature, thus preventing an 
oedema.   
TEM (prepared by G. Neville and A. Forge) images from a basal turn Cx30
+/+
 
mouse injected with a saline control, showed normal strial morphology (Figure 5-10A). 
The intrastrial space was not visible due to the tight compaction of marginal and 
intermediate cell processes. After treatment with bumetanide, numerous fluid-filled 
spaces (oedema) appeared within the stria vascularis (Figure 5-10B). TEM images from 
a basal turn Cx30
–/– 
mouse showed characteristic morphologies such as a thinning of 
stria vascularis and abnormal marginal cell nuclei (Figure 5-10C), as reported above. 
Bumetanide injection into a Cx30
–/–
 mouse also caused oedema in the intrastrial space 
(Figure 5-10D). Numerous fluid-filled spaces were apparent between marginal and 
intermediate cells. These data further suggest that the endothelial barrier is intact in the 
Cx30
–/–
 mice. 
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Figure 5-10. Loop diuretic injection causes intrastrial oedema in both Cx30
+/+
 and 
Cx30
–/–
 mice. 
(A) TEM micrograph of basal turn stria vascularis from an adult Cx30
+/+ 
mouse. 
Projections from marginal cells (mc) and intermediate cells (ic) were interwoven and 
packed tightly within the intrastrial space and around capillaries (cap). bc, basal cells. 
(B) Intraperitoneal injection of a loop diuretic (bumetanide) caused oedema in the 
intrastrial space, noticeable as white spaces between marginal and intermediate cell 
processes (black arrows). (C) TEM micrograph of a Cx30
–/–
 basal turn stria. Notice that 
the marginal cell nuclei are abnormal in shape and the strial compartment is thinner than 
the wild-type counterpart. (D) Administration of bumetanide also caused oedema within 
the intrastrial space in a similar fashion to wild-type (black arrows). Tissue preparation 
for EM imaging was carried out by G. Neville and A. Forge. Scale bars, 5 µm. 
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5.2.4 Disrupted epithelial repair in Cx30–/– mice 
In addition to the abnormalities described in the stria vascularis, an unusual 
pathology of the sensory epithelium was observed in aged Cx30
–/– 
mice. Supporting 
cells play a vital role in the repair and maintenance of the epithelium in response to hair 
cell death. In the organ of Corti, chronic aminoglycoside treatment causes the hair cell 
body to degenerate within the epithelium. In response, the supporting cells expand to 
close the space once occupied by the hair cell. During this process, an apical fragment 
of the hair cell is retained within the reticular lamina to maintain epithelial integrity. 
Only when supporting cells have expanded and formed new tight junctions is the apical 
fragment released into the scala media. This mechanism occurs through a controlled 
process that enables maintenance of the permeability barrier during structural 
reorganisation (Forge, 1985; McDowell et al., 1989; Raphael and Altschuler, 1991; Li 
et al., 1995; Ahmad et al., 2007). 
The epithelial repair process in Cx30
–/–
 mice appears to be defective, but still 
maintains an epithelial boundary. Cryosections of adult Cx30
–/–
 cochleae showed a 
continuous epithelium of cells growing on the surface of the tectorial membrane from 
the attachment point after the third row of outer hair cells to the base of Reissner’s 
membrane as early as P38 (Figure 5-11Ai-iii). By 8-months, the area below the ectopic 
epithelium was swollen and the majority of the organ of Corti was degenerated, except 
for the structure of inner and outer pillar cells. In addition, the epithelial cells 
surrounding the tectorial membrane expressed Cx26, whereas the rest of the outer 
sulcus supporting cell network had little discernable Cx26 labelling (Figure 5-11Bi-iii). 
Thin sections of older cochleae revealed a progressive pathological effect that worsens 
with age. A control section from a 15-month old Cx30
+/–
 mouse showed a normal 
cochlear morphology with an intact tectorial membrane and supporting cell epithelium 
(Figure 5-11C). In contrast, an age-matched Cx30
–/–
 section showed engulfment of the 
tectorial membrane, severe swelling and detachment of the supporting cell epithelium. 
Only the pillar cells remained attached to the basement membrane (Figure 5-11D). 
Additionally, a cochlear section from a 16-month old Cx30
–/–
 mouse is shown as an 
example of a worsening phenotype (Figure 5-11E). The supporting cells appeared to 
scale Reissner’s membrane, enclosing the tectorial membrane in a large cyst-like 
compartment. Again pillar cell remnants were left attached to the basement membrane. 
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These data suggest an important role for Cx30 in the maintenance of the sensory 
epithelium and in regulating repair after hair cell loss. In mice lacking Cx30 protein, it 
appears that the repair of the epithelium is abnormal, leads to engulfment of the tectorial 
membrane and the formation of a cyst-like compartment within the extracellular space 
of supporting and organ of Corti cells.   
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Figure 5-11. Degenerative response in the Cx30
–/– 
organ of Corti.  
Basal turn cochlear cryosections from P38 (A) and 8-month (B) old Cx30
–/–
 mice. Basal 
turn thin sections from 15-month old Cx30
+/–
 (C), 15-month old Cx30
–/–
 (D) and 16-
month old Cx30
–/–
 (E) mice. (Ai) Nuclei were stained with DAPI (blue). (Aii) DIC 
image showing Reissner’s membrane (rm), tectorial membrane (tm), inner sulcus (is) 
and organ of Corti (oc). (Aiii) Merged image showed an abnormal epithelial growth 
from the attachment point of tectorial membrane to organ of Corti (open arrow), over 
the tectorial membrane and towards the attachment point of Reissner’s membrane. (Bi) 
Cryosection was immunolabelled for Cx26 (green). (Bii) Corresponding DIC image. 
(Biii) Merged image with DAPI (blue) channel showed a more severe epithelial 
pathology and a Cx26-expressing epithelium (closed arrow) had grown over the 
tectorial membrane (open arrow). In addition, the organ of Corti appeared degenerated, 
with only pillar cell (pc) remnants and a swelling of the extracellular space (asterisk). 
(C) A basal turn of a Cx30
+/–
 mouse showed normal morphology and an intact tectorial 
membrane. (D) Abnormal epithelial growth (open arrow) and oedema (asterisk) in an 
age-matched Cx30
–/–
 mouse. Pillar cell remnants were visible. (E) A Cx30
–/– 
basal turn 
showed an even more severe phenotype. Epithelial cells appeared to have scaled the 
Reissner’s membrane, enclosing the tectorial membrane and leaving pillar cell 
remnants. Scale bars, 20 µm. 
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5.3 Discussion 
The data presented in this chapter indicates a disruption of homeostasis in the 
Cx30
–/–
 stria vascularis. Thinning of the tissue, abnormal marginal cell nuclei and down-
regulation of the potassium channel Kir4.1 were apparent within the first week of 
hearing onset. Expression of other proteins important in the development and 
maintenance of EP were normal. In addition, and in contrast to a paper published by 
Cohen-Salmon et al. (2007), we found no evidence of capillary leakage in Cx30
–/–
 stria 
vascularis. An abnormal pathology in the epithelial region of the organ of Corti was also 
found in aged Cx30
–/–
 mice, which has not been reported previously. These differences 
and pathologies are discussed below. 
5.3.1 Abnormalities in the stria vascularis of Cx30–/– mice indicate retarded 
developmental 
5.3.1.1 Morphological differences in Cx30–/– stria vascularis 
Thinning of stria vascularis has been shown in several cochlear pathologies and 
mutant mouse models. Taylor et al. (2008) have shown a thinning of stria in response to 
kanamycin-bumetanide treatment and suggest this is due to a reduction of marginal cell 
infoldings and apoptotic cell death (Taylor et al., 2008). This has also been shown for 
chronic aminoglycoside treatment (Forge et al., 1987) and with ageing (Spicer and 
Schulte, 2005). In addition, mouse (Steel and Barkway, 1989) and rat (Kitamura et al., 
1994) models of deafness caused by melanocyte/intermediate cell defects have reduced 
or no EP and a thinner stria vascularis. A more recent study  of a mouse model of 
secondary hypothyroidism has also demonstrated a thinning of stria vascularis, 
reduction of Kir4.1 and reduced EP in mice (Mustapha et al., 2009). Thus, strial thinning 
and/or reduction in Kir4.1 levels are associated with hearing loss.  
During early stages of stria vascularis development, immature marginal cells are 
evident by the lack of processes projecting into the intrastrial space and by the rounded 
nuclei within the cell body. As marginal cells mature, basal projections gradually extend 
outwards into the intrastrial space and nuclei flatten at the apical surface (Steel and 
Barkway, 1989; Souter and Forge, 1998). Here, detailed analysis of the dimensions of 
marginal cell nuclei revealed a significant number in Cx30
–/–
 animals were rounded in 
shape in comparison to flat or plano-concave nuclei in age-matched wild-types. This 
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phenotype suggests that marginal cells may not mature fully in the Cx30
–/–
 mouse. 
Abnormal nuclei were noticed both in the younger (P17-P19) and older aged groups 
(P38-P51), yet cells expressed normal marginal cell proteins (including NKCC1, Na,K-
ATPase and KCNQ1) in both genotypes. Marginal cells are not predicted to 
malfunction in Cx30
–/–
 mice since the endolymphatic [K
+
](e) develops normally, and are 
unlikely to be responsible for the absence of EP. Further work, including measurements 
of strial cell numbers, volume fractions and fractions of unit area, determined by 
electron microscopy, would be useful for determining changes in cell structure (Forge et 
al., 1987). 
5.3.1.2 Reduced Kir4.1 expression and loss of EP  
Data here suggests a reduction, though not complete loss of Kir4.1 mRNA and 
protein in the stria vascularis. Since Kir4.1 channels are required for generating the high 
intrastrial potential across the intermediate cell membrane (Takeuchi et al., 2000), 
reduction in this protein may account for the lack of EP in Cx30
–/–
 mice. Expression of 
Kir4.1 in intermediate cells increases significantly at P7-P8 in mice and coincides with 
the onset and rise of EP (Hibino et al., 1997). Incidentally, [K
+
]e has already reached 
adult levels by this stage (Bosher and Warren, 1971), indicating that the initial supply of 
K
+
 required for development of endolymph may not be dependent on Kir4.1. In the early 
stages of development (up to P7), marginal cells express the necessary K
+
 transport 
proteins, such as Na
+
-K
+
-ATPase, to continuously transfer K
+
 into endolymph (via 
KCNQ1/KCNE1 channels). Concurrently there is a steep rise in [K
+
]e. The source of K
+
 
for this process is predicted to be the perilymph (Marcus, 1986). Thus, in the early 
stages of development, marginal cells are comparable to vestibular dark cells, which are 
not part of an EP generating compartment and obtain K
+
 from perilymph. The 
differences between marginal cells and dark cells arise when intermediate cells, 
capillaries and basal cells all migrate into position and undergo maturation to form a 
sealed compartment with marginal cells, consisting of tight junctions between basal 
cells and between endothelial cells. Tight junction formation between basal cells  and 
between endothelial cells begins ~P7 and isolates the intrastrial space from perilymph 
and the lumen of capillaries – a process essential for EP generation (Souter and Forge, 
1998). Consequently, the basal surfaces of marginal cells become isolated from 
perilymphatic fluid and are likely to require K
+
 from an alternative source.  
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During the latter stages of cochlear development and once the high [K
+
]e is 
reached around P7 (Bosher and Warren, 1971; Yamasaki et al., 2000), the EP is 
generated by expression of Kir4.1 in intermediate cells (Hibino et al., 1997), sealing of 
basal cell tight junctions, and formation of gap junctions (Souter and Forge, 1998). 
These processes permit generation of the EP whilst also permitting K
+
 recycling from 
the spiral ligament. In addition, Kir4.1 channels now supply K
+
 to marginal cells. 
Therefore, if the main source of K
+
 in the adult mouse is from K
+
 recycling via gap 
junctions and Kir4.1 channels, then a reduction of Kir4.1 in Cx30
–/–
 mice can account for 
the lack of EP. This may also explain the reduction of [K
+
]e in adult Cx30
–/–
 mice, as 
described by Teubner et al. (2003). In agreement, Kir4.1
–/–
 mice have a complete loss of 
EP and a partial, but not complete reduction in [K
+
]e (Marcus et al., 2002).  
The reason for a reduction of Kir4.1 in Cx30
–/–
 intermediate cells is not known. 
Recent studies have shown that mutation or loss of Cx30 leads to differences in the 
permselectivity of gap junction channels in the cochlea. In particular, one study (Chang 
et al., 2008) showed that intercellular transfer of a fluorescent, non-metabolizable D-
glucose analogue (2-NBDG) was impaired in Cx30
–/–
 mice. Similar decreases of 
glucose transfer were also seen with 1-octanol (a non-specific gap junction blocker). 
The authors suggest that functional Cx26/Cx30 gap junctions are required for efficient 
transfer of glucose from blood vessels into the supporting cell syncytium. In addition, 
the same study also showed that glucose deficiency resulted in an increase of reactive 
oxygen species (ROS) in Cx30
–/–
 mice. Therefore, the loss of Cx30 might also affect the 
extent of glucose transfer between strial cells (basal and intermediate) that are coupled 
by gap junctions in Cx30
+/+
 mice. As well as deficiencies in glucose transport, the 
metabolic coupling of second messengers involved in lateral wall development may be 
impaired. Ca
2+
 wave propagation or IP3 transfer have not been investigated in lateral 
wall tissue. Therefore, it would be beneficial to investigate whether these signalling 
pathways are required for normal lateral wall development/reorganisation and whether 
these processes are altered in Cx30
–/–
 mice. 
There remains the possibility that intermediate cells are coupled by gap 
junctions to endothelial cells or pericytes in the stria vascularis (Takeuchi and Ando, 
1998a), although this has been questioned by Cohen-Salmon et al. (2007) who did not 
find dye transfer between intermediate/basal cells and endothelial cells. If the former is 
true then Cx30 could have a role in forming gap junction channels between capillary 
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cells, which may be important for intermediate cell maturation and Kir4.1 expression. If 
this is the case then it also raises the question as to why Cx26 cannot compensate for the 
loss of Cx30 in Cx30
–/–
 mice. Both isoforms belong to the beta family of connexins and, 
as a result, would be expected to bind to similar connexin subtypes within the same 
family. One explanation could be that Cx30 has unique properties in respect to binding 
to an unknown connexin subtype in endothelial cells. These cells have been shown to 
express Cx45 with increasing expression from birth into adulthood (Cohen-Salmon et 
al. 2004). Whether Cx30 hemichannels could form heterotypic gap junctions with 
endothelial hemichannels such as Cx45 is unknown. This theory is unlikely, however, 
since both connexins belong to different connexin families (Cx45, gamma; Cx30, beta) 
and, to date, there is no evidence of cross-over between connexin families. 
5.3.2 Endothelial barrier breakage theory 
The differences seen here compared to the publication by Cohen-Salmon et al. 
(2007) could be due to differences in the experimental techniques used. Cohen-Salmon 
et al. detected IgG and albumin in the Cx30
–/–
 stria vascularis with immuno-labelling 
after cardiac perfusion of PBS and 4% paraformaldehyde (PFA). It has been shown that 
the process of cardiac perfusion can cause an imbalance in the normal pressures within 
the vasculature, which may lead to tissue damage (Ohno et al., 2006). In particular, one 
study has shown leakage from blood vessels and variable albumin diffusion artefacts as 
a consequence of artificial perfusion pressures during fixation (Shi et al., 2011). Thus, 
the method of intracardiac perfusion used by Cohen-Salmon et al. (2007) may have led 
to a disruption of the endothelial barrier during the wash stage prior to fixation. Leakage 
of IgG and albumin into the extracellular space could have been directed by two factors 
during the perfusion-fixation step. Firstly, the change in normal capillary pressure may 
have damaged the endothelial barrier, thus enabling it to become leaky. Secondly, the 
continuous pumping of fluid, and likely high pressures incurred, may exacerbate the 
movement of both IgG and albumin through the damaged endothelial barrier into the 
intrastrial space prior to fixation. The differences seen between wild-type and Cx30
–/–
 
mice in the earlier study could be due to differences in perfusion-pressures between 
experiments and/or between different animals used. The same principle could also apply 
to the cardiac-perfused fixations used for EM processing, where the authors reported 
damage of endothelial cell tight junctions. 
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 BSA-FITC injections into the vasculature have been used elsewhere to 
investigate blood vessel permeability (Cronin et al., 2008). This technique was applied 
here as an alternative method for investigating the theory of endothelial breakage in 
Cx30
–/–
 mice. In the present study, the fixation (4% PFA) was carried out by gentle 
cochlea perfusion through the round/oval windows immediately after the animal’s death 
followed by immersion in fixative for a further hour. Therefore, the pressure within 
strial capillaries was not altered in a way that might cause damage to the endothelial 
barrier. BSA-FITC was detected only within the capillaries of whole-mounts and 
cryosections of both genotypes. This would suggest that if BSA-FITC had leaked into 
the intrastrial space, it would have been readily detected. Additionally, live, unfixed 
strial tissue from mice injected with BSA-FITC showed bright fluorescence within strial 
capillaries, but not in the intrastrial space of either genotype (data not shown). Also, 
tight junctions between strial endothelial cells viewed by TEM were not disrupted in 
Cx30
–/–
 mice (data from A. Forge, not shown). 
The issue of capillary leakage was approached with a further alternative 
technique. Injection of a loop diuretic (Bumetanide) into normal mice has been shown 
to cause an oedema within the intrastrial space (Santi and Duvall, III, 1979), by 
blocking the function of marginal cell NKCC1 transporters. Oedema forms because the 
intrastrial compartment is structurally isolated from the lumen of blood vessels, 
perilymph and endolymph. If the endothelial barrier was disrupted in Cx30
–/–
 mice it 
would be expected that the oedema would dissipate through the damaged blood vessel 
barrier and not accumulate in the intrastrial space. Results here demonstrate that oedema 
occurs in both Cx30
+/+
 and Cx30
–/–
 mice, adding further evidence for an intact 
endothelial barrier.  
It is unclear in the publication by Cohen-Salmon et al. (2007) as to how gap 
junction dysfunction can result in damage to the endothelial barrier. They report high 
levels of homocysteine in Cx30
–/–
 stria vascularis and suggest that this may cause 
endothelial damage. Cx26 and Cx30 are not expressed in strial endothelial cells. 
Therefore, the question arises as to how does the down-regulation of one connexin 
result in endothelial damage? The authors propose that Cx30 normally forms 
hemichannels (presumably in the intermediate or basal cell layers) and that a loss of 
Cx30 hemichannels may cause an osmotic imbalance, leading indirectly to an increase 
in homocysteine. These theories are somewhat ambiguous considering there has been 
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no evidence to suggest Cx30-hemichannels exist in the stria vascularis, and secondly, 
that Cx30-hemichannels should be closed under physiological conditions (Valiunas and 
Weingart, 2000). The authors do note however, that the mechanism requires further 
exploration. Results presented in this chapter argue against this mechanism as the cause 
of EP loss, and that further experiments are required to discover whether functional 
connexin hemichannels exist in the stria vascularis. 
5.3.3 The epithelial barrier and repair in Cx30–/– mice 
In unison with defects in the stria vascularis, it is conceivable that the loss of EP 
and death of hair cells are aided by a disrupted epithelial barrier separating perilymph 
from endolymph. Cx30 is known to be the predominant connexin expressed in Deiters’ 
cells and is the only region in the cochlear duct where Cx26 does not significantly co-
localise with Cx30 (Sun et al., 2005; Jagger and Forge, 2006). Studies here have 
identified an abnormal growth of epithelial cells from the Hensen’s cell region to the 
Reissner’s membrane attachment point. In conjunction with this abnormal pathological 
growth, which ensheathes the tectorial membrane and presents with swelling of the 
underlying epithelium, we found a reduction of Kir4.1 expression in Cx30
–/– Deiters’ 
cells. Whether this reduction is a direct result of Cx30 loss or a secondary effect of hair 
cell loss and epithelial repair is currently unknown. It will be important to determine 
whether Kir4.1 expression ever reaches mature levels in Cx30
–/– Deiters’ cells (i.e. at the 
age of hearing onset) or whether reduction of the potassium channel occurs before hair 
cell death, or as a consequence of hair cell death. Investigation of Kir4.1 channel activity 
was attempted with the whole-cell patch clamp method. However, due to difficulties in 
obtaining intact Deiters’ cells from aged cochleae and time constraints, these studies 
were unsuccessful. Work in our lab is on-going with regard to these queries.  
The apparent down-regulation of Cx26 in outer sulcus supporting cells in older 
Cx30
–/–
 animals suggests that Cx30 might have an important role in regulating the life 
cycle of Cx26 channels. This agrees with a previous report that showed ~3-fold 
reduction of Cx26 protein levels in Cx30
–/–
 mice (Ahmad et al., 2007). The authors 
suggest that reduced availability of gap junctions may hinder the K
+
 recycling pathway 
or intercellular movement of other molecules important for cell survival. This could also 
explain why the older Cx30
–/–
 mice formed cyst-like compartments below the ectopic 
epithelium. A reduction of Kir4.1 and lack of gap junction channels may result in an 
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accumulation of ions as a result of impaired homeostasis. In regard to this finding, 
future experiments will need to address whether the regulation of integrins, tight 
junction proteins, such as ZO-1, and other supporting cell markers important for cell 
adhesion and/or differentiation differ in the epithelium of Cx30
–/–
 mice. 
 
5.4 Conclusion 
The data described in this chapter present novel mechanisms for deafness and 
lack of EP in the Cx30
–/–
 mouse. Abnormalities including irregular shaped marginal cell 
nuclei, thinning of the stria vascularis and reduced expression of Kir4.1 are most likely 
due to retarded development of the strial tissue. Marginal and basal cells expressed 
known protein markers important for EP generation, suggesting that the main 
developmental defect occurs within the intermediate cell. Although not shown in other 
Cx30
–/–
 studies, these data suggest that Cx30 is important for stria vascularis maturation. 
In addition, an abnormal epithelial growth that encompass the tectorial membrane and 
leads to formation of cyst-like compartments has been identified in aged Cx30
–/– 
mice, 
suggesting a role for Cx30 in epithelial repair. In contrast to a publication by Cohen-
Salmon et al. (2007), capillary leakage in Cx30
–/– 
stria was not observed here. This 
theory was investigated with two different approaches; injection of fluorescently-tagged 
BSA to visualise possible leakage and loop diuretic injection to induce oedema. Both 
techniques suggested that the Cx30
–/–
 strial endothelial barrier was intact. 
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6 GENERAL DISCUSSION 
This thesis has investigated the functions and properties of Cx26 and Cx30 using 
three experimental systems: in vitro studies to investigate the trafficking properties of 
Cx26 and Cx30; in situ studies to investigate GJIC during lateral wall development and 
in vivo studies to investigate the role of Cx30 in stria vascularis development. To fully 
understand the pathogenic effects of clinical connexin mutations, it is essential to 
elucidate the life-cycle, functions and properties of these proteins in cellular physiology. 
Since Kanno and Loewenstein first identified direct cell-to-cell communication over 
four decades ago (Kanno and Loewenstein, 1964a; Kanno and Loewenstein, 1964b), 
research in the field of connexins and gap junction biology has increased rapidly – and 
especially since connexin mutations were first associated with human disease. Gap 
junctions in the cochlea are predicted to play a role in electrical coupling, biochemical 
coupling, K
+
 buffering and K
+
 recycling. In addition, hemichannels are suggested to 
enable the release of second messengers required for organ of Corti development 
(Tritsch et al., 2007). In the mature cochlea, Cx26 and Cx30 are the predominant 
connexins expressed in the epithelial and connective tissue gap junction networks 
(Forge et al., 2003a). Mutations in these two subtypes account for most of the inherited 
cases of hearing loss, yet the exact mechanisms and functions underlying the disease 
phenotype are not clear.  
6.1 Divergent Cx26 and Cx30 trafficking pathways: a mechanism for 
asymmetric coupling? 
Gap junctions in cells engineered to express both Cx26 and Cx30 have different 
dye tracer permeabilities in comparison to those in cells expressing Cx26 (Marziano et 
al., 2003). In addition, gap junctions composed of Cx26/Cx30 heterotypic and/or 
heteromeric channels in organ of Corti supporting cells have electrically and chemically 
rectifying functions, which is proposed to lead to asymmetric current flow between 
supporting cells (Zhao and Santos-Sacchi, 2000; Zhao, 2000). This hypothesis is 
supported by selective dye transfer through medial and lateral compartments within the 
mature supporting cell syncytium (Jagger and Forge, 2006). This compartmentalisation 
is proposed to result from differential expression of Cx26/Cx30 heteromeric channels 
and Cx26 homotypic gap junctions in distinct regions of the supporting cell network. 
Therefore, the precise intermixing of connexins may be regulated so that 
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homotypic/heterotypic and/or heteromeric gap junctions are formed to direct current or 
biochemical intercellular transfer in a particular direction in the cochlea. Selective 
coupling has been shown to occur in other systems, such as glial cells of the central 
nervous system, which feature heterotypic gap junctions between different cell types 
(e.g. astrocytes and oligodendrocytes). These cell types express different connexin 
subtypes and it is this complexity that is thought to enable asymmetric coupling (Zahs, 
1998).  
Most of the cells within the epithelial and connective tissue gap junction networks 
of the cochlea express both Cx26 and Cx30. Therefore, intracellular regulatory 
mechanisms are likely required to produce specific heterotypic configurations for 
permselectivity and/or directional coupling. Regulating the trafficking pathways 
through specific organelles may be an evolutionary mechanism that permits or prevents 
connexin inter-mixing. Cx30 trafficking appears to be insensitive to the Golgi 
disrupting drug BFA, suggesting Cx30 can reach the plasma membrane independently 
of the Golgi apparatus. During the course of this study similar results have been 
reported elsewhere (Qu et al., 2009). These authors also suggest that Cx30 delivery and 
anchoring to the PM is dependent on actin, rather than microtubules. It is proposed that 
trafficking along actin cables could allow direct delivery of Cx30 from the endoplasmic 
reticulum to the PM. 
There remains the possibility that Cx30 acts as a stabilising connexin, with an 
unusually long half-life at the PM. This seems unlikely though, since connexins 
generally have characteristically quick turn-over rates (Laird, 2006). However, data 
published elsewhere suggests that loss of Cx30 leads to unstable Cx26-containing gap 
junctions and an overall reduction in Cx26 protein (Ahmad et al., 2007). Cx30 could, 
therefore, act in the cochlea by exerting a longer half-life on Cx26 at the PM.  
In the current study Cx26, in contrast to Cx30, was sensitive to BFA treatment, 
suggesting that it requires a functional Golgi apparatus for correct transport to the PM. 
In agreement with these data, a previous study has shown that Cx26 trafficking is 
dependent on a functional Golgi apparatus in transfected BICR-M1Rk cells (Thomas et 
al., 2005). In contrast, as discussed in chapter 3, Cx26 has also been suggested to traffic 
via a Golgi-independent pathway in transfected HeLa and COS-7 cells (Martin et al., 
2001a). These conflicting results may represent direct examples of intracellular 
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regulation due to variability in conditions and cell types used. Regulation of Cx26 
trafficking in cochlear cells deserves further study. 
It is known that supporting cells and fibrocytes have intracellular mechanisms that 
permit both intermixing of Cx26 and Cx30 because heteromeric configurations have 
been detected using immunofluorescence co-localisation, immuno-gold labelling, co-
immunoprecipitation, electrophysiology recordings, fluorescence resonance energy 
transfer (FRET) and dye permeability studies (Ahmad et al., 2003; Forge et al., 2003b; 
Jagger and Forge, 2006; Yum et al., 2007). Accordingly, separate trafficking pathways 
may also exist to prevent or reduce heteromeric connexon formation to maintain 
expression of some homotypic gap junctions. This novel mechanism could be similar to 
that of CD45 trafficking (as discussed in 3.1.2) which has been shown to occur both 
conventionally (through the Golgi) and non-conventionally (bypassing the Golgi) 
(Baldwin and Ostergaard, 2002). 
6.2 Dye-coupling in the lateral wall supports a role for K+ recycling 
Data in this thesis has demonstrated compartmentalised GJIC in the lateral wall of 
rat cochlear slices as early as P2. From this stage onwards there is a rapid increase in 
connexin expression and gap-junctional coupling between type I, II and V fibrocytes. 
The connective tissue gap junction network appears to largely mature by P7, as shown 
by extensive dye spread throughout lateral wall fibrocytes and basal cells. In addition, 
intermediate cells are coupled to basal cells and are identifiable by Kir4.1 expression at 
this stage (Hibino et al., 1997; Kelly et al., 2011). These data suggest that the 
connective tissue gap junction network matures several days in advance of hearing onset 
and is capable of re-circulating K
+
 for secretion by intermediate cells as early as P7.  
During earlier stages of development (from birth to P7), marginal cells are 
comparable to vestibular dark cells and continuously pump K
+
 into endolymph. The 
source of K
+
 during these early developmental stages and before strial maturation is 
predicted to be from perilymph (Marcus, 1986). However, it is also possible that 
compartmentalised regions of GJIC may act as a source of K
+
 ions for marginal cells 
before formation of the sealed stria vascularis unit, which may coincide with a gradual 
increase of Kir4.1 expression in developing intermediate cells. The temporal expression 
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of Kir4.1 in developing intermediate cells requires further study to elucidate a role in 
providing K
+
 to marginal cells in early developmental stages (<P7). 
Once tight junctions begin to form between basal cells, and Kir4.1 expression is 
upregulated (P7 onwards), EP generation advances to adult levels. At this stage, 
marginal cell access to perilymph is restricted and likely requires the gap junction 
network to provide a direct route of K
+
 to intermediate cells. Our observations that the 
lateral wall GJIC pathway appears to largely mature by P7, and that intermediate cells 
are identifiable by Kir4.1 expression, both suggest that endolymphatic K
+
 could be 
derived from the connective tissue gap junction network well in advance of hearing 
onset. Therefore, the lateral wall would be competent to receive and buffer K
+
 derived 
from the supporting cells when that pathway is activated by air-borne sound (~P12). It 
would be beneficial to visualise these K
+
 transport pathways in cochlear slices with K
+
 
sensitive dyes and/or K
+
-selective electrodes, however these techniques are not yet 
available or are not yet precise enough to record such phenomena.  
6.3 Cx30 is essential for cochlear physiology, strial maturation and 
EP generation             
Recent studies and data in this thesis confirm that Cx26 and Cx30 are required for 
cochlear development and homeostasis and that the loss of one connexin cannot 
compensate for the other. Conditional Cx26 knockout and transgenic mice have 
impaired organ of Corti development in association with hair cell death (Inoshita et al., 
2008; Sun et al., 2009; Wang et al., 2009). In contrast, Cx30-null mice appear to have 
normal organ of Corti development up to the age of hearing onset, but impaired stria 
vascularis and EP development. The changes described suggest a role for Cx30 in strial 
maturation and also K
+
 recycling. Loss of Cx30 disrupts the normal expression of Kir4.1 
in intermediate cells and prevents generation of the EP (as measured by Teubner et al., 
2003b).  
Due to the extensive serial arrangement of gap junctions and the expression of K
+
 
transporters and channels in discrete regions of the cochlea, it is not surprising that a 
potassium recycling pathway is a popular hypothesis in cochlear physiology (Kikuchi et 
al., 2000; Wangemann, 2002; Hibino and Kurachi, 2006). However, some studies now 
suggest roles for gap junctions other than in K
+
 recycling. One such study proposes that 
184 
 
 
lack of glucose and biochemical transport in Cx30
–/–
 mice is the major cause of hearing 
loss (Chang et al., 2008). The authors suggest that there is no difference in the 
transjunctional whole-cell currents between Claudius/outer sulcus cells in Cx30
+/+
 and 
Cx30
–/–
 mice, which is understandable since any wild-type gap junction channel can 
pass K
+
 ions and Cx26 homotypic channels are known to still exist in the absence of 
Cx30. Although the electrical coupling of Claudius/outer sulcus cells appears to be 
normal in Cx30
–/–
 mice, the same cannot be said for Deiters’ cells. Cx30 expression is 
dominant in these cells (Jagger and Forge, 2006) and only 5% of their gap junctions 
show Cx26 co-labelling (Sun et al., 2005). These authors did not carry out electrical 
recordings from this region; it will be important to determine whether the ionic coupling 
of Deiters’ cells is different between Cx30+/+ and Cx30–/– animals. A loss of Cx30 in 
these cell types may be detrimental to cochlear physiology and may explain the 
degeneration and swelling of the organ of Corti in aged Cx30
–/–
 mice. K
+
 buffering and 
recycling may be affected predominantly in Deiters’ cells, which may lead to an 
accumulation of K
+
 ions and homeostatic (e.g. osmolarity) deficits. The role of 
aquaporins in supporting cells during this process has not been investigated, but will be 
of interest for future studies. 
One interesting question that arises from the study by Chang et al. (2008), is 
whether the permeability of glucose is determined by connexin subtype? The 
fluorescent glucose analogue (2-NBDG) used in that study has a molecular weight of 
342 Da. This is only slightly larger than Neurobiotin
TM
 tracer (MW = 287 Da), which is 
known to permeate Cx26 and Cx30 homotypic, as well as heteromeric, gap junctions. 
Data suggests that in the absence of Cx30, 2-NBDG is less-permeable through 
remaining Cx26 homotypic gap junctions. It would be of interest to determine whether 
specific connexin subtypes regulate the permeability of glucose. Future studies could 
investigate 2-NBDG transfer in HeLa cells stably expressing Cx26 and/or Cx30 to 
determine their relative permeabilities. 
Though evidence for functional Cx26/Cx30 gap junction channels in the 
regulation of biochemical transport now seems compelling (Beltramello et al., 2005), it 
does not rule out a parallel role in K
+
 recycling. Biochemical coupling through gap 
junctions, or possibly hemichannels, may be essential for cochlear development and cell 
survival, but in addition, gap junctions are also likely to act both in a K
+
 buffering and 
recycling syncytium. Transgenic mouse lines that specifically disrupt spiral ligament 
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fibrocytes support a K
+
 recycling role for the connective tissue gap junction system. For 
example, deficiency of the transcription factor Brn-4 expression in type I, II, III and V 
fibrocytes leads to profound deafness and a dramatic reduction of EP (Minowa et al., 
1999). Severe ultrastructural alterations and atrophy of fibrocytes, coupled with a 
reduction of Cx26 is proposed to disrupt GJIC specific to the lateral wall (Minowa et 
al., 1999; Xia et al., 2002). In addition, mice lacking Tbx18, a transcription factor 
expressed in mesenchymal fibrocytes, are profoundly deaf and do not have an EP. The 
authors propose that defective differentiation of fibrocytes, coupled with a resultant loss 
of Cx26 expression, interferes with strial generation and K
+
 recycling through the 
connective tissue gap junction network (Trowe et al., 2008). However, direct evidence 
of K
+
 flux through the epithelial and subsequently through the connective tissue gap 
junctions systems is lacking. Novel experimental techniques will be required to 
conclusively show a role for gap junctions in K
+
 recycling.  
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